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CHAPTER I 

INTRODUCTION 
1. Perspective. 
The association with a wide variety of malignancies 1n their Infected 
hosts has gained RNA tumor viruses the particular attention of cancer 
research ever since their discovery (Rous, 1911). Over the course of 
decades, animal systems were developed which allowed the demonstration of 
a causal relationship between virus and cancer. The introduction of tissue 
culture techniques and the advent of molecular biology quickly led to the 
accumulation of a vast body of mostly descriptive knowledge; but 1t was 
not until the early IQBO's that these newly gained Insights would reveal 
certain aspects of the mechanisms by which RNA tumor viruses transform 
normal cells (Weiss et al., 1984). 
For a long time, 1t was hoped that the association of retroviruses 
with tumorigenesis in animals might be extrapolated to human disease; but 
it is now generally accepted that RNA tumor viruses, with a few 
exceptions, are not major direct causes of human cancer. However, our 
knowledge of avian and mammalian RNA tumor viruses and the experimental 
methodology available to study them have contributed in unexpected ways to 
some recent developments 1n the study of human disease, most notably the 
isolation of the retrovirus human Immunodeficiency virus (HIV), the 
probable cause of acquired Immune deficiency syndrome (AIDS). 
Furthermore, the field of RNA tumor virology can take full credit for 
the discovery of oncogenes and proto-oncogenes which we will discuss in 
more detail below. It 1s this set of genes that largely shapes the 
picture of what we presently know about human cancer at the molecular 
level. 
Finally, RNA and DNA tumor viruses, have been Instrumental 1n 
studying the molecular biology of the cell. Several key steps 1n normal 
cell growth and differentiation such as DNA replication, rearrangement, 
transcription (control) and splicing are incorporated in the life cycle of 
these viruses which have become valuable models to study these processes. 
Recently, knowledge of the viral life cycle has led to the use of the 
retrovirus as a vehicle of foreign genetic material in gene transfer 
experiments. For these reasons, RNA tumor viruses will continue to be 
both subject and tool of molecular biology. 
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2. Characteristics of Murine Leukemia Virus (MuLV). 
Retroviruses have been extensively reviewed in RNA Tumor Viruses 
(Weiss et. al., 1984). Below, we present a brief summary of those aspects 
directly pertaining to the work presented in this thesis. Specific 
references are given only for those studies relevant to our work that have 
appeared subsequent to the publication of the RNA Tumor Virus book. 
2.1 Taxonomy 
The RetroviMdae form a class of animal RNA viruses characterized by 
the presence of a viral reverse transcriptase. Although originally 
thought to be unique to the retroviruses, reverse transcriptase has now 
been found encoded by DNA viruses (Hepatitis В Virus and Cauliflower 
Mosaic Virus) and by mobile genetic elements in Drosophila and yeast 
(Baltimore, 1985; Varmus, 1985). The retroviruses are divided Into three 
subfamilies: the OncoviMnae, to which MoMuLV belongs; the Lentivirinae, 
such as visna virus and the AIDS virus (HIV or HTLV-III/LAV); and the 
Spuma vi ri пае or foamy viruses that may cause slowly developing 
neurological disorders. 
The Oncovirinae are further subdivided on the basis of their 
morphology into B-, C-, and D-type viruses. More types have been 
proposed, but not yet recognized. The type С group is by far the most 
extensive, containing virus particles seen in many vertebrates. Of these, 
the leukemia viruses of chicken, mouse and cat (and recombinant viruses 
derived thereof) are the most thoroughly studied. The Moloney strain of 
murine leukemia virus (MoMuLV), the subject of our studies, is a prototype 
of the murine leukemia viruses. 
2.2 Virion Structure and Composition 
MuLVs belong to the so-called C-type viruses. I.e., viruses with a 
central core or nucleoid, as visualized by electronmlcroscopy. C-type 
viruses are spherical and have a diameter of 80-120nm. The viral envelope 
is derived from the host cell, and therefore contains cellular membrane 
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protein as well as viral protein. The budding process leaves the host 
cell Intact. Unlike viruses that are released after a burst, retrovirus 
production does not kill the host cell, which only spends a few percent of 
Its energy on virus production. The viral core consists of an 
eicosahedral capsid composed of mainly p30 molecules and encloses two 
molecules of vRNA that are attached to each other through base pairing of 
palindromic sequences near the 5' end (the dimer-Hnkage region). Also in 
this area lies the psi region required for packaging. The presence of 
various cellular proteins and certain RNAs of host origin (apparently 
trapped during virion assembly) has been reported. Finally, each vRNA 
molecule is attached by base pairing to a specific tRNA molecule that 
serves as initiator of reverse transcription. 
2.3 Replication and Transcription 
As for most other maimalian and avian retroviruses, the integrated 
genome (provirus) of MoMuLV measures about 8000 base pairs. In 5' to 3' 
order, it contains the gag-, pol-, and env-gene and is flanked on each end 
by an Identical sequence (594 nucleotides in the case of MoMuLV) called 
the Long Terminal Repeat (LTR). 
The LTR has been subdivided into three regions: U3, R and U5. The U3 
region contains enhancer and promotor elements. Transcription of the 
provirus runs from the 5' end of R 1n the 5' LTR to the 3' end of R in the 
3' LTR, resulting in genomic RNA flanked on each end by the direct repeat 
R to which a 5' cap and a 3' poly(A) tail are added post-
transcriptlonally. In most retroviruses the poly(A) addition signal is 
located in the U3 region; but in some (including MoMuLV) it is part of the 
R region, and therefore is present both at the 5' end and the 3' end of 
the transcript. In those cases where the poly(A) addition signal 1s 
transcribed twice, it is not clear why it appears to function as such only 
in the 3' LTR. 
The genomic RNA, which is packaged Into virions, obviously cannot be 
spliced because it is the sole carrier of viral genetic information for 
part of the life cycle and must be capable of forming a new provirus upon 
reverse transcription after Infection of another cell. 
Reverse transcription Initiates at the 3' end of U5 using as primer a 
specific tRNA, part of which is hybridized to a sequence (PBS, primer 
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binding site) immediately adjacent to U5. Synthesis proceeds through a 
complicated series of template switches mediated by the R repeat and part 
of the tRNA primer. The resulting double stranded circular proviral DNA 
is cut between the two LTRs by the pol-gene-encoded endonuclease (also 
called integrase) which recognizes the U5-U3 junction sequence. 
Integration takes place at random sites; and, from then on, the provirus 
becomes a stable Integral part of the genome of that cell and all its 
progeny. 
Expression of the viral env-gene involves a splice of the primary 
transcript, which removes the gag- and pol-gene. It is not known whether 
this primary transcript is Identical to genomic (virion) RNA; but there 
appear to exist at least two kinetic pools of (near-) genomic length RNA. 
Nor, 1s it clear whether gag(-pol) mRNA and virion RNA are identical. For 
example, gag(-pol) mRNA, Isolated as total poly(A)- containing RNA from 
Infected cells, is more efficiently translated 1n vitro than 1s virion RNA 
(this thesis). Although both are about 8 kb long, it cannot be excluded 
that gag mRNA production Involves subtle splicing. In particular, one of 
the two gag precursor proteins would seem to require a splice, although 
alternative explanations presently seem more likely (see below). 
The pol-gene 1s expressed exclusively as a fusion protein with the 
gag-gene (Baltimore, 1985; Varmus, 1985; Weiss et al., 1984), which is 
subsequently processed to yield the mature pol-gene products. Although 
the gag- and pol-gene in MoMuLV are 1n the same reading frame, this 1s not 
the case for many other retroviruses, which also synthesize gag-pol 
polyprotelns (i.e., RSV, MMTV, HIV, HTLV-II). For a while, it was 
supposed that readthrough Involves splicing of the gag terminator. 
However, more recent evidence supports the idea that all readthrough 
occurs by true nonsense suppression and ribosomal frameshifting; 
therefore, gag mRNA and gag-pol mRNA are probably identical. In Sections 
2.5 and 3.4, we discuss the readthrough mechanism in more detail. 
2.4 Expression of the gag-Gene. 
The gag-gene encodes (in 5' to 3' order) the viral proteins pl5, pl2, 
p30 and plO (ρ for protein, the number for kD estimated in a standardized 
PAGE system). Other virus strains contain gag-gene products homologous to 
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those of MoMuLV, albeit of slightly different sizes. The mature proteins 
arise by proteolytic cleavage of a precursor Pr65 9 a 9. This precursor 
(and, consequently, pl5) is myristylated at its amino terminus. pl5 
contains a highly hydrophobic domain and is found partly 1n the viral 
envelope and partly 1n the viral core. pl2 is an acidic protein and, 
because some of these molecules are phosphorylated (on serine), it is 
often indicated as ppl2 (pp for phosphoproteln). A small fraction of the 
pl2 molecules is tightly associated with virion RNA in a type-specific 
manner. Despite the fact that the name gag 1s an acronym for group-
specific antigen, (which means that it is carried by all or most MuLVs), 
pl2 carries mostly type-specific antigenic determinants (I.e., specific 
for the Moloney strain of MuLV). p30 1s the major capsid protein of the 
viral nucleoid and plO is a basic protein, associated with virion RNA. 
A second mode of expression of the gag-gene is a polyprotein 
called gPr803a9 (g for glycosylated) (Evans et al., 1977; Ledbetter et 
al., 1978; Ledbetter, 1979; Edwards and Fan, 1979; Schultz et. al., 1981). 
Its In vitro translation product, Pr759a9, differs from Pr659a9 by an 
amino terminal leader sequence L (Schultz and Oroszlan, 1978; Edwards and 
Fan, 1980; this thesis). In vivo, gPr809a9 becomes glycosylated, while 
being synthesized and transported to the cell surface. Though its 
function is still unknown. It was shown to be dispensable for viral 
replication (Schwartzberg et al., 1983; Fan et al., 1983) and, probably, 
for virus-induced lymphomagenesis in mice (Weiss et al., 1984). Finally, 
the gag-gene 1s expressed as readthrough products Into the pol-gene. 
Mechanisms responsible for multiple expression of the gag-gene and 
readthrough are discussed in more detail in sections 3.4 and 2.5, 
respectively. 
2.5 Expression of the pol-Gene 
The pol-gene of MoMuLV 1s expressed as a gag-pol precursor 
polyprotein. As shown in this thesis, two versions of this precursor are 
found: Prl80 9 a 9" p o 1 and gPr200 9 a 9" p o 1. The gag moieties of these 
precursors correspond to Pr659a9 and gPr809a9, respectively, which means 
that both nascent Pr659a9 and nascent gPr809a9 are subject to whatever 
mechanism that fuses the gag- and pol-sequences into one molecule. Either 
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both or only one of the gag-pol precursors are processed Into functional 
pol-gene products. The identification of these products has been hampered 
by their low level of expression, which is estimated to be only 1-5% of 
that of the gag-gene. Only 20-70 molecules of the best known pol product 
reverse transcriptase (or p80P ) are present in one virion. Reverse 
transcriptase contains mainly group-specific antigens. 
The C-terminal 37 kD of the MoMuLV poi open reading frame probably 
encode an endonudease, as do the corresponding sequences in ALV for the 
endonuclease p32 p o 1. This protein is essential for integration of 
provi ral DNA Into the host's chromosome. 
The amino terminus of the MoMuLV pol-gene encodes (part of) the viral 
protease responsible for processing of the gag and gag-pol precursors. 
Isolation and sequencing of the MoMuLV protease has recently shown that 
the first four amino acids overlap with the four carboxy terminal amino 
acids of the gag-gene (Yoshinaka et al., 1985). In ALV, this protease is 
entirely encoded by the carboxy terminus of the gag-gene. 
Among the retroviruses sequenced to date, a wide variation in 
organization is observed at the gag-pol Junction (Weiss et al., 1984). In 
all cases, we find the two genes separated by at least one stop codon 
which either terminates or precedes the viral protease, which, thereby, 
belongs to the gag-gene or the pol-gene, respectively. The gag- and pol-
gene can be in frame (MoMuLV, FeLV) or out of frame (RSV, HIV). Even more 
complex 1s the situation found in MMTV, HTLV-II, BLV and some D-type 
viruses, where the protease is out of frame with respect to both gag and 
poi. Yet, in ail cases, a gag-pol fusion protein Is synthesized. 
Obviously, the termination codons need to be circumvented somehow; and it 
has been a long-standing question whether this occurs by ribosomal 
suppression and frameshiftlng or by subtle splicing. Although it had been 
shown that readthrough of MoMuLV virion RNA In vitro was enhanced by amber 
suppressor tRNA (Philipson et al., 1978), the In vivo synthesis still may 
involve spliced mRNA, which might comprise part of the virion RNA. 
Moreover, amber suppression would not explain those cases where one (RSV) 
or two (MMTV) frameshifts are required to form the fusion product. 
However, recent experiments have shown convincingly that amber suppression 
is, indeed, the major in vivo mechanism by which readthrough occurs in 
MoMuLV. Sequencing at the protein level of the MoMuLV gag-pol junction 
(as it appears in the viral protease) indicates that the amber codon is 
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read as glutamlne (Yoshinaka et al., 1985). 
The recent development of In vitro transcription systems using 
bacteriophage promotor/polymerase combinations (SP6, T7) has allowed 
another type of experiment in which possible contamination with small 
amounts of spliced RNA can be excluded. SP6 transcripts of the MMTV gag-
protease-pol region yield in vitro translation products through single and 
double ribosomal frameshifts, in the same relative amounts as In vivo 
(Jacks et al., 1987; Moore et al., 1987). Similar findings have been 
reported for RSV (Jacks and Varmus, 1985) and HIV (Jacks et al., 1988). 
It seems probable that translatlonal suppression and frameshifting 
accounts for all forms of readthrough into the pol-gene. The expression 
of reverse transcriptase may be universally controlled by these unusual 
features of translation, since they are highly conserved among 
retroviruses and are even predicted to be operational in reverse 
transcriptase-encoding genetic elements as remote as the transposons of 
Drosophila and yeast (Baltimore, 1985; Varmus, 1985; Craigen and Caskey, 
1987). 
2.6 Expression of the env-Gene. 
The env precursor polyprotein of MoMuLV, gPr82env, is coded for by a 
24 S mRNA, which arises through splicing of the 5' terminal genome 
sequences to a site at the end of the pol-gene. The env-gene uses a 
reading frame different from that of the other two genes, and its coding 
region overlaps 61 bases with that of pol. 
The env precursor protein is incorporated 1n the host cell membrane 
and subsequently processed into the major envelope glycoprotein gp70 and 
the transmembrane protein pl5(E), (E for envelope, to avoid confusion with 
pl59a9). virion assembly takes place at the cell membrane from which newly 
formed virions are released by budding. During this process, some of the 
pl5(E) molecules are cleaved on the Inner side of the viral membrane to 
yield a 16 amino acid C-terminal, so-called "R" peptide, and the trimmed 
transmembrane protein known as pl2(E). 
The first step of cell infection by a virus is the attachment of the 
viral glycoprotein (gp70) on the surface of the virion to specific 
receptors on the cell surface. Cells lacking the appropriate receptor 
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cannot be Infected by this virus; and, therefore, the structure of the 
glycoprotein is one of the factors that determine viral host range. Once 
infected, the cell produces large amounts of gp70 which saturate the 
receptors used for the initial entry, thus preventing reinfection by any 
virus using the same receptor. This phenomenon is called interference. 
2.7 Retroviruses and Cancer. 
With respect to their oncogenic potential, retroviruses can be 
divided into two major classes: the acutely transforming viruses which 
cause disease within weeks and are capable of transforming cells In tissue 
culture, and the non-acute or slow transforming viruses, which cause 
disease after a long latency (months and up to a year) and do not 
transform cells In vitro (Weiss et al., 1984). 
The acute viruses owe their high tumorigenicity to one of several 
rare recomblnatlonal events, in which part of their genome has been 
replaced by a normal cellular gene (proto-oncogene), which, in its new 
setting (thereby called oncogene) confers altered growth properties to the 
infected cell. Acute viruses (with a few singular exceptions. Including 
RSV) have acquired their oncogenes at the expense of essential viral 
genes, and are therefore replication-defective. Defective viruses can 
still replicate and spread, but this requires the presence of a so-called 
helper virus, to provide the missing functions in trans. 
The non-acute viruses carry no dominant transforming genes; and it 
has only been recently that we started to understand some aspects of their 
mechanism of oncogenesis. Most of what we know at this time can be 
summarized by the broad term "insertional mutagenesis". Common to all 
variants of this phenomenon is the interaction between the provirus and 
the resident DNA into which it has integrated. The first such variant to 
be discovered was that of promotor insertion in ALV-induced lymphomas in 
chicken, where the ALV provirus Is frequently found to have integrated 
upstream from, and 1n the same orientation as, the c-myc transcription 
unit. The viral promotor 1n the 3' LTR drives the transcription of the c-
myc gene and overrides the regulatory elements that control normal c-myc 
transcription, resulting in constitutive (but not neccessarily elevated) 
expression of the (otherwise unaltered) gene product. Promoter insertion 
as a mode of activation has subsequently been found for a number of other 
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oncogenes. A variation on this theme has been observed for ALV-1nduced 
activation of the c-erb В gene, where transcription starts in the 5' LTR, 
proceeds through the provlrus, occasionally Ignores termination signals in 
the 3' LTR, and continues Into the adjacent gene (c-erb B ) . These 
mechanisms explain why non-acute viruses do not appear to transform cells 
In tissue culture. With the acute viruses, each infected cell will have 
acquired the viral (activated) oncogene, while the non-acute viruses 
depend on rare proviral Insertions to activate such genes. 
The realization that non-acute viruses can be oncogenic through 
Integration 1n the vicinity of a proto-oncogene prompted a major effort to 
identify other such preferential integration sites by the method of 
proviral tagging. "Preferential", 1n this context, refers to the overall 
outcome of (possibly non-random) integration and subsequent selection to 
form a tumor. Sequences flanking the integrated provi ruses are cloned 
from tumors with single Integrations, using the viral sequences as a tag 
and subsequently are used to screen a large number of Independently 
derived virus-Induced tumors to see if a particular locus was hit more 
than once. Careful analysis of a large number of coimon Integration sites 
identified In this way (and often termed putative oncogenes) has shown 
that a mechanism far more cornnon than promotor insertion 1s that of 
enhancer Insertion. Proviruses often Integrate upstream in the opposite 
orientation or downstream from the resident gene, sometimes at large 
distances. It is assumed in these cases that the enhancers in the viral 
LTR override the regulatory environment of the normal promoter of the 
nearby gene, resulting 1n constitutive and/or enhanced transcription. 
Additional effects may occur when integration takes place within the 
transcription unit, which, by virtue of the poly(A) addition signal In the 
viral LTR, truncates the transcript and removes sequences that confer 
instability or even truncates the gene product. It should be noted that 
no transcripts have been found for several loci on the rapidly growing 
list of common Integration sites. Therefore, It 1s quite possible that 
there are mechanisms of transformation by non-acute viruses yet to be 
discovered. 
As mentioned in a previous section, retroviruses do not appear to be 
directly Involved In human cancer. The single known exception to this Is 
a rare form of Τ cell leukemia associated with the human C-type virus 
HTLV-I. Although its mechanism of transformation is not clear, an unusual 
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feature of this virus points to a potential novel mechanism. In addition 
to the standard gag- pol- and env-gene, HTLV-I (as well as HTLV-II and 
HIV) contains a so-called x-gene (or x-lor or tat) (Chen, 1986). The 
product of this gene controls expression of other viral genes 1n trans by 
activating their transcription. In HIV, control appears to be at the level 
of translation. Thus, it is conceivable that HTLV also trans-activates 
cellular genes, among them proto-oncogenes. 
It was unclear for some time what hallmarks the change when proto-
oncogenes turn Into oncogenes. For example, transduced genes will have 
accumulated several lesions during the years (sometimes decades) that the 
virus was propagated in the laboratory. It is assumed that at least one 
of the effective changes took place before, or at, the moment of 
transduction, because rendering the virus replication-defective can hardly 
be considered an evolutionary advantage and would have to be compensated 
for by giving the cell harboring the defective genome some growth 
advantage. Otherwise, the rare transduction event would go unnoticed and 
the new virus would be lost. Subsequent changes in the transduced gene 
may be either neutral or may enhance the effect of the original change; 
therefore, it Is not often Immediately obvious what made the oncogene. 
Now that a large number of such proto-oncogene/oncogene pairs has been 
studied, no hard and fast rules emerge, although a few broad categories 
can be defined. Many of the known oncogenes are found either 
preferentially in one category or are more clearly excluded from one. 
Thus, certain oncogene products (such as myc) are Identical to their 
proto-oncogene counterparts; and their deregulated expression alone 
constitutes the activation. Others (most notably, the ras-family) are 
activated by point-mutation of one of a few strategic amino acids. Still 
others, in particular the group exhibiting protein kinase activity, often 
have suffered truncations removing a ligand-blnding domain (growth factor 
receptors) or other controlling domains (C-termlnal phosphorylation site 
In the src-fam1ly). Again, exceptions are found with a point-mutation 
activating the neu gene (a receptor) and certain viral src-isolates, 
whereas sustained elevated levels of the normal proto-oncogene product 
seem to be the mode of action for the lek and p1m-l kinase and, 
presumably, for amplified growth factor receptors. 
Apart from not knowing an oncogene when we see one, there 1s the 
problem of not seeing one at all. Undoubtedly, our view of what 
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constitutes an oncogene (more generally, what genetic changes are Involved 
In oncogenesis) 1s very much biased by the experimental approach. For 
example, some oncogenes may be Incompatible with viral transduction or may 
not register as oncogenes in our assay. The latter is a serious 
limitation, because it also applies to the second method by which 
oncogenes were discovered, by transfectlon of tumor DNA into recipient 
cells (usually NIH-3T3) and scoring for transformed cells (foci or tumors 
in nude mice). Based on statistical analysis (cancer incidence/time) 
alone, it has been known for a long time that cancer 1s a multi-step 
process. Even in the highly simplified system of transfecting cells In 
culture, we can observe effects of cooperation. Many oncogenes transform 
NIH-3T3 cells only because these cells are already on the verge of being 
transformed; and, Indeed, these oncogenes require the co-transfection of 
another oncogene to transform primary cells, which presumably lack these 
premallgnant changes. Certain oncogenes may register as such only when 
the recipient Indicator cell is of a certain lineage or harbors a specific 
combination of premalignant changes. In the wrong recipient, the putative 
oncogene may be either neutral or lethal and therefore remain Invisible. 
The tranfectlon assay has revealed a number of oncogenes involved in human 
malignancies, although many of these were the same as those transduced by 
animal retroviruses. For example, certain forms of human cancer 
frequently correlate with a point-mutation 1n one of the ras-genes, much 
like the activations found in viral ras-genes. Others show activating 
translocations of c-myc or c-abl, and growth factor receptor genes have 
been found amplified. Yet, the majority of human tumors show no 
activation of any of the oncogenes isolated at this time. To discover 
additional genetic lesions Involved 1n tumorlgenesls, we may need an 
essentially different approach. 
In addition to the activation of oncogenes, lesions may also 
represent a loss of certain genes. Many years ago, fusion of transformed 
and normal cells proved the existence of "suppressor" genes; and they have 
been mapped to certain chromosomes that are consistently lost from 
transformed revertants of these non-transformed hybrids. Procedures are 
currently being developed to isolate these genes through transfectlon of 
transformed cells with "supressor-DNA" and selection of non-transformed 
transfectants with suicide drugs or by cell sorting. Such genes might be 
Involved 1n certain recessive forms or aspects of human cancer and, at 
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least, be of diagnostic value. An example of this is the retinoblastoma 
gene which has already been cloned and sequenced and encodes a nuclear 
DNA-binding protein. 
Having seen that certain genetic lesions require a particular genetic 
background in the cell in order to have a phenotype, the effects may also 
be modulated by the genetic content of surrounding cells. For example, 
negative control has been observed 1n transfection studies where success 
depends on the density of the recipient cells. Because stable 
transformation by calcium phosphate-mediated DNA uptake is a low frequency 
event, most successful transfectants will be surrounded by normal cells 
which apparently can suppress the transformed phenotype, reportedly by 
direct contact through gap-junctions. The transfected oncogene may 
transform a particular cell, while abolishing the ability of that cell to 
suppress the transformed phenotype of a neighboring cell. Indeed, when 
effective DNA uptake is more efficient (e.g., through retroviral 
infection) the transformation frequency depends less on cell density. 
Positive cooperation between cells is also Hkely to be important for 
tumorlgenesis. Perhaps the early tumor tissue may be regarded as an 
organ, or micro-environment, effectively increasing the target size for 
subsequent genetic lesions, which need no longer occur 1n the same cell. 
In this view, the early tumor is seen as a holding-pond of targets for the 
genetic changes that allow entry into the next stages of tumor 
progression, such as metastasis, escape from imnune-surveillance, hormone 
indépendance, invasion and vascularization. Several oncogenes are known 
to induce the synthesis of growth factors or are themselves growth 
factors. Although rendering the cells producing them factor-independent, 
these dlffusable factors could easily act on other cells as well. More 
direct Interactions could occur through gap-junctions or be mediated by 
(modified) extra-cellular matrices. Systems to study these higher-order 
cooperations are currently being developed using organs that are easily 
reconstituted or repopulated, such as prostate, bone marrow and thymus. 
The crucial improvement over existing systems is that the assay of 
oncogene action will be in the (progressing) tumor Itself. It is in these 
areas that retroviruses may once again play a leading role as tools of 
investigation, as insertlonal mutagens (proviral tagging). Genes detected 
in this way will largely be limited to those that act through deregulated 
expression (rather than changes of the gene product by truncation or 
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point-mutation) or by 1nact1vat1on. Still, they represent an Important 
novel set of genes, because their detection will be based on statistics of 
natural tumor progression. The various aspects of oncogenes, suppressor 
genes and their Involvement In tumorlgenesis have been extensively 
reviewed (Bishop, 1983, 1985a, 1985b, 1987; Hunter, 1984, 1987; Hunter and 
Cooper, 1985; Klein and Klein, 1985; Klein, 1987; Sager, 1985; Varmus, 
1982a, 1982b, 1984; Weinberg, 1985; Weiss et al., 1984). 
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3. Introduction to the Chapters. 
3.1 Aim of the Study 
At the time that the studies presented in this thesis were carried 
out, our knowledge of MoMuLV was still fragmentary. Without any molecular 
clones and sequence information available, large portions of the genome, 
especially near the 3' end, had not been assigned to a gene product. By 
analogy with RSV, it was anticipated that these regions might encode a 
protein involved in tumorlgenesis; so we decided to analyze viral RNA of 
subgenomic size for its coding potential. We devised a method to separate 
RNA according to size without loss of biological activity. This method, 
which 1s described in Chapter II, was also applied to study the multiple 
expression of the gag-gene of MuMoLV. 
During the course of our investigation, it was reported that, in 
addition to coding for the precursor of viral structural proteins, the 
gag-gene is expressed as a glycosylated cell surface polyprotein. When it 
became clear that this surface protein represented the long-known 
iimiunologically defined Gross Cell Surface Antigen (GCSA), which marks the 
onset of leukemia in AKR mice, we decided to analyze these products of the 
gag-gene and their mode of synthesis in more detail. In order to 
precisely map the differences between these gag-related molecules, we 
needed to generate fragments 1n a reproducible manner. Although several 
chemical cleavage methods were available, few were suited to analyze 
minute amounts of radiolabeled protein. We, therefore, adapted one method 
(hydroxylamine cleavage). This was shown to be applicable to a wide range 
of biomolecular studies as detailed 1n Chapter III. We used this method 
along with other means of cleavage to determine the structure of the 
various gag- and gag-pol polyproteins. In Chapter IV, we describe the 
details of this analysis and discuss the implications of our findings for 
the way in which these polyproteins are synthesized. 
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3.2 The Blotting of Biologically Active RNA 
Transfer of nucleic a d d from gels onto a solid support (blotting) 
has become a widely used tool in molecular biology (Meinkoth and Wahl, 
1984). At the time the experimental work 1n this thesis was Initiated, 
two such blotting procedures had been developed. Denatured DNA was shown 
to transfer from agarose gels to nitrocellulose (Southern blot) 1n high 
salt, and could be Irreversibly InrnoMUzed by subsequent baking. RNA 
could similarly be transferred (Northern blot) after covalent modification 
with glyoxal or formaldehyde. Alternatively, a chemically activated 
cellulose was used to bind DNA or RNA by direct covalent linkage during 
the transfer. 
For the purpose of studying subgenomlc MoMuLV- related RNAs, we 
needed the powerful resolution of gel electrophoresis, but could not take 
advantage of the available transfer techniques, since the RNAs would not 
be accessible to further analysis (other than by hybridization) once 
InmoMllzed. We, therefore, developed a solid support which reverslbly 
binds RNA. Although the initial Intent was to elute RNA after transfer 
for further characterization by finger printing and In vitro translation, 
we found that the latter could be done while the RNA was still bound to 
the solid support and we focussed our efforts on this aspect. 
The article In Chapter II describes the chemical synthesis of ECTEOLA 
Ion-exchange paper; and in situ translation is shown using virion RNA from 
MoMuLV. The technique is presented as a generally applicable approach to 
the rapid isolation and characterization of size-fractionated RNA. 
Our main reason for developing this technique had been to identify 
potential subgenomlc messengers, which might encode an as yet unidentified 
(oncogenic) gene product. It had been shown for the src gene of RSV that 
such Internally located open reading frames can be made translatlonally 
active In vitro by fragmenting genomic RNA. When virion RNA of MoMuLV 
(which 1s always randomly degraded to some degree) was denatured and 
poly(A)-selected to generate an overlapping set of fragments from the 3' 
end, we found, upon size fractionation on sucrose gradients, that the 14 S 
size class of RNA efficiently translated into a 36 kD protein. The newly 
developed blotting technique would have met all requirements to purify 
this RNA and show by RNA fingerprinting whether it was of viral origin. 
But, we did not further pursue this Une when, through the work of others, 
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the 36 kD protein was positively Identified as the cellular glycolytic 
enzyme glyceraldehyde-S^phosphate dehydrogenase (GAPDH)(Adkins and Hunter, 
1980). Apparently, GAPDH mRNA 1s efficiently packaged by several 
retroviruses. 
After the work presented in this Chapter had been submitted for 
publication, we found that ECTEOLA-bound RNA can also be efficiently in 
situ reverse transcribed. Using this In situ first strand synthesis 
followed by second strand synthesis in solution, we made several min1-cDNA 
libraries, each representing a highly purified RNA size class. Directed 
by the In situ translation assay to find the RNA size class of Interest, 
we were able to generate several cDNA clones of one of the cellular 
substrates (p36) of tyrosine protein kinases (unpublished). 
Alternative methods employing reversible binding of RNA to a solid 
support have now been published. One method uses binding to 
nitrocellulose 1n the presence of Nal followed by elutlon in water at high 
temperature (Bresser et al., 1983); another employs binding to DEAE 
cellulose and release with strong dénaturants (Holland and Wangh, 1983). 
A third approach uses poly(U) cellulose to which poly(A)-contain1ng RNA 
binds through hybrid formation (Werner et al., 1984). 
3.3 The Study of Protein Structure by a Combination of Chemical Cleavage. 
Immunopredpitatlon and Gel Electrophoresis. 
Comparative studies of related proteins frequently make use of 
monospecific antisera to show shared antigenic determinants. A widely 
used version of this approach Is Immunoprecipitation (IP) combined with 
PAGE in the presence of sodium dodecyl sulphate (SDS-PAGE). 
Alternatively, protein can be fragmented (enzymatlcally or otherwise) into 
small segments which are then resolved by HPLC or on thin layer plates. 
When the fragments are sufficiently small, the relatedness or identity of 
proteins can be inferred from the comlgratlon of some or all of their 
fragments. Large fragments are not very useful in this system, because 
they generally do not separate well; and the probability of comigration of 
two non-Identical large fragments is rather high. Once some degree of 
relatedness has been established, often the regions of dissimilarity 
become more Interesting. This is especially true when studying localized 
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differences such as those found between precursor proteins and their 
products after proteolytic processing, or modification, such as 
glycosylation or phosphorylation. Other examples Include the differences 
between primary translation products and their readthrough products and 
between multiple products encoded by one gene through differential 
splicing. Neither of the above-mentioned techniques are suitable for the 
purpose of localizing the differences on the molecule. Straight IP leaves 
the molecules intact; and, in the case of peptide mapping, many fragments 
will remain unresolved (especially glycosylated ones), while the others 
are too small and numerous to be placed in order. In addition, peptide 
maps of radioactive protein are even poorer representations, because only 
a fraction of the fragments is labelled (usually through [35 S]-
meth1on1ne,[35 S]-cyste1ne, or [125 I]-1odotyros1ne) and thus detected. 
Ideally, one generates relatively large fragments, almost all of which 
will carry a radioactive label and together represent the entire molecule, 
including the modification. When several epitopes have been ordered 1n a 
given molecule, the fragments are easily placed on a linear map; and, when 
enough overlaps have been generated, the modifications can be mapped very 
precisely. 
Since the proteins we wanted to study (the MoMuLV Pr659ag, its 
readthrough product Prl80 9 a 9" p o 1 and their modified variants gPr809a9 and 
gPr2009a9"po1) were suitable for this approach, we optimized some methods 
to produce large fragments. Although cleavage at only some of a larger 
number of possible sites by limited enzyme digestion has been successfully 
used for this purpose, we argued that chemical cleavage at a small number 
of tentative sites might be more reproducible. Methods for chemical 
cleavage of the peptide back bone at a limited number of specific sites 
include the use of CNBr (cleaves at methionine), NH20H (cleaves at asn-
gly) and H+ (cleaves preferentially at asp-pro). All three methods are 
well established, but have been used only for large amounts of non-
radioactive proteins and include steps like dialysis and precipitation 
which, when applied to minute amounts of radioactive protein, result in 
very low recoveries. Since our proteins were more easily obtained as 
radioactive bands in Polyacrylamide gels, we modified these methods to 
take place in the gel, using the Polyacrylamide matrix as a carrier 
throughout the entire procedure. Cleavage products were effeciently 
recovered from the gel band by electrophoresis, either directly into a 
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second analytical gel or into solution from which they could be 
1rmiunoprec1p1tated. These applications are shown using a number of 
different proteins. We also showed a two-dimensional version which is 
useful for the simultaneous comparison of a large number of related 
proteins, such as a nested set of internally initiated or prematurely 
terminated in vitro translation products. 
3.4 The Structure and Mode of Synthesis of the gag and gag-pol Precursor 
Proteins. 
In Chapter IV, we describe a detailed analysis of the major gag 
precursor proteins Pr659a9 and gPr809a9 and their readthrough products 
PrlBOgag and gPr200gag. The cleavage methods which we developed for this 
study (described in Chapter III) allowed precise mapping of the 
differences between P65gag and gPr809a9; a 7 kD leader at the ami no-
terminus and three N-linked carbohydrate groups, one attached to the N-
termlnal region and two to the p30 domain. In addition, we showed that 
the two pol precursors are, indeed, C-terminal extentlons of the two gag 
precursors, with gPr2009a9"Po1 containing at least one carbohydrate group 
attached to the poi domain. 
Since the completion of our studies, few findings pertaining to this 
subject have been reported. Two reports, largely responsible for the drop 
in interest, showed that mutants, which synthesize no glycosylated gag, 
replicate normally (Schwartzberg et al., 1983; Fan et al., 1983) and are 
unaffected in their leukomogenlc properties (Weiss et al., 1984). But, two 
important questions remain unanswered: 1) What is the function of 
gPr809a9? and 2) How is it synthesized? Perhaps the question of function 
is best rephrased to ask: Why is the synthesis of glycosylated gag so 
highly conserved among mammalian retroviruses in the absence of an 
apparent function? 
As to the way in which glycosylated gag 1s synthesized, the mutants 
used in the above studies define, at least in part, the sequences that 
encode the leader segment. The reading frame of Pr659a9, which begins at 
nucleotide 621, is open for another 330 nucleotides toward the 5' end 
before it encounters a stop codon at position 288-290. A single base 
change that generates an in-frame stop codon just up-stream from the 
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Рг65 9 а 9 Initiator codon abolishes all synthesis of gPrBO 9* 9, whereas 
Pr65 9 a 9 1s unaffected (Fan et al., 1983). The same result 1s obtained 
with two Independent mutants, 1n which stretches of 56 and 63 (I.e., not 
multiples of 3) nucleotides were deleted, starting at positions 400 and 
402, respectively (Schwartzberg et al., 1983). When a 66 base pair 
deletion was Introduced from position 537 to 602, again no gPr80 9 a 9 was 
made, but Instead, a 71K non-glycosylated gag-related protein was found 1n 
addition to the normal Pr65 9 a 9. Probably, the 66 base pair deletion 
shortens the peptide backbone of gPr80 9 a 9 by 22 amino adds containing the 
signal directing it to the cellular compartment where 1t would normally be 
glycosylated. Together, these mutational analyses Indicate that the 
leader sequence of gPr80 9 a 9 1s encoded, at least in part, by the genomic 
sequence immediately upstream from Pr65 9 a 9 and read In the same frame. 
However, this still does not show where translation Initiates. The 
first 600 nucleotides of the MoMuLV genomic RNA contain three AUG codons, 
but all are out of frame with respect to Pr65 9 a 9. Therefore,it has been 
proposed that the synthesis of gPr80 9 a 9 may require a small splice to 
bring an AUG codon 1n frame with the main reading frame. Alternatively, 
this could be achieved by ribosomal frame-shifting which, as we now know, 
can efficiently occur 1n eukaryotlc cells. 
Although frame-shifting by either mechanism could theoretically 
account for the synthesis of MoMuLV gPr80 9 a 9, 1t cannot explain the 
synthesis of a similar protein by the related AKV virus, because the 
genomic sequence of AKV contains not a single AUG codon in any frame 
upstream from Pr65 9 a 9. Early studies Indicated (Ledbetter, 1979) that AKV 
does synthesize a glycosylated gag protein of approximately the same size 
as MoMuLV gPr80 9 a 9. However, a more recent study (PiHemer et al., 1986) 
has claimed that the leader sequence L of the AKV glycosylated gag Is as 
large as 20 kD. If correct, this would create nearly insurmountable 
obstacles for the synthesis of this protein, because the 5' genomic 
sequence barely suffices to encode 20 kD of protein and would require such 
exotic features as Initiation of transcription 5' to the normal promoter 
or trans splicing of a segment elsewhere in the genome onto the gag 
reading frame. A more plausible explanation would be that both MoMuLV and 
AKV make a glycosylated gag with a peptide backbone of about 72-75 kD, the 
synthesis of which initiates on a codon other than AUG. Several recent 
findings indicate that non-AUG codons can indeed efficiently initiate 
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eukaryotic protein synthesis, provided that they occur in a favorable 
context as defined by Kozak (1987a). Examples Include the ACG codon for a 
mutant dihydrofolate reductase (DHFR) gene (Peabody, 1987) and a Sendai 
virus protein (Curran and Kolakofsky, 1988); CUG for the larger of the two 
oncogene products of c-myc (Hann et al., 1988) and pim-l (Saris et al., 
unpublished). In all cases, the sequence surrounding the Initiator codon 
closely resembles the optimal ' 'Kozak-sequence" (G)CCGCC(G/A)CCATGG. 
Within the open reading frame upstream from and contiguous with Pr659a9, 
both MoMuLV and AKV contain a CUG codon 88 codons upstream from the 
Pr659a9 initiator AUG. In MoMuLV, this codon lies within the sequence 
GCCGCAACCCUGG; while in AKV, the sequence reads ACCGCAGCCCUGG. The close 
resemblance of these sequences to the Kozak consensus sequence, together 
with the predicted size of the leader (88 amino acids for both MoMuLV and 
AKV) make this CUG a promising candidate for being the initiator codon of 
the glycosylated gag protein. If this is the case, we can predict that 
the amino-terminal carbohydrate of MoMuLV gPrSO999 is attached to the 
asparagine residue at nucleotide positions 693-695 1n pl5, because it 
would be the only asparagine that is part of the consensus sequence (Asn-
X-Ser/Thr) for N-linked glycosylation. A second implication would be the 
presence of a methionine residue at the L-pl5 junction 1n gPrBO9*9. 
In Chapter IV, we proposed that this AUG codon may be part of a 
region that Is spliced out because we were unable to show cyanogen bromide 
cleavage at this putative methionine in gPrSO939. Now that we no longer 
need splicing to explain initiation of gPr809a9 synthesis, 1t seems likely 
that this methionine is actually present; but we still cannot explain why 
it appears refractory to cleavage. 
We have recently taken another look at the above questions (Saris and 
van Beveren; unpublished) using the newly available technology. One of 
the problems with previous experiments was that we could not precisely 
define the genetic content of the messenger RNAs used in the In vitro 
translations. In particular, we could not be sure that size-selected 35S 
RNA (either from virions or as poly(A) RNA from infected cells) did not 
contain a small amount of subtly spliced mRNA which exclusively encoded 
the glycosylated gag protein. Using an In vitro transcription system, we 
can now synthesize homogeneous RNA populations that are characterized by 
their molecularly cloned template DMAs. Proviral Kpn restriction 
fragments of MoMuLV (nucleotides 32-2858) and of AKV (nucleotides 32-2873) 
30 
were cloned in both orientations behind the SP6 promoter In the 
transcription vector IBI 76. RNA was synthesized In vitro using template 
DNA (linearized behind the Insert), SP6 RNA-polymerase and the RNase 
Inhibitor RNAsin in an appropriate buffer containing the four rNTPs as 
well as 7mG(5l ^ ppíB' )G to ensure capping. In vitro translation of these 
cRNAs in a reticulocyte cell-free system gave the following results: 
Antisense RNA of MoMuLV and AKV did not give rise to any protein. On the 
other hand, the sense transcript of MoMuLV yielded two major proteins of 
65 kD and 75 kD and a minor component slightly larger than the 75 kD 
protein. All three of these products were precipltable by an anti-pl5 
serum and yielded hydroxylamine cleavage fragments that were Identical to 
those of authentic Pr659a9, Pr759a9 and P77 (see Chapter IV), 
respectively. AKV sense RNA gave a similar result except that both 
Pr659a9 and Pr75 9 a 9 were slightly larger than their MoMuLV counterparts 
and P77 was absent. These experiments prove for the first time that 
genomic RNA (which by definition is the primary transcript of the 
provlrus) encodes both major gag precursors. The remote possibility of 
non-enzymatic self splicing aside, these results also imply that there is 
no need for splicing to synthesize Pr759a9 (and P77). Finally, we have 
confirmed that the leader sequences L of MoMuLV and AKV glycosylated gag 
are the same size. The well defined genetic content of the AKV cRNA now 
allows us to conclude that the synthesis of Pr759a9 Indeed Initiates on a 
non-AUG codon. We are currently making site-directed mutations to test 
the effects of changes in the above discussed Initiator codon candidate 
CUG. Another approach we are taking is that of direct protein sequencing. 
Preliminary results indicate that we can prevent amino terminal blocking 
of Pr759a9 by adding oxaloacetate and citrate synthase during cell-free 
synthesis, so that it should be possible to perform sequential Edman 
degradation of specifically labeled Pr759a9 and generate enough 
aminotermlnal sequence to deduce the Initiator codon. 
Finally, solving the problem of glycosylated gag initiation Is of 
more than mere academic interest. An Increasing number of examples of 
multidstronic eukaryotlc messengers is emerging 1n the literature. 
Upstream Initiation clearly affects the translational efficiency of 
downstream Initiators; and therefore, multiple initiation represents a 
novel level of gene regulation. In which initiation at non-AUG codons 
could provide additional means of fine-tuning. The multiple expression of 
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the MuLV gag gene 1s an excellent model system to study these mechanisms. 
Such studies may also shed new light on the still enigmatic function of 
gPr809a9. Perhaps the high degree of conservation 1n this genomic region 
of retroviruses Involves control of Pr653a9 synthesis rather than, or in 
addition to, encoding a functional gene product. In this light, we may 
also have to reevaluate the mutants that show the dispensability of 
gPr80ga9. In these mutants, elimination of gPr809a9 was achieved by 
creating a minicistron upstream of Pres939, leaving 1n tact possible 
modulation of Pr65 9 a 9 synthesis; because it has been shown that 
reinitiation critically depends on the spacing of the clstrons (Kozak, 
1987b). A better mutation, in this respect, would be to remove the 
initiator of gPr80 9 a 9. Because this same region is also Involved in RNA 
packaging, removal would have to be done in a subtle way (i.e., by single 
base changes). Such mutants might also be valuable for designing better 
retroviral vectors, which have never really been tested for possible 
negative effects of this region on the translational efficiency of 
inserted (downstream) genes. 
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ABSTRACT 
We present the preparat ion of an ion exchange paper which can be used as a 
s o l i d c a r r i e r in the t r a n s f e r of RNA from gels. 
In a d d i t i o n to detect ion by b l o t h y b r i d i z a t i o n to s p e c i f i c probes, t r a n s ­
ferred RNA can be characterized by c e l l - f r e e t r a n s l a t i o n -en i-ctu. Preparation 
of the paper i s s imple, inexpensive and reproducib le. Examples of appl icat ions 
are shown and possible other appl icat ions are discussed. 
INTRODUCTION 
Transfer of DNA (1) and more recent ly of RNA ( 2 , 3) from gels onto a s o l i d 
c a r r i e r has become an important t o o l in molecular biology over the past few 
years. In these so-cal led b l o t t i n g procedures, subsequent c h a r a c t e r i z a t i o n of 
the t r a n s f e r r e d nucleic a c i d s , i s l i m i t e d t o detect ion by h y b r i d i z a t i o n to 
radioact ive probes. The ease wi th which i n d i v i d u a l RNA species are separated 
on and recovered from gels by b l o t t i n g , prompted us to seek a modi f icat ion of 
t h i s procedure t h a t would al low c h a r a c t e r i z a t i o n of t r a n s f e r r e d RNA by in ііло 
t r a n s l a t i o n in a d d i t i o n to detect ion by h y b r i d i z a t i o n . Our strategy was t o 
develop a s o l i d c a r r i e r that would bind RNA i n a non-covalent fashion and such 
that the RNA could be e luted i n a v o l a t i l e b u f f e r from which i t could be r e ­
covered f o r in vjjüio t r ans la t i on by l y o p h i l i z a t i o n . A v o l a t i l e e lu t i on buf fer 
was chosen because ethanol p rec i p i t a t i on o f RNA from any other buf fe r system 
would require the add i t ion of r e l a t i v e l y large amounts o f c a r r i e r mater ial which 
might i n t e r f e re w i th subsequent analyses. 
An obvious choice f o r non-covalent binding being e l e c t r o s t a t i c i n t e rac t i ons , 
we tested a number of ion exchange papers for t h e i r binding charac te r i s t i cs 
by chromatography o f RNA using two d i f f e r e n t bu f fe r systems. C r i t e r i a f o r 
su i tab le binding were: low mob i l i t y of RNA at moderate ion ic strength and 
neutral pH (100 mM KAc-HAc pH 7.4) and high mob i l i t y at high ion ic strength 
and elevated pH (30 % t r ie thy lamine carbonate, TEC, pH 9 .0 ) . I t soon became 
© IRL Press Limited, Oxford, England. 4B31 
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apparent that commercially avai lable ion exchange papers (DEAE ce l lu lose and 
Servacel WB-2) and ECTEOLA paper synthesized according to published procedures 
(4) a l l bound RNA, larger than 10 S, too s t rong ly ; no bu f fe r system could be 
found in which RNA could be e luted i n t ac t . We therefore set out to modify the 
synthesis of ECTEOLA paper such tha t RNA binding was s u f f i c i e n t l y weakened. 
A good compromise between the two binding c r i t e r i a was found in the procedure 
presented here. RNA was quantat ive ly bound to the paper in t rans fe r from aga-
rose gels and a f t e r e lu t i on from the paper and l y o p h i l i z a t i o n the RNA could be 
accurately t rans la ted in a c e l l - f r e e system (not shown). An even more prac t ica l 
procedure was found in t r ans l a t i ng RNA while s t i l l bound to the paper, by im-
mersing and incubat ing an RNA containing sect ion of the b l o t in t rans la t ion 
mixture. 
In th i s report we w i l l re fe r to ¿n v-Lùio t r ans la t i on o f ECTEOLA paper-bound 
RNA as ¿n iiiu. t r a n s l a t i o n . During t r a n s l a t i o n , RNA remained bound to the paper 
and, in add i t i on , c e l l - f r e e t rans la t iona l products were immobilized at t h e i r 
s i t e of synthesis. This l a t t e r aspect of the ¿n ¿ita t r ans la t i on allowed us to 
develop a two-dimensional procedure which involves in iiXu. t r ans la t i on of an 
en t i re s t r i p of the ECTEOLA b lo t and subsequent Polyacrylamide gel electropho-
resis of the t rans la t i on products. To be able to cor re la te Ы л-ііа t r a n s l a t i o ­
nal products w i t h s p e c i f i c RNA species, detected by h y b r i d i z a t i o n to s p e c i f i c 
probes, we needed t o covalent ly couple the RNA to the paper, since the e l e c t r o ­
s t a t i c i n t e r a c t i o n s were too weak t o bind RNA under condit ions general ly used 
f o r h y b r i d i z a t i o n . A s a t i s f a c t o r y procedure was found i n the carbodiimide 
mediated phosphodiester bond formation between terminal phosphates of the RNA 
and hydroxyl groups of the paper, according t o the method described by Gil ham 
( 5 ) . 
The problem o f 2'-3' c y c l i c phosphate formation i n t h i s react ion was over­
come by generating 5' phosphates by l i m i t e d fragmentation of paper-bound RNA 
w i t h PI nuclease. 
We here present examples of the ECTEOLA b l o t t i n g procedure and discuss 
possible a p p l i c a t i o n s . 
MATERIALS AND METHODS 
Preparation of ECTEOLA paper 
The react ion protocol described here i s based on the procedure of Peterson and 
Sober ( 4 ) . Several adaptations however were needed t o make i t s u i t a b l e f o r the 
s p e c i f i c purpose of b l o t t i n g of large RNA molecules. Since b l o t t i n g requires 
sheets of the s o l i d c a r r i e r r a t h e r than a suspension ( f o r which the published 
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procedure is described) a number of problems connected with this aspect had to 
be worked out. F i r s t l y , a number of different kinds of paper was tested since 
the source of the cellulose (wood or cotton) strongly influences the react iv i ty. 
Of the papers tested, Whatman 1 MM gave the best results. Secondly, when using 
paper sheets, the reaction mixture does not remain homogeneous because i t can 
not be st i rred vigorously as is the case with cellulose powder. This problem 
was overcome by altering the sequence in which the reactants were added. 
Finally, a large number of different reactant ratios were tested to y ie ld a 
paper with the desired binding characteristics. Binding c r i t e r i a were: immobi­
l izat ion of (ribosomal) RNA in 100 mM KAc-HAc pH 7.4 and release in 30 % TEC 
pH 9.0. The resulting protocol is as follows: a sheet of Whatman 1 MM paper was 
irmersed in 10 M NaOH in a Pyrex oven dish at 0° С for 30 minutes. Excess NaOH 
was blotted by f irmly pressing the sheet between two layers of Whatman 3 MM 
paper. Pressurewas applied with a ro l l ing device, commonly used in the drying 
of photographic pr ints. The sheet was then immersed for 15 minutes at room 
temperature (fume hood) in a reaction mixture which typical ly consisted of 8.1 
g triethanolamine (Merck, Darmstadt, West Germany) and 22.5 ml epichlorohydrin 
(Merck). Excess reaction mixture was blotted as described before for NaOH and 
the sheet was placed back in the Pyrex dish with 10 M NaOH. The dish was trans­
ferred to a waterbath and kept at 85-90° С for 2 hours. Care was taken that 
the sheet remained f u l l y submerged in NaOH during the reaction by placing glass 
weights along the edges. During the reaction the sheet should not turn yellowish 
which occasionally did happen when excess reaction mixture had not been blotted 
off suff ic ient ly. Yellowish ECTEOLA paper w i l l bind RNA too strongly. Reaction 
was stopped by placing the ECTEOLA sheet in ice cold 3 M KAc-HAc pH 7.4, 
followed by three successive washings in 1 M HAc and 1 M КОН. Final ly, the paper 
was washed unti l neutral with water and a ir dried after washing in absolute 
ethanol. 
ECTEOLA blott ing 
Moloney murine leukemia virus (M-MuLV) 70S RNA was isolated from virions (har­
vested at 2 hours or 12 hours intervals) by Proteinase К digestion and sucrose 
gradient centri fugati on. Cytoplasmic RNA from virus-infected tissue culture 
cells was isolated by magnesium-precipitation according to Palmiter (6), 
followed by oligo dT-cellulose (Collaborative Research, T-3 grade) chromato­
graphy. RNA was separated on 2 uri thick vertical 1 % acid urea agarose gels 
according to Rosen et a l . (7). After electrophoresis, RNA was blotted onto 
ECTEOLA paper following the procedure of Southern (1) using 100 mM KAc-HAc 
pH 7.4 as transfer buffer. In the experiments shown here transfer was for 
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16 hours at 4° C, although transfer is probably complete in a much shorter 
time. ECTEOLA blots were washed in transfer buffer and stored unt i l further 
use under 1 volume of transfer buffer and 2 volumes of ethanol at -20 С 
Blot-hybridization 
For covalent binding of RNA to ECTEOLA paper the blot was f i r s t treated with 
PI nuclease to generate 5'-phosphates. Blots were washed in PI buffer (10 mM 
NaAc-HAc pH 5.3, 0.4 mM ZnSO. , 4 mg/ml bovine serum albumin) and incubated 
for 1 hour at 37 С in 15 μΐ/спг of PI buffer containing 10" units/ml PI 
nuclease (Boehringer, Mannheim) and 33 pg/ml rabbit tRNA. Subsequently, the 
blot was washed in 20 mM sodium 2-(N-morpholino) ethanesulfonate (MES) 
pH 6.0, 5 mM EDTA followed by extensive washing in water and complete drying 
•Ln vacuo at room temperature. Then the blot was gently agitated for 24 hours 
at room temperature in excess carbodiimide reaction mixture, typical ly pre­
pared by dissolving 150 mg N-cyclohexyl-N'-e-(4-methylmorpholinium)ethyl 
carbodiimide p-toluenesulfonate (Merck) in 0.3 ml 0.2 M MES pH 6.0 and 2.4 ml 
water. After the reaction the blot was br ief ly washed i n , successively, dilute 
ammonia pH 9.0; 5 mM HEPES pH 7.5; and pre-hybridization buffer. Hybridization 
to Ρ nick translated probes was for 16 hours at 41° C, essentially as 
described by Adkins et a l . (8). 
Hybridization to M-MuLV specific cDNA (prepared according to Van der Putten 
et a l . (9)) was for 4.5 hours at 68° С in 10 nfl TES pH 7.4, 1 mM EDTA, 1 M 
NaCl, 0.2 % SDS, 2 yg/ml Polyvinylchloride, 1 mg/ml denatured calf thymus DNA, 
10 yg/ml poly A, 5 χ Denhardt solution, 20 mM phosphate, followed by successive 
washings in 50 % formami de, 5 χ SSC, 1 % SDS and 2 χ SSC, 1 % SDS at 41° С, 
and 0.1 χ SSC, 0.1 % SDS at 50° С. 
Blot-translation and SDS-PAGE 
Strips or sections of ECTEOLA paper were washed in 100 mM KAc-HAc pH 7.4, blot­
ted between Whatman 3 MM paper and saturated (5 minutes at 0 C) with excess 
complete translation mixture, only lacking radioactive amino acid(s). ECTEOLA 
was again f irmly pressed between two layers of 3 MM paper and incubated in 
33 ui/cm of complete translation mixture for 2 hours at 30° С Small paper 
sections were incubated in 0.5 ml Eppendorf v ia ls, entire strips in sealed 
plastic bags. In iltu translational products were released from the paper in 
electrophoresis sample buffer (10 M urea, 62.5 mM Tris-HCl pH 6.8, 3 % SDS, 
5 % 2-niercaptoethanol) and analyzed on 10 % Polyacrylamide slab gels according 
to the discontinuous system of Laemmli (10). 
For SDS-PAGE of entire s t r i p s , the strips were sealed in low melting agarose 
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(Sea-plaque) i n the gel s l o t a f t e r washing in 62.5 mM Tris-HCl pH 6 . 8 , 5 % 2-
mercaptoethanol. The c e l l - f r e e t r a n s l a t i o n system used was the mRNA dependant 
r e t i c u l o c y t e c e l l - f r e e system prepared e s s e n t i a l l y as described by Pelham and 
Jackson ( 1 1 ) , except that white blood c e l l s were removed by chromatography over 
SP-Sepharose a f t e r Perucho e t a l . (12). 
Reticulocyte lysates were t reated wi th micrococcal nuclease in the presence 
of 2 mM DTT, 10 pg/ml hemin, 50 vg/ml creat ine kinase and stored at -70 С 
Typical t r a n s l a t i o n mixtures ( f i n a l volume 200 μΐ) contained 120 yl of r e t i c u ­
locyte lysate and (added) f i n a l concentrations of 100 yg/ml creat ine kinase, 
10 mM creatine phosphate, 0.3 mM spermi dine-HCl, 0.1 mM of each unlabeled amino 
acid (always inc lud ing glutamine), 50 yg/ml r a b b i t tRNA, 1 mM MgAc-, 100 mM KAc, 
1 mM ATP, 0.2 mM GTP in a d d i t i o n to radioact ive amino a c i d ( s ) . 
RESULTS 
In i-Ltu t r a n s l a t i o n 
Having modified the synthesis of ECTE0LA paper to y i e l d a s o l i d c a r r i e r t h a t 
reta ins RNA i n b l o t t i n g from agarose gels in 100 пМ KAc-HAc pH 7.4 and releases 
i t i n 30 % TEC pH 9 . 0 , we found t h a t ¿n v-ifio t r ans la t i on could be performed 
wi th the RNA s t i l l bound to the paper (¿n ¿¿tu) . Immersing and incubat ing the 
paper-bound RNA in t rans la t i on mixture d i r e c t l y a f t e r t rans fe r from the g e l , 
resul ted however in many a r t i f a c t u a l t rans la t ion products; mostly premature 
terminat ions. A f te r many unsuccessful attempts to improve the t r ans la t i on accu-
racy by a l t e r i n g the concentrat ion of ind iv idua l const i tuents of the t r ans la t i on 
mixture, we found that t rans la t i on could be performed wi th great f i d e l i t y by 
f i r s t soaking the RNA containing paper w i th complete t rans la t i on mixture i n 
which only the radioact ive amino acid had been omit ted. I t seems tha t binding 
s i tes on the paper need to be saturated w i th cer ta in factors to prevent deple-
t ion of the t rans la t i on mixture. 
A comparison of t r ans la t i on products of increasing concentrations of Moloney 
murine leukemia v i rus (M-MuLV) 70 S v i r i on RNA t rans la ted e i t he r in so lu t ion 
(lanes 1-4) or ¿n i-ctu on ECTE0LA paper (lanes 5-8) i s shown in Figure 1 . 
The autoradiogram of the ana ly t i ca l SOS gel shows tha t w i th a small reduction 
in the amount of high molecular weight polypept ides, the -си ÍÁXU. t r ans la t i on 
y ie lds a set of products which is v i r t u a l l y ind is t ingu ishab le from the set 
synthesized i n s o l u t i o n . Later we found that the small reduction in high 
molecular weight proteins i s due to re tent ion on the ion exchange paper rather 
than to the qua l i t y of the t rans la t ion i t s e l f . The problem can eas i l y be over-
come by inc lud ing the paper piece in the s l o t on the ana ly t i ca l SDS gel (not 
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Fig. 1. SDS-PAGE analysis of c e l l -
free t r a n s l a t i o n a l products of 
M-MuLV 70 S v i r i o n RNA. RNA d i s ­
solved in water i n increasing con­
centrat ions was e i t h e r added to a 
r e t i c u l o c y t e t r a n s l a t i o n mixture 
or was spotted on 3 χ 3 mm ECTEOLA 
paper sect ions. Translat ion in 
s o l u t i o n was performed i n a f i n a l 
volume of 10 μΐ , of which 3 μΐ was 
appl ied to the gel a f t e r mixing 
w i t h 20 μ! of e lectrophoresis sample 
b u f f e r . ECTEOLA sections were wash­
ed in 100 mM KAc-HAc pH 7.4 to r e ­
move unbound RNA ( i f any) and pre­
pared f o r -in ò-itu. t r ans la t i on as 
described in Materials and Methods. 
Translat ion in 3 ul of complete 
mixture per 9 mm2 of ECTEOLA paper 
was stopped by addi t ion of 20 μΐ 
sample b u f f e r to e lute immobilized 
t r a n s l a t i o n products. The super­
natant (23 μ ΐ ) , leaving behind the 
paper, was appl ied to the g e l . 
Final RNA concentrations ( i n yg/ml) 
are ind icated at the bottom of 
each lane. Lanes 1 and 8 are longer 
exposures of lanes 3 and 6 respec­
t i v e l y . 
shown). Also we found that s p o t t i n g the RNA on ECTEOLA paper in a denaturing 
b u f f e r (the same b u f f e r as used f o r RNA gel e lectrophoresis) rather than in 
water, s l i g h t l y increases the in ¿¿tu t rans la t i on e f f i c i e n c y . Thus, ¿n i-ita 
t r ans la t i on of RNA bound to ECTEOLA paper is h ighly accurate and makes e lu t i on 
of RNA from the paper fo r t h i s purpose superf luous. 
Blot hybr id iza t ion 
In order to show detect ion of spec i f i c RNA species by hyb r i d i za t i on , p u r i f i e d 
M-MuLV 35S v i r i on RNA, poly A selected cytoplasmic RNA from Moloney sarcoma 
v i rus (MSV) transformed M-MuLV in fected c e l l s , and Ρ labeled RNA from M13 
i n f e c t e d E c o l i c e l l s were electrophorezed on acid urea agarose gels (7) and 
b l o t t e d onto ECTEOLA paper. A f t e r l i m i t e d PI nuclease d igest ion and carbodiimide 
coupling the b l o t was div ided in two sections and autoradiographed ( F i g . 2) 
32 
e i t h e r d i r e c t l y (lane 1) or a f t e r h y b r i d i z a t i o n to Ρ labeled M-MuLV s p e c i f i c 
cDNA (lanes 2 and 3). 
Bands at 35S (M-MuLV) and at 30S (MSV) are detected s p e c i f i c a l l y against a 
low background h y b r i d i z a t i o n . The sharp marker bands i n lane 1 ind icate t h a t 
no spreading of RNA takes place during PI nuclease d igest ion and carbodiimide 
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Fig. 2. Autoradiography of an ECTEOLA 
blot. RNA was separated on a 1 % acid 
urea agarose gel, transferred to ECTEOLA 
paper and covalently bound by carbodiimide 
treatment after l imited PI nuclease d i ­
gestion. The blot was divided in two and 
autoradiographed either direct ly (lane 1) 
or after hybridization to M-MuLV specific 
cDNA (lanes 2 and 3). RNAs were: ·32ρ 
labeled RNA from M13 infected E.coli 
(lane 1); sucrose gradient purif ied 
M-MuLV 35S virion RNA (isolated from 
virions harvested at 2 hours intervals) 
(lane 2); and poly A selected cytoplasmic 
RNA from Clone 124 MSV transformed M-MuLV 
infected cells (lane 3). 
2 3 8 — Щ 
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reaction. The sensit iv i ty of detection is comparable to what we f ind (not 
shown) with blott ing onto nitrocellulose following the procedure of Thomas 
(3). 
Correlation of translation and hybridization profi les 
To demonstrate the possibi l i ty of accurately correlating ¿n ¿¿tu translat io-
nal products with specific bands in the hybridization pattern, we show an 
analysis of poly A selected cytoplasmic RNA from tissue culture cells and of 
retroviral vir ion RNA. RNA was separated on an acid urea agarose gel and 
transferred to two layers of ECTEOLA paper. The lower layer consisted of two 
separate (1 χ 11 cm) strips which were placed on top of and in direct contact 
with the gel, each covering the lengthwise central section of one (2 cm wide) 
lane. The strips were notched along one side to allow accurate alignment of 
paper sections used for In iltu translation with the hybridization prof i le of 
an upper layer of ECTEOLA (6 χ 11 cm) which covered the two strips and the 
rest of the gel. This way, RNA migrating within the central 1 cm of each lane 
was transferred to the lower layer of ECTEOLA (the str ips) whereas material 
migrating along the edges (0.5 cm on either side) was transferred to the upper 
layer. To prevent degradation of transferred RNA, the ECTEOLA layers were 
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stored u n t i l f u r t h e r use under 70 % e thanol , 33 mM KAc at -20 C, immediately 
a f t e r t r a n s f e r . A f t e r treatment w i t h PI nuclease and carbodi imide, the upper 
32 layer of ECTEOLA was hybridized to a Ρ nick t r a n s l a t e d probe and autoradio-
graphed ( F i g . 3, l e f t panel) . 
The RNA in lane В had been i s o l a t e d from Abelson leukemia virus (AbLV) 
transformed ANN c e l l s which were product ively i n f e c t e d w i t h M-MuLV. Although 
the AbLV genome contains sequences re lated to M-MuLV, the probe (cloned pro-
v i r a l M-MuLV DNA; pMLV) does not c l e a r l y detect AbLV s p e c i f i c 30 S RNA. This 
i s probably due to r e l a t i v e l y low concentrations of t h i s RNA species and to 
the nature of the probe (M-MuLV s p e c i f i c rather than AbLV s p e c i f i c , and nick 
P r 6 5 - ^ 
_2_ —35 3 1 
3 
—21 S 
Fig. 3. L e f t panel. M-MuLV 70 S v i r i o n RNA ( i s o l a t e d from v i r i o n s harvested at 
12 hours i n t e r v a l s ) (lane A) , and poly A selected cytoplasmic RNA from AbLV 
transformed M-MuLV infected c e l l s (lane B) were electrophorezed on a 1 % acid 
urea agarose gel and t r a n s f e r r e d to two layers of ECTEOLA paper as described 
in the t e x t . The upper layer was hybridized to 3 2 P nick t r a n s l a t e d cloned 
M-MuLV p r o v i r a l DNA (pMLV). The autoradiogram i s shown. 
Right panel. SDS-PAGE analysis of-en л-ótu t rans la t i ona l products. Lower layer 
ECTEOLA s t r i ps (see tex t ) were lengthwise cut in h a l f and the notched ha l f was 
subdivided in 4 χ 4 mm sections (spanning a s ingle notch each). Sections i n d i ­
cated in the l e f t panel were analyzed by SDS-PAGE a f t e r ¿n 4-ctu t rans la t i on . 
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translated cloned DNA rather than cDNA). In general we found that cDNA probes 
(as used in Fig. 2) gave better results than nick translated probes. 
M-MuLV specific RNA is detected as discrete bands at 35S (genomic RNA, gag 
mRNA and gag-po£ mRNA) and at 21S (enu mRNA). The faint background hybridi-
zation within the lane, starting at 35S, indicates that breakdown of RNA 
occurred prior to or during electrophoresis. 
The native M-MuLV 70S virion RNA (lane A) is a di mer of 35S genomic RNA, 
complexed with some minor contaminants of both viral and cel lular RNA's. As is 
to be expected for total RNA isolated from virions harvested at 12 hours inter-
vals, the 35S RNA is substantially fragmented. The absence of hybridization in 
the center of both lanes A and В indicates that RNA from this part of each lane 
was quantatively retained by the lower layer ECTEOLA strips in the transfer 
procedure. 
These lower layer str ips were cut in half lengthwise and translated -Ln ¿¿tu 
as described above for spotted RNA. The smooth edged half was translated 
entirely and the further analysis of i t , which is shown in Figure 4, w i l l be 
discussed later. The notched half was subdivided as indicated in Figure 3 
( le f t panel) and individual sections, each spanning a single notch, were trans-
lated. Product analysis by SDS-PAGE of sections surrounding the position of 35S 
is shown in Figure 3 (r ight panel). Clearly the onset of synthesis of 35S RNA 
encoded Pr659a9 coincides with the position of 35S RNA in the hybridization 
prof i le . Thus the ECTEOLA blott ing procedure allows transiational products to 
be accurately correlated with specific RNA species. 
A two-dimensional version of the blott ing procedure is shown in Figure 4, 
where translational products of the entire smooth edged half of the lower 
layer st r ip of lane В in Figure 3 ( l e f t panel) were analyzed by SDS-PAGE. 
After translation incubation in a sealed plastic bag, the s t r i p was washed 
and placed horizontally in a wide slot in the stacking gel. To prevent hor i­
zontal spreading of protein by direct contact of the str ip with electrophoresis 
sample buffer, the s t r i p was f i r s t sealed in the slot with low melting agarose 
which, after so l id i fy ing, was overlayered with sample buffer and electrophore­
sis buffer. In separate small slots on either side of the wide s l o t , sections 
of ¿n ¿-Uu translated ECTEOLA paper were placed, onto which M-MuLV vir ion RNA 
(A) and poly A RNA from AbLV/M-MuLV infected ANN cells (B) had been spotted. 
The autoradiogram, consisting of sections with different exposure times, shows 
that the majority of translational act iv i ty migrates at the bottom of the RNA 
gel (15-20 S). The fact that the translational products of RNA in this size 
range appear as discrete spots, indicates that these RNAs migrated as discrete 
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Fig. 4. SDS-PAGE analysis of ¿n ¿¿tu t rans la t iona l products of an en t i re top 
to bottom s t r i p of the ECTEOLA b l o t of which the hybr id iza t ion p r o f i l e was 
shown in Figure 3, ( l e f t panel , lane B) , and which i s again shown hor i zon ta l l y 
at the top of t h i s f i g u r e . 
The smooth edged s t r i p was cut from the lower layer notched s t r i p as indicated 
in th i s f igure and was prepared fo r -Ln i-ita t r ans la t i on and subsequent SDS-
PAGE analysis as described in the t e x t . The RNA preparations which were analyzed 
by gel e lectrophoresis in the l e f t panel of Figure 3 (A and B) were also spot-
ted on 4 χ 4 mm ECTEOLA paper sections and t h e i r ¿n iitu. t rans la t iona l pro-
ducts were run alongside those of the hor izontal s t r i p in th is f i g u r e . The 
autoradiogram was composed of d i f f e r e n t exposures of gel sections which are 
indicated at the bottom. Exposure was fo r 6 hours on slow X-Ray f i l m (section 
1) and fo r 24 hours (sect ion 2) and 1 week (sect ion 3) on fas t f i l m . 
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bands and that no horizontal spreading of protein occurred during in iita 
translation and subsequent analysis. In contrast, the products of the larger 
RNAs appear as horizontal bands. The set of bands start ing at a discrete 
position in the SDS gel, which coincides with the position of 35S RNA in the 
hybridization prof i le (shown at the top), is characteristic for translational 
products of M-MuLV vir ion RNA (lane A on the l e f t ) . Apparently the high molecu-
lar weight RNA is predominantly virus specific. As was already evident from 
the hybridization prof i le this RNA appears to be substantially degraded. We 
therefore believe that the appearance of bands instead of spots in this region 
of the SDS gel is due to translation of RNAs truncated at their 3' ends, 
rather than to horizontal spreading of protein during or after In i-Ltu. trans-
lat ion. Thus the two-dimensional ECTEOLA blott ing procedure allows rapid 
analysis of translational products of a large number of individual RNA species 
separated on gels. 
DISCUSSION 
We presented an RNA blott ing procedure that allows subsequent characteriza-
tion of transferred RNA by hybridization as well as by cel l- free translation. 
The efficiency and accuracy of ¿n ¿¿ta translation of paper-bound RNA was 
shown to be at least as good as translation of RNA in solution. Since in i-Lta 
translational products are released from the paper in electrophoresis sample 
buffer, they can be analyzed by imnunoprecipitation (not shown) following the 
procedure of Dougherty and Hiebert (13). Although we have only shown examples 
of transfer of RNA from acid urea agarose gels, the retention of RNA by 
ECTEOLA paper being based on electrostatic interactions, transfer can probably 
be conducted from other gel systems as wel l . An interesting aspect of the 
binding properties of ECTEOLA paper is that, at neutral pH and moderate ionic 
strength, in addition to RNA, also protein is bound. This aspect made i t 
possible to analyze entire strips of ECTEOLA blots in a two-dimensional 
fashion. Analyses of this kind are part icularly suitable for the study of 
translational products of RNA species which migrate very close together in 
the RNA gel. 
M-MuLV 35S RNA is an example of an RNA which in fact may consist of several 
closely related species. The viral genome contains the genes gag, poi and гп 
(in this 5'-3' order). Amino acid sequences related to the gag and poi genes 
occur in various overlapping precursor proteins, such as Pr65' ", Pr759 9 and 
P r l 8 0 9 a 9 " p o 1 . The DNA sequence of this virus (14) reveals that for the synthe­
sis of at least one of the gag-gene encoded polyproteins (Pr759 ") a (small) 
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splice is required, and thus one or more 35S mRNAs may exist which are 
s l ight ly different from genomic RNA. A similar conclusion can be drawn from a 
comparison of the translational efficiency (not shown) of M-MuLV virion RNA and 
of mRNA from M-MuLV infected cel ls. The relat ively low translation efficiency 
of vir ion RNA for both Pr65^a9 and Pr759a9 suggests that translational act iv i ty 
of this RNA may in fact reside in a small amount of contaminating true mRNA(s) 
rather than in the genomic RNA i t se l f . Also separate 35S mRNA species for the 
synthesis of gag-pot readthrough products may be generated by a small splice 
at the gag-po£-junction. Readthrough into the poi-gene can be enhanced by 
suppressor tRNAs (15) but i t has not been shown that this mechanism is indeed 
operative ¿n vivo. Although small splices are unlikely to cause physical 
separation of these large (hypothetical) mRNA species on denaturing gels, 
their effect on the secondary structure may be suff ic ient to result in separa-
tion on semi-denaturing gels such as acid urea agarose gels. The analysis, 
shown in Figure 4, reveals that the synthesis of a l l gag- and gag-poi-related 
polypeptides comiences at a position which coincides with the 35S band in the 
hybridization prof i le . These include Pr659a9, Pr759a9 (arrows) and a number of 
polyproteins between 80-180 kD which have been shown to be premature termina-
tions of Prl809 a 9"p o 1 (unpublished data). Thus, i f indeed several M-MuLV 35S 
RNAs ex is t , they are not separated on this gel system. 
The covalent coupling of RNA to ECTEOLA paper is rather laborious. When 
only hybridization profi les are wanted, ECTEOLA blott ing is by no means advanta-
geous over established procedures. However, when individual RNA species are to 
be correlated with translational products, the procedure is far more sensitive 
and rapid than the only alternative, which is elution of RNA from gel slices 
which in addition generally involves o l i go dT-cellulose chromatography re-
quiring the presence of poly A sequences. Recently we found that RNA can be 
irreversibly bound for hybridization purposes by simply keeping i t at 50 С 
-tn vacuo for 10 minutes after complete drying. RNA bound to ECTEOLA in this 
manner hybridizes specif ical ly to radioactive probes albeit with a much lower 
eff iciency. Thus when detection levels are not a problem, ECTEOLA blot-hybri­
dization can be simplif ied considerably. 
The potential of ECTEOLA paper, which apparently allows a process as complica­
ted as protein synthesis to go on, may include the possibi l i ty of carrying out 
a large number of enzymatic reactions which involve nucleic acids. Conceivably, 
reversed transcription of ECTEOLA blotted RNA is possible and perhaps also 
following reactions involved in cDNA cloning may be conducted -tu ¿¿tu. 
In ¿.¿ta translation showed that also protein is bound by the paper, which 
4842 
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opens the possibi l i ty of blott ing proteins from gels and subsequently testing 
their enzymatic act iv i ty . 
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Hydroxylamine Cleavage of Proteins in Polyacrylamide Gels 
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Department of Biochemistry and 'Department of Zoology University of Nijmegen Nijmegen The Netherlands 
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A modification of the hydroxylamine cleavage of proteins is presented in which proteins were 
cleaved while immobilized in the malnx of a Polyacrylamide gel The reaction under these 
conditions retains its high specificity for Asn-Gly bonds and has the advantage that the gel 
matrix, acting as a earner facilitates simultaneous treatment of many samples, and contributes 
to a high recovery efficiency (60-90%) of the cleavage products The cleavage is performed with 
individual protein bands excised from dried slab gels after detection by staining, autoradiography, 
or fluorography The procedure can be easily combined with other techniques to further char-
actenze the cleavage fragments Also a two-dimensional version of the cleavage method was 
developed which allows rapid recognition of interrelationships between proteins m a complicated 
mixture The versatility of the procedure is demonstrated in a number of applications Highly 
related strains of munne leukemia viruses were easily distinguished from one another by the 
unique cleavage patterns of their gag- and em precursor polypeptides Comparing the env-pre-
cursor gPr82"'v synthesized in the presence or absence of tumcamycin with its cell free synthesized 
counterpart revealed the presence of an ammo-terminal signal sequence Cleavage patterns of 
pro-opiomelanocortin (POMC) from three different species revealed a high degree of homology 
between rat and mouse POMC whereas Xenopus POMC was very different Regions to which 
carbohydrates are attached could be identified by comparing glycosylated and unglycosylated 
forms of POMC Combining the hydroxylamine cleavage procedure with immunological char-
actenzation of the fragments showed a small but significant difference between the amino-
terminal sequences of the recombinant transforming protein P120 of Abelson munne leukemia 
virus and of its parent molecule РгбЗ*4 of Moloney munne leukemia virus 
KEY WORDS hydroxylamine cleavage Polyacrylamide gel electrophoresis, two-dimensional 
analysis, pro-opiomelanocortin, viral polyproteins, processing of proteins 
Hydroxylamine cleavage has been instru- substantial amounts of protein are being pro-
mental in the study of proteins for many years cessed With the development of the poly-
The reaction mechanism of this cleavage being acrylamide slab gel electrophoresis technique, 
such that cleavage occurs specifically at a lim- many proteins are being identified by their 
ited number of sites (Asn-Gly) and only par- position in gels after staining or autoradiog-
tially ( 1,2) made it particularly suitable for the raphy Further analysis of these small amounts 
generation of protein fragments on a prepar- of protein by hydroxylamine cleavage would 
ative scale to be used in sequence studies require time consuming large-scale elution 
However, recovery of the fragments from the from the gel followed by precipitation, cleav-
reaction mixture requires techniques (such as age, and again precipitation or dialysis Be-
dialysis) that can only be performed with a sides considerable loss of protein material in 
reasonable recovery efficiency when indeed each of these steps, this approach has a dis­
advantage in that only a small number of 
' Present address. Tumor Virology Labóralo^ ТЪе Salk S a m P l e S C a n ^ analyzed Simultaneously 
Institute San Diego, California 92138 W e therefore sought a modification of the 
2
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proteins immobilized in Polyacrylamide gels. 
The cleavage method which we present here 
allows treatment of individual bands cut from 
Polyacrylamide slab gels. The gel matrix acts 
as a carrier throughout the entire procedure, 
resulting in a high recovery efficiency of cleav­
age fragments, and facilitating treatment of 
many samples simultaneously. Rapid analysis 
of cleavage fragments by SDS3-polyacryl-
amide gel electrophoresis is possible by pro­
cessing the gel bands in a manner similar to 
the procedure used for proteolytic cleavage of 
protein gel bands described by Cleveland et 
al. (3). 
We chose to show a number of applica­
tions, to demonstrate the versatility of the 
technique. In a comparative study of retro­
viral precursor proteins we show that any 
number of gel bands could be rapidly ana­
lyzed and that the highly reproducible cleavage 
patterns allowed detailed conclusions with re­
spect to the protein structure. Using prohor­
mones from different species we show that 
fixing and processing of gels for fluorography 
do not interfere with the cleavage method. An 
example of how the cleavage method can be 
combined with other techniques is shown in 
an immunological characterization of cleav­
age fragments. 
Finally, we developed a two-dimensional 
version of the cleavage method. We show the 
application of this version to a mixture of cell-
free synthesized proteins. 
MATERIALS AND METHODS 
Chemicals. L-[35S]Methionine (sp act 800-
1300 Ci/mmol), U- ' t labe led protein hydro-
lysate (sp act 54 mCi/matom carbon), 
3
 Abbreviations used: ACTH, adrenocorticotropic hor­
mone; DEP, diethyl pyrocarbonate; DMEM, Dulbecco's 
modified Eagle's medium; MuLV, murine leukemia virus 
(AKR-MuLV, M-MuLV, R-MuLV, the AKR, Moloney, 
and Rauscher strains of MuLV); AbLV, Abelson Leu­
kemia Virus; NET, PBS, PBS-TDS, buffers (for compo­
sition, see Materials and Methods); POMC, pro-opiome-
lanocortin; SDS, sodium dodecyl sulfate; Hepes, 4-(2-hy-
droxyethyl)-l-piperazine ethanesulfonic acid; DMSO, 
dimethyl sulfoxide; PPO, 2,5-diphenyloxazole. 
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L-[35S]cysteine (sp act 1140 Ci/mmol), L-H.S-
'HJIysine (sp act 75 Ci/mmol), l.-[2,6-
'HJphenylalanine (sp act 50 Ci/mmol), and 
14C-marker proteins ('''C-methylated protein 
mixture) were obtained from Amersham, En­
gland. Tunicamycin was purchased from Cal-
biochem. La Jolla, California; oligo(dT)-cel-
lulose (T-3 grade) from Collaborative Re­
search Inc., Waltham, Massachusetts; 
acrylamide (electrophoresis grade) from Serva, 
Heidelberg, West Germany; bisacrylamide 
(electrophoresis grade) from Bio-Rad Labo­
ratories; Tris base (p.a.), lithium hydroxide 
(98%), formic acid (98-100%, p.a.), methanol 
(p.a.), and acetic acid (96%, p.a.) from Merck, 
Darmstadt, West Germany; guanidine hydro­
chloride from Sigma, St. Louis, Missouri; hy-
droxylamine hydrochloride (puriss. p.a.) and 
diethyl pyrocarbonate (purum) from Fluka 
A. G., Buchs, Switzerland; protein A-Se-
pharose CL-4B and SP-Sepharose (C25) from 
Pharmacia, Uppsala, Sweden; sodium dode­
cyl sulfate (SDS) from BDH Chemical Ltd., 
Poole, England. All water used was Dowex 
mixed bed deionized and Millipore filtered 
(Milli-Q). 
Cells and viruses. Cell lines used to meta-
bolically label retroviral precursor proteins 
were: Rauscher murine leukemia virus (R-
MuLV) producing JLS-V9 cells (4); Moloney 
murine leukemia virus (M-MuLV) producing 
Clone 1A cells (5); XH19 virus producing 
CCL-64 cells (6); AKR-MuLV producing 
NIH-3T3 cells (established by transfection of 
cloned proviral AKR DNA (7) onto NIH-3T3 
cells according to the procedure of Graham 
and van der Eb (8)). This cell line was a gift 
of F. A. van der Hoom. Abelson murine leu­
kemia virus (AbLV) transformed ANN-1 cells 
superinfected with and producing M-MuLV 
were a gift of Dr. С J. M. Melief (C. L. В., 
Amsterdam, The Netherlands). 
All cell lines were grown in Dulbecco's 
modified Eagle's medium (DMEM) contain­
ing 10% calf serum. AbLV transformed pro­
ducer cells were passaged by shaking the tissue 
culture flask and collecting the detached cells 
from the supernatant medium by low-speed 
56 SARIS ET AL. 
centrifugation; cells that remain firmly at­
tached to the substrate were shown to no lon­
ger express the AbLV-specific polyprotein 
(unpublished data). 
Antisera. Rabbit anti-MuLV p30 serum was 
prepared and described by van Zaane et al. 
(9). Goat anti-Rauscher pi5 serum and goat 
anti-Rauscher gp70 serum were obtained 
through the Office of Program Resources and 
Logistics of NCI/NIH Bethesda, Maryland. 
Rabbit anti-AKR-MuLV ρ 10 serum was a gift 
of Dr. J. N. Ihle, Frederick Cancer Research 
Center, Frederick, Maryland. 
Metabolic labeling. Subconfluent mono­
layer cells, chronically infected with and pro­
ducing a murine retrovirus, were labeled for 
20-30 min essentially as described by van 
Zaane et al. (IO). Per 25 cm2 of monolayer, 
1 ml of labeling medium containing 50-200 
μΟ of radioactive amino acids was used. 
When the labeling was with [35S]cysteine, cells 
were preincubated in labeling medium lack­
ing unlabeled methionine as well as cysteine. 
Labeling of cells in the presence of tuni-
camycin ( 1 Mg/ml labeling medium) was pre­
ceded by 4-h incubation in DMEM contain­
ing 1 Mg/m I tunicamycin. When labeling 
AbLV-transformed cells, the cells were col­
lected by low-speed centrifugation after each 
change of medium. 
To obtain radioactive mouse, POMC, in 
vitro incubations were conducted with mouse 
pars intermedia tissue. This tissue rapidly 
synthesizes two forms of the prohormone (II). 
Briefly, neurointermediate lobes of hetero­
zygous Tabby (TA/-I-) mice were separated 
from freshly dissected pituitary glands and in­
cubated in 0.1 ml of Hepes-buffered Ringer's 
solution for 30 min in the presence of 50 дСі 
each of [3H]lysine and [3H]phenylalanine. The 
lobes were homogenized in 0.5 ml 0.1 N HCl, 
centrifugea for 5 min at 10,000g, and the su­
pernatant was lyophilized in preparation for 
electrophoretic analysis. The same procedure 
was followed using neurointermediate lobes 
of Wistar rats. Further details concerning 
the labeling procedure can be found else­
where ( 12). 
Radioactive Xenopus POMC was obtained 
following a similar procedure. The neuroin-
termediate lobes used were from black back­
ground adapted animals which have been 
shown to have a high rate of synthesis of the 
two forms of POMC ( 13,14). 
To obtain nonglycosylated POMC, for each 
of the three species, similar experiments were 
conducted, except that the lobes were prein­
cubated in medium containing tunicamycin 
(10 iig/ml) for 4 h prior to the labeling with 
radioactive amino acids. 
Diethyl pyrocarbonate treatment. All solu­
tions used in RNA isolation, cell-free trans­
lation, and hydroxylamine cleavage were 
treated with DEP to eliminate possible con­
tamination with ribonuclcase or protease. 
Solutions were vigorously shaken with 0.1 % 
(v/v) DEP for 5 min and left overnight at 
room temperature. DEP was removed by 
boiling, while vigorously stirring, for 2-3 h. 
Solutions were brought to the original volume 
with DEP-treated water and finally auto-
claved. Complete removal of DEP proved to 
be essential for solutions used in cell-free 
translation. 
Isolation of RNA and cell-free translation. 
Cytoplasmic RNA was isolated from retro­
virus infected tissue culture cells by the method 
of Palmiter (15). The magnesium-nucleic 
acid-protein precipitate was dissolved in 10 
т м Tris-HCl, pH 6.9, 20 т м NaCl, 10 mM 
EDTA, 0.5% SDS and incubated with 0.5 mg/ 
ml self-digested (for 1 h at 5 mg/ml and 37 0C) 
proteinase К for 30 min at 370C. The solution 
was heated to 680C for 45 s, cooled to 450C, 
and added to an oligo(dT)-cellulose suspen­
sion in the same buffer. After 5 min at 450C 
the suspension was brought to 0.5 M NaCl 
and unbound material was eluted batchwise. 
After extensive washing, the cellulose was 
poured into a column and poly(A)+ RNA was 
eluted with 10 т м Tris, pH 7.4, and precip­
itated twice in 0.3 M LiCl, 70% ethanol. 
Virion 70 S RNA of M-MuLV was isolated 
as follows. Clone 1A cells were grown in roller 
bottles in a Bélico automatic harvester and 
medium was collected at 2-h intervals. The 
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virus was concentrated by Amicon ultrafiltra­
tion and further punned by discontinuous and 
linear sucrose gradient centnfugation. Pel­
leted virus was resuspended in 10 т м Tns-
HC1, pH 7 4, 100 т м NaCl, I т м EDTA, 
20% glycerol and stored at -70°C. For iso­
lation of RNA the virus suspension was 
brought to final concentrations of 0.5% SDS, 
0.1 mg/ml proteinase К (self-digested) and in­
cubated for 15 mm at 37CC. The suspension 
(4 ml) was then layered on an isokinetic SW27 
gradient of 15 9-41 6% (w/v) sucrose in 10 
т м Tns-HCl, pH 6.9, 100 т м NaCl, 1 т м 
EDTA, 0.2% SDS and centnfuged for 5 5 h 
at 24,000 rpm and 220C Material sediment-
ing at 70 S was precipitated twice with 0.3 м 
LiCl, 70% ethanol 
Cell-free translations were performed with 
the mRNA-dependent rabbit reticulocyte ly-
sate. Preparation of this lysate was essentially 
as described by Pelham and Jackson (16) ex­
cept that white blood cells were removed by 
chromatography over SP-Sephadex after Per­
ucho et al (17). RNA was translated at a final 
concentration of 25 Mg/ml for 2 h at 30oC. 
Translation was stopped by addition of 0 5 
mg/ml (final concentration) nbonuclease A 
and incubation for 10 mm at 370C. 
After addition of at least 5 vol of electro­
phoresis sample buffer, the samples were in­
cubated for 2 h at 370C and analyzed by Poly­
acrylamide gel electrophoresis. Alternatively 
the translation mixtures were prepared for 
immunoprccipitation as described below. 
Immunoprecipitation Viral polypeptides 
were immunoprecipitated from lysates of 
metabohcally labeled cells essentially as de­
scribed by van Zaane et al (9). After labeling, 
washed cells (25 cm2 of subconfluent mono­
layer cells) were lysed in 2 5 ml PBS-TDS (10 
т м sodium phosphate, pH 7.2, brought to 
pH 8.0 with Tns base), 0.9% (w/v) NaCl, 1% 
(v/v) Tnton X-100, 0 5% (w/v) sodium de-
oxycholate, and 0.1% SDS. The lysate was 
clanfied by centnfugation at 4 0 C and 45,000 
rpm in a Beekman Ti-50 rotor for 20 mm 
(start/stop). One ml of lysate was kept over­
night at 4 0 C with 5 ді of antiserum. Then 0.1 
ml of a 10% (v/v) suspension of protein A-
Sepharose was added and the mixture was 
shaken for 30 mm at room temperature. The 
immunoprecipitate-Sepharose complex was 
collected by centnfugation in an Eppendorf 
Minifuge for 2 mm and washed three times 
with PBS-TDS and once with PBS (PBS-TDS 
without detergents). Radioactive polypeptides 
were released from the complex by suspen­
sion in electrophoresis sample buffer (2 h 
370C; 5 min 950C) and subjected to SDS-gel 
electrophoresis. 
Immunoprecipitation of cell-free synthe­
sized polypeptides was initially performed by 
the same procedure as above except that SDS 
concentration in PBS-TDS was raised to 0.5%, 
to prevent nonspecific precipitation. Later we 
found that the polypeptides from cell-free sys­
tems were (specifically) precipitated with a 
much higher efficiency following the proce­
dure published by Dougherty and Hiebert ( 18). 
Ribonuclease treatment of translation mix­
tures was performed in the presence of 10 т м 
(final concentration) EDTA To 10 μΐ of this 
mixture 20 μ\ of 3% SDS, 5% mercaptoeth-
anol, 15% glycerol, 62.5 т м Tns-HCl, pH 
6 8 was added. After a 5-min incubation at 
95 0 C, 60 μΐ of NET buffer (150 т м NaCl, 5 
т м EDTA, 50 т м Tns-HCl, pH 7.4) con­
taining 0 05% Nonidet-P40, 1 mg/ml oval­
bumin, and 1 mg/ml methionine (or cysteine) 
was added. Finally 2 μΐ of antiserum was added 
and the mixture was kept at room tempera­
ture for 2 h and at 4 0 C for 16 h. Immuno-
precipitates were collected with Protein A-
Sepharose as desenbed above, washed three 
times with NET buffer containing 0.05% 
Nonidet-P40, once with NET buffer alone, 
released from the complex in electrophoresis 
sample buffer, and subjected to SDS-gel elec­
trophoresis. 
Polyacrylamide gel electrophoresis Sam­
ples were dissolved in electrophoresis sample 
buffer (10 M urea, 62.5 т м Tns-HCl, pH 6.8, 
3% SDS, 5% 2-mercaptoethanol) and applied 
to a Polyacrylamide slab gel prepared accord­
ing to the discontinuous gel system desenbed 
by Laemmh (19) The acrylamide-bisacryl-
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amide ratio was 40 1 07 and gel percentages 
are indicated by their percentage of mono-
mer After electrophoresis the gels were dned 
onto Whatman 3MM paper, either directly or 
after fìxmg and processing for fluorography 
according to published procedures (20). 
Hydroxylamine cleavage SDS-gel electro-
phoresis was performed and slab gels were 
dned as described above. Starting at this point 
in the procedure only heat-stenlized glassware 
or disposable plastics were used All solutions 
were made with DEP-treated Milli-Q water 
and gloves were worn when handling gels. 
Protein bands in the dned gel were located 
by autoradiography and excised The gel pieces 
(approximately 0 7 5 X 1 X 4 mm) were swelled 
in 5% methanol, paper backing was peeled off, 
and free SDS was removed by washing at 4<>C 
in four changes of 3 ml 5% methanol Pieces 
cut from low-percentage gels (less than 10%) 
were swelled in 40% methanol, 5% acetic acid, 
before washing in 5% methanol. Gel pieces 
could be stored at this point in 5% methanol 
at 40C for at least 1 month without degra-
dation of protein, provided the water used in 
the procedure had been DEP treated Gel 
pieces were brought to near-dryness m a vac-
uum desiccator and submerged in reaction or 
control mixture (50-200 μΐ of mixture per 3 
μΐ of gel material) in closed polypropylene vials 
and incubated for 3 h at 45 "С. The reaction 
mixture was made by dissolving 1.1 g hy­
droxylamine hydrochloride (final concentra­
tion 2 M), 4.6 g guamdine hydrochloride (final 
concentration 6 м), and 15 mg Tris base (final 
concentration 15 т м ) in 4 5 M lithium hy­
droxide to give a pH of 9.3 and a final volume 
of 8 ml. Control mixture was 6 м guamdine 
hydrochloride, 15 т м Tns base, pH 9.3. 
To prevent formation of insoluble carbon­
ates when making 4.5 м LiOH, it is important 
to use DEP-treatcd water that had been freshly 
boiled or had been stored in lightly closed 
bottles When necessary, the reaction mixture 
was clarified by filtration through glass-fiber 
filters After the reaction, gel pieces were blot­
ted on tissue paper and washed with four 
changes of 3 ml 5% methanol Again, low-
percentage gel pieces were briefly (5 mm) 
washed in 40% methanol, 5% acetic acid prior 
to the 5% methanol washing, to prevent elu-
tion of small fragments After washing the gel 
pieces are again brought to near-dryness, sub­
merged in electrophoresis sample buffer (30 
μΙ of buffer per 3 μΙ of gel material), and kept 
at 370C for 2 h and at 95 0C for 5 mm At 
this point protein was released from the gel 
matrix either by electroelution or by direct 
analysis on a second SDS-gel For electroelu­
tion, gel pieces were embedded in 1 % agarose 
in electroelution buffer (50 т м ammonium 
bicarbonate, pH 8 0, 0.1% SDS) in polypro­
pylene Eppendorf vials. After solidifying of 
the agarose the lid and the bottom of the vial 
were cut off with a razor blade and the vial 
was placed on top of a cylindrical gel tube 
which was closed at the bottom with dialysis 
membrane and filled with electroelution 
buffer The tube was placed in an apparatus 
for cylindrical gel electrophoresis filled with 
electroelution buffer and 5 mA per tube was 
applied for 8-16 h. Upper compartment buffer 
was removed by aspiration, leaving 0.4 ml of 
buffer in each tube Protein was recovered 
from the dialysis membrane by pipetting the 
0 4 ml of buffer up and down 10 times and, 
after addition of 0.1 ml of 5X PBS-TDS, im-
munoprecipitation was earned out as de­
scribed above 
Alternatively, protein suspended in elec­
troelution buffer was analyzed by SDS-gel 
electrophoresis directly after repeated lyoph-
ilization and dissolving in electrophoresis 
sample buffer lacking SDS. Protein immo­
bilized in gel pieces, equilibrated with sample 
buffer, was analyzed by SDS-gel electropho­
resis directly by placing the gel pieces at the 
bottom of a slot in the stacking gel. The slot 
was filled with sample buffer, the upper com­
partment electrophoresis buffer was carefully 
overlayered, and electrophoresis was con­
ducted as normal. Manipulation of gel pieces 
between glass plates was facilitated by choos­
ing the analytical gel slightly thicker than the 
preparative gel from which the gel pieces had 
been excised. Generally, we used 0.75- and 
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1 O-mm spacers for preparative and analytical 
gels, respectively When equilibrated gel pieces 
had been stored at -20CC, the excess sample 
buffer used for equilibration was taken to 
overlayer the gel piece in the stacking gel slot, 
since some protein material was released from 
the gel matrix by the freezing-thawing pro-
cess For this reason entire gel strips which 
were analyzed by the two-dimensional ver-
sion of the cleavage procedure, were always 
subjected to SDS-gel electrophoresis imme-
diately after equilibration in sample buffer 
The two-dimensional cleavage analysis was 
performed essentially as described above for 
individual gel bands except that the cleavage 
reaction was earned out by sealing the gel strip 
in small plastic bags which were filled with 
reaction mixture 
Counting of gel bandì Gel bands excised 
from preparative or analytical gels were 
washed in 5% methanol, lyophilized, and dis-
solved with 0 165 ml 70% HCIO4, 0 335 ml 
30% H2O2 by incubating them in tightly 
capped glass scintillation vials for 16 h at 60oC 
After addition of 10 ml Aquasol, radioactivity 
was measured in the combined Ή and ' 4 C 
channel 
RESULTS AND DISCUSSION 
Idenhfiiation and Characterization of 
Related Polypeptides 
To demonstrate how the cleavage proce­
dure presented here allows rapid and simple 
discrimination between related proteins, we 
show in Fig 1 the analysis of precursor pro­
teins of a number of highly related retrovi­
ruses Tissue culture cells, chronically in­
fected with one of four retroviruses, were pulse 
labeled with ["SJmethionme, and precursor 
proteins encoded by the gag and env gene of 
these viruses were punfied by immunoprecip-
itation with monospecific antisera followed 
by SDS-gel electrophoresis Radioactive bands 
were located by autoradiography and excised 
from the gel Gel bands were treated with hy-
droxylamine and placed on a second SDS-
polyacrylamide gel as desenbed in Materials 
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and Methods As a control we included the 
analysis of the gag gene precursor PróS*38 of 
M-MuLV which was either treated with hy-
droxylamine reaction mixture (lane 1) or with 
reaction mixture from which hydroxylamine 
was omitted (lane 2) 
From more extended studies (not shown) 
we know that M-MuLV PróS6"8 yields four 
major fragments in addition to a substantial 
amount of uncleaved material The latter phe-
nomenon as well as the fact that two of the 
four fragments are generated by partial cleav-
age are intrinsic to the reaction mechanism 
(2) In Fig 1, lane 1, only three of the four 
fragments are visible because one fragment 
does not contain methionine which was the 
only radioactive amino acid used in this ex-
periment. A 6-kDa, methionine containing, 
fragment which can be predicted on the basis 
of the cleavage map is also not seen because 
polypeptides smaller than approximately 10 
kDa are generally not recovered in this pro-
cedure The control (lane 2) clearly shows that 
all cleavages are hydroxylamine specific 
Moreover, the deduced positions of the two 
cleavage sites (Asn-Gly) are in excellent 
agreement with those predicted on the basis 
of the known amino acid sequence (21) and 
DNA sequence (22) of this virus This obser-
vation along with similar findings with other 
proteins leads us to believe that the known 
high specificity of hydroxylamine cleavage of 
proteins in solution is retained in this mod-
ified procedure in which the proteins are im-
mobilized in the gel matrix during the reac-
tion 
The companson of gag precursors (lanes 
3-6) and of env precursors (lanes 7-10) shows 
that the cleavage method allows one to clearly 
distinguish the four highly related retrovi-
ruses 
As an extension to the analysis of the env 
precursors we show (lanes 11 -13) the cleavage 
pattern of three variants of the env gene prod-
uct of M-MuLV These vanants are gPr82env 
which is synthesized m vivo, the related poly-
protein that is formed in vivo in the presence 
of tumcamycin which we designate P62env, and 
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Fio. 1. Hydroxylamine cleavage analysis of retroviral precursor proteins. Mink cells infected with XH19 
virus (lanes 3 and 7), M-MuLV (lanes I, 2, 4, 8, 11, and 13), R-MuLV (lanes 5 and 9), or AKR-MuLV 
(lanes 6 and 10) were labeled for 20 min with [3iS]methionine in the presence (lane 11) or absence (lanes 
1-10, 13) of tunicamycin. Viral precursor proteins were purified by immunoprecipitation with anti-p30 
serum or anti-gp70 serum followed by SDS-gel electrophoresis. Radioactive bands oí gag precursor PróS1" 
(lanes 1-6) and env precursor gPr82t"v (lanes 7-10, 13) were located by autoradiography, excised from the 
gel, and treated with hydroxylamine reaction mixture (lanes 1, 3-13) or a control mixture (lane 2). SDS-
gel electrophoresis of the reaction products is shown. The slowest-migrating band in each lane represents 
uncleaved material. Lane 11 shows the cleavage pattern of M-MuLV P62t"v, the unglycosylated variant of 
the env precursor which is synthesized in the presence of tunicamycin. Lane 12 shows the cleavage pattern 
of M-MuLV P67env, the unglycosylated, cell-free synthesized variant of the env precursor which was purified 
by immunoprecipitation with anti-gp70 serum from a reticulocyte translation mixture programmed with 
poly(A)+ RNA from infected cells. The radioactive molecular mass marker proteins in the lane M are 
Phosphorylase (94,000 D), bovine serum albumin (69,000 D), ovalbumin (46,000 D), and carbonic an-
hydrase (29,000 D). Additional proteins present in this marker mixture (but not visible in lane M) are 
myosin (200,000 D) and lysozyme (14,500 D). This Figure is composed of autoradiograms of three different 
gels: lanes M, 1, and 2; lanes 3-10; and lanes 11-13. 
the env gene product synthesized in vitro which 
we designate P67env. All three proteins yield 
a single cleavage fragment. The difference be-
tween the molecular weights of the fragment 
and uncleaved molecule is approximately 
5000 for gPr82env and P67cnv, and 2000 
for P62env. 
Sequence studies (21 ) predict a single cleav-
age site some 20 amino acids away from the 
N-terminus of gPr82env, thus predicting the 
generation of a fragment which is approxi-
mately 2 kDa smaller than the uncleaved 
molecule. This being the case for P62env, we 
believe the 5-kDa fragment cleaved from 
gPr82env to consist of 2 kDa of protein se-
quences and 3 kDa of carbohydrate. The lat-
ter agrees with the generally accepted contri-
bution to the apparent molecular mass weight 
on SDS-gels of 2-4 kDa (23) of a single 7V-
glycosidically linked carbohydrate core. The 
5-kDa fragment cleaved from P67env must, 
however, completely consist of protein se-
quences since the reticulocyte cell-free sys-
tem. from which P67env was isolated, is known 
to be incapable of glycosylation (25). On the 
basis of this result we conclude that the pri-
mary translation product of the env gene con-
tains a 3-kDa leader sequence which is re-
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moved in vivo. This finding confirms predic-
tions made by others on the basis of the DNA 
sequence (22). 
Cleavage of Proteins in Fluorographed Gels 
When tritium-labeled proteins are sepa-
rated on Polyacrylamide gels, one needs to 
treat the gel with a scintillating agent before 
autoradiography (which is then called fluo-
rography) can be performed (20). To prevent 
elution from the gel, the proteins are generally 
fixed in the gel in acid methanol prior to this 
treatment. We anticipated that preparation of 
gels for fluorography might interfere with the 
hydroxylamine cleavage method by introduc-
ing nonspecific cleavage, interfering with the 
cleavage reaction itself, or by altering the elec-
trophoretic behavior of the reaction products. 
We therefore analyzed protein bands, excised 
from a gel which had been processed for fluo-
rography, and show in Figs. 2 and 3 that none 
of the above mentioned problems occur. The 
proteins used for this analysis were glycosyl-
ated and nonglycosylated forms of POMC 
isolated from three different species (Xenopus, 
rat, and mouse). In each case the prohormone 
was labeled with tritiated amino acids in the 
presence and absence of tunicamycin and ex-
tracted as described under Materials and 
Methods. Lyophilized proteins were sepa-
rated on a preparative SDS-gel which was 
subsequently fixed and prepared for fluorog-
raphy according to published procedures. The 
fluorogram is shown in Fig. 2. During the short 
pulse labeling in the absence of tunicamycin, 
all three species synthesize two major proteins 
with slightly differing molecular masses be-
tween 30 and 40 kDa (lanes 2,4, and 6). These 
proteins have been shown to be immunolog-
ically related to ACTH and /î-endorphin and 
are processed to biologically active peptides 
during chase-incubations ((11); Jenks, un-
published data). They have therefore been 
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Ею. 2. Preparative gel electrophoresis of POMC derived from rat (R, lanes 1 and 2), mouse (M, lanes 
3 and 4), and Xenopui (X, lanes 5 and 6). Neurointermediate lobes were incubated for 30 min with [3H]lysine 
and [3H]phenylalanine in the presence (T, lanes 1, 3, and 5) or absence (lanes, 2, 4, and 6) of tunicamycin. 
Prohormones were acid extracted from the lobes, lyophilized, and subjected to SDS-gel electrophoresis. 
The 10% Polyacrylamide gel was subsequently fixed for 16 h in 10% (v/v) acetic acid, 10% (w/v) trichlo­
roacetic acid, 30% methanol and prepared for fluorography. The fluorogram is shown. Lanes M are ra­
dioactive marker proteins as in Fig. 1. 
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Fio. 3. Hydroxylamine cleavage analysis of POMC from rat (R), mouse (M). and Xenopus (X). Various 
forms of POMC synthesized in the presence (RT, and RT2 for rat. MT for mouse. XT, and XT2 for 
Xenopus) or absence (R! and R2 for rat. M, and M2 for mouse. X, and X2 for Xenoptn) of tunicamycin 
were located on the preparative gel by fluorography (shown in Fig. 2) and the gel bands were excised. Gel 
bands were treated with hydroxylamine and subjected to SDS-gel electrophoresis on a 12.5% analytical 
gel. The fluorogram of the analytical gel is shown. The lanes are indexed after the individual gel bands 
indicated in Fig. 2. The slowest-migrating material in each lane represents uncleaved POMC. The positions 
of three marker proteins, run on the same gel. are also indicated. 
designated pro-opiomelanocortin (POMO. In 
the presence of tunicamycin (lanes 1, 3, and 
5) all precursor proteins are between 4 and 8 
kDa smaller, reflecting the absence of car­
bohydrate. In the case of the mouse only a 
single nonglycosylated protein could be re­
solved on the short preparative gel. 
Individual bands were treated with hy­
droxylamine as described for unfixed gels and 
reaction products were separated on a second 
SDS-gel. The result is shown in Fig. 3. All 
four forms of POMC isolated from rat yielded 
a single cleavage fragment in addition to un­
cleaved material. This result is in agreement 
with the single cleavage site near the A'-ter-
minus as predicted from the nucleotide se­
quence of at least one rat POMC gene (26). 
We therefore conclude that neither fixation 
nor DMSO-PPO treatment of preparative gels 
causes any artifacts with respect to the spec­
ificity of the cleavage method or to the elec-
trophoretic behavior of the generated frag­
ments. In comparing the cleavage pattern of 
the rat and mouse POMCs we see a striking 
similarity. The two prohormones of Xenopus 
have been shown to possess several unique 
characteristics. Unlike the situation with rat 
and mouse, they do not differ in their degree 
or position of glycosylation. and the /З-еп-
dorphin moieties within each of the two Xen­
opus prohormones have a different primary 
structure (14). The hydroxylamine cleavage 
patterns, shown in Fig. 3, indicate that the 
sequence difference between POMC of Xen­
opus and those of rat and mouse, may be 
rather substantial. 
In addition to this comparative study, the 
hydroxylamine cleavage method may be in­
strumental in locating glycosylation sites on 
the POMC molecule, when combined with 
other cleavage methods. 
Two-Dimensional Cleavage Analysis afa 
Protein Mixture 
A fortuitous aspect of hydroxylamine 
cleavage of proteins in Polyacrylamide gels is 
that the protein and the generated fragments 
remain immobilized in the gel during the re­
action and subsequent washings. This aspect 
enabled us to efficiently remove the constit­
uents of the reaction mixture using the gel 
matrix as a carrier and thus keeping the loss 
of protein to a minimum. Taking advantage 
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of this fact we developed a two-dimensional 
version of the cleavage method which is par­
ticularly suitable for establishing interrela­
tionships between proteins in a complicated 
mixture. An analysis of this kind is shown in 
Fig. 4. When messenger RNA is purified and 
translated in a cell-free system one usually 
finds a number of translational products. Most 
of these will either be full-length proteins or 
premature terminations and artificial initia­
tions encoded by the purified RNA. Others 
may be encoded by minor contaminants in 
the RNA preparation which are translation-
ally highly active or which happen to be rich 
in the amino acid used as radioactive label. 
When 70S virion RNA of M-MuLV is trans­
lated in a reticulocyte cell-free system, a large 
number of translational products ranging from 
10 to 180 kDa are found. On the basis of the 
translational strategy of the virus it is expected 
that most ofthese proteins are encoded by the 
gag gene with some occasional readthrough 
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FIG. 4. Two-dimensional hydroxylamine cleavage analysis of in vitro translational products of M-MuLV 
70 S virion RNA. Virion RNA was translated in reticulocyte cell-free system in the presence of ("Cjcysteine 
and the translation mixture was subjected to preparative SDS-gel electrophoresis. A lengthwise central strip 
was cut from the preparative lane and treated with hydroxylamine reaction mixture. Part of the autora­
diogram of the preparative 10% gel, after cutting the strip, is shown at the top of the Figure. Migration 
was from left to right. After the reaction the gel strip was prepared for electrophoresis on a second-dimension 
12.5% gel. The strip was placed horizontally in a wide slot in a standard stacking gel which was polymerized 
on top of the 12.5% gel and overlayered with sample buffer. Migration was from top to bottom. Radioactive 
marker proteins were run alongside and their positions have been indicated. 
62 
64 SARIS ET AL 
into the pol gene From detailed studies of the 
m VÌVO and m vitro products of the gag gene 
((27-29), Sans et al. unpublished data) we 
know that this gene codes for two proteins 
РгбЗ
8
"
8
 and a protein called Рг75^в which 
contains all the sequences of Pr65Bag plus 7 
kDa of additional protein sequences at the N-
terminus Pr75e a e is only found in vitro or in 
vivo in the presence of tumcamycin In the 
absence of tumcamycin Pr75e a 6 becomes gly­
cosylated to form gPrSCF8 PróS«·*6 is found 
both in vitro and m vivo and is processed by 
proteolytic cleavage to form mature vinon 
proteins 
In Fig 4 we show the two-dimensional 
cleavage analysis of m vitro synthesized prod-
ucts of 70 S virion RNA of M-MuLV The 
entire protein mixture was subjected to elec-
trophoresis on a preparative 10% SDS-gel and 
a lengthwise central strip was cut from one 
lane of the gel The autoradiogram of this pre-
parative lane after cutting the strip is shown 
horizontally on top of the second-dimension 
gel in Fig 4 The gel strip was treated with 
hydroxylamine as described for small gel 
pieces and placed horizontally in a wide slot 
on top of a second-dimension 12 5% SDS-
gel Uncleaved molecules are seen as spots on 
a diagonal line, indicating that no spreading 
of the protein occurred during the reaction or 
second-dimension electrophoresis Homolo-
gous fragments of related proteins are found 
on horizontal lines For instance РгбЗ™ and 
Pr75e a e share C-terminal fragments A and a, 
and В and b, whereas (N-terminal) fragments 
С and c, and D and d are different in sue, 
reflecting the presence of the leader sequence 
in Pr75eag The assignment of fragments as N-
or C-terminal and the implied correspon­
dence between fragments A and a, В and b, 
etc, follow from an analysis of serological 
properties to be published elsewhere One 
protein (No 1 ) clearly shares N-terminal frag­
ments С and D (and not A and B) with PróS828 
suggesting that it arose by premature termi-
nation Similarly, another protein (No 2) ap-
pears to be a premature termination of Pr75Bag 
An interesting finding was protein No 3 The 
molecular weight of this protein and of its 
single cleavage fragment (arrow) are identical 
to what we find with a protein immunopre-
cipitaled from the in vitro translational prod-
ucts of messenger RNA of M-MuLV infected 
cells with anti-ewv sera, as was shown in Fig 
1, lane 12 Apparently 70 S vinon RNA con-
tains some translational activity of the em 
gene and the discovery of this activity dem-
onstrates the resolving power of the two-di-
mensional cleavage analysis, since protein No 
3 was not visible as a separate band in the 
first-dimension gel Finally, low-intensity spots 
each with one major cleavage fragment are 
seen in the range 180-80 kDa They represent 
the precursor of the viral reverse transcriptase 
and its artificial (internal) initiation products 
Immunological Identification of Fragments 
A limitation of the cleavage method pre-
sented thus far is that the generated fragments 
were charactenzed by their apparent molec-
ular weight in a second SDS-gel only 
We therefore included an expenment which 
demonstrates that this cleavage method need 
not exclude characterization of fragments by 
other means such as immunoprccipitation 
The genome of Abelson leukemia virus 
(AbLV), a virus (30) which arose by genetic 
recombination between M-MuLV and cel-
lular sequences (31), encodes a polyprotein, 
P120Êaeabl, which consists of cellular se-
quences fused to sequences which are derived 
from the gag gene of M-MuLV (32,33) 
As dibcussed in the previous section, M-
MuLV RNA directs the in \itro synthesis of 
two gag-related proteins PróS108 and Pr75eae 
The additional sequences in Pr75gag are be-
lieved to contain a signal for glycos} lation to 
yield the in vivo glycosylated gPrSO1^8. Since 
we found that the rale of synthesis and stiuc-
ture of Р120 8 а в а Ы was unaffected by tu­
mcamycin (not shown), it seemed unlikely 
that these sequences would be present in 
Ρ120gab-abl Unambiguous establishment of this 
fact is given by the autoradiogram of the high-
resolution gel shown in Fig 5 For unknown 
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FIG. 5. Immunoprecipitation of hydroxylamine frag­
ments. AbLV-lransformed ANN-1 cells superinfected with 
M-MuLV were labeled with '"C-amino acids. Polypro-
teins Р120е"*"аЬ1 and PróS"· were purified by immuno-
precipitation with anti-pl5 serum and subsequent SDS-
gel electrophoresis. Individual gel bands were treated with 
hydroxylamine and, after electroelution, the fragments 
were again precipitated with anti-pl5 serum. The precip-
itates from fragments of Ρ\2ΰΤ*-'Μ (lane I) and Рт65ш 
were analyzed on a 30-cm-long 7-18% gradient gel. The 
autoradiogram of the relevant part of this gel is shown. 
In this type of gel some fragments arc resolved as a double 
band (see text). In these cases, molecular weight estimates 
shown in the Figure apply to the average of the estimated 
values for the separate bands. 
reasons, hydroxylamine cleavage at a partic­
ular site consistently produces either single or 
double bands (not shown). Thus in Fig. 5, the 
fragments at 29 and 32 kDa are always dou­
ble; that at 23, never. The phenomenon is 
definitely not due to the presence of a cluster 
of two Asn-Gly bands, as follows from se­
quence data (21,22). Apparently, other spe­
cific structural features are involved. In some 
cases, the occurrence of a double band can be 
used to identify the cleavage site. In the pres­
ent experiment the presence of the double 
band at 29 kDa, and the single 23-kDa band 
derived from РгбЗ838 and their slightly heavier 
counterparts derived from Ρ120e a B a b l support 
the evidence presented below. 
Hydroxylamine fragments of M-MuLV 
РгбЗ
8
"
6
 and AbLV p ^ O 8 3 8 3 " 1 were immuno-
precipitated with an antiserum directed against 
the amino-terminal sequences of РгбЗ8"8 and 
analyzed on an SDS-gel. Clearly hydroxyl­
amine fragments are still immunogenic. 
РгбЗ
836
 yields amino-terminal fragments 
of 23 and 29 kDa, both of which appear to 
have a counterpart in P120gag'abl. In addition 
P1208a8"abl yields an amino-terminal fragment 
(double band) of 32 kDa. Apparently a mu­
tation in the p30 domain of Р1208а8"аЬ| intro­
duced a new cleavage site, or the cellular se­
quences which replaced the p30 domain con­
tain such a site. Although the 23- and 29-kDa 
fragment of Ρ120ga8'abl are very similar in size 
to the Pr65Eae fragments, a small difference of 
0.3 kDa is apparent. The leader sequences in 
PrTS838 were shown to be 7 kDa in size (un­
published data) and therefore the difference 
between PróS828 and p^O838"1" must be of a 
different nature. The slight alteration in elec-
trophoretic mobility could be due to amino 
acid changes or to some posttranslational 
modification of Р120» |**ы. One such modi­
fication could be the recently discovered tight 
association of lipid with Pi20 8 a 8 a b l (34). 
Recovery Efficiency of Fragments 
When cleavage fragments of PróS8"8 of M-
MuLV are separated on gels on which pro-
teins as small as 4 kDa are clearly visible, the 
predicted cleavage fragment of approximately 
6 kDa (the sequence between the two cleavage 
sites) is absent. On the other hand cleavage 
of AbLV Ρ120 and of Xenopus POMC (Fig. 
3) reproducibly yields fragments of approxi­
mately 10 kDa. Apparently the 6-kDa frag­
ment is lost during the reaction or subsequent 
washings, whereas the 10-kDa fragments are 
recovered. Having studied a large number of 
different proteins, we believe that the mini­
mum size of fragments that can be recovered 
in this procedure is, depending on the hydro-
phobicity, somewhere around 10 kDa. 
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In addition to loss of material due to elu-
tion from the gel piece at some point in the 
procedure, a small amount of material re-
mains irreversibly bound to the gel matrix as 
can be seen by autoradiography of the gel 
pieces following the reaction and electropho-
resis on the analytical gel Although predicted 
fragments larger than 10 kDa are invariably 
present in the analytical gel, the above ob-
servations prompted us to quantitate the re-
covery efficiency of the entire procedure As 
a model protein we chose actin, which con-
tains a single hydroxylamine cleavage site at 
approximately 1 kDa from the amino ter-
minus (35) Since the 1-kDa amino-tcrminal 
fragment was expected to be lost during the 
cleavage procedure, we used [15S]methionine-
labeled actin, because all methionines are 
contained within the larger fragment A 
[35S]melhionine-labeled NIH-3T3 cell lysate 
was equally divided over eight lanes of a pre-
parative 10% acrylamide gel After electro-
phoresis, the gel was fixed in 40% methanol, 
10% acetic acid, washed in water, and dned 
Actin bands were located by autoradiography, 
excised, and stored under 5% methanol (four 
gel pieces) or treated with hydroxylamine (four 
gel pieces) Two treated and two untreated gel 
pieces were prepared for scintillation count-
ing as described under Materials and Meth-
ods The remaining two gel pieces from each 
group were equilibrated with sample buffer 
and placed back on a second 10% gel After 
electrophoresis the gel pieces were recovered 
from the top of the gel and counted Upon 
re-electrophoresis, untreated gel pieces yielded 
a discrete actin band in addition to a faint 
background smear from the top of the gel to 
the actin band Hydroxylamme-treated gel 
pieces yielded a similar background smear and 
two discrete bands, one comigrating with ac-
tin and one migrating slightly faster Discrete 
bands of actin and of its single (radioactive) 
cleavage fragment were cut from the gel for 
counting Radioactivity in the background 
smear was quantitated by extrapolation from 
a few representative sections of this region of 
the gel Sections of similar size were cut from 
an empty lane to serve as background sub-
traction ( 110 cpm) The following results were 
obtained Radioactivity in untreated actin 
bands which were counted directly (11,500 
cpm) was set at 100% After hydroxylamine 
cleavage and subsequent washings, 95% of the 
input radioactivity was still associated with 
the gel matrix, indicating that virtually no loss 
of material occurs during this treatment, pro-
vided that the fragments are at least 10 kDa 
When untreated gel pieces were subjected to 
re-electrophoresis, 60% of the input radioac-
tivity was recovered as a discrete actin band, 
10-15% remained irreversibly bound to the 
gel matrix, and 25-30% was found in the 
background smear Hydroxylamine-treated 
samples gave similar results with 7-12% still 
bound to the gel piece, 20-25% in the back-
ground smear, and 60% as two discrete bands 
of uncleaved actin (35%) and the single cleav-
age fragment (25%), leaving 10% (of which 
5% was already lost) dunng the treatment) 
unaccounted for Thus the recovery of protein 
in discrete bands is 60% in both treated and 
untreated samples The amount of material 
present in the background smear vaned from 
time to time In particular when preparative 
gels were dned directly rather than being fixed 
first, the trailing to the top of the gel was prac-
tically absent and therefore appears to be due 
to time-dependant release from the gel ma-
trix The nature of the protein involved also 
appears to be of some influence since pro-
opiomelanocortins did not show any trailing 
despite the fact that they were recovered from 
fixed, PPO-treated gels The amount of pro-
tein material irreversibly bound to the gel ma-
trix was found to be 5-15% irrespective of the 
treatment of the gel pnor to drying or of the 
gel piece after being cut from the preparative 
gel Thus routine recovenes of both hydrox-
ylamine-treated and untreated bands are be-
tween 60 and 90% This is substantially higher 
than what we find with cleavage of these mi-
nute amounts of protein in solution Recov-
ery of cleavage fragments (of any size) from 
the high-salt reaction mixture proved very dif-
ficult Precipitation by addition of 9 volumes 
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of 20% trichloroacetic acid in absolute ace­
tone gave a recovery of 10-15%, while all other 
procedures tested (including dialysis) were less 
efficient. Thus, in addition to the advantage 
of allowing the processing of multiple sam­
ples, hydroxylamine cleavage in gel matrices 
results in a 5- to 10-fold higher recovery than 
cleavage in solution. 
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Precursor polyprotems containing translational products of the gag gene of 
Moloney munne leukemia virus were purified by gel electrophoresis and cleaved 
into large fragments by hydroxylamine mild acid hydrolysis, or cyanogen 
bromide The hydroxylamine cleavage method (specific for asparagine-glycine 
bonds) was adapted especially for this study The electrophoretic mobility and 
antigenicity of the fragments and, in some cases, the presence or absence of 
[•"Sjmethionme revealed detailed information on the structure of PréS*"*, 
gPrSO*"*, and Pr75,'"f (the unglycosylated variant of gPrSO*"* formed in vivo in the 
presence of tunicamycin or in vitro in a reticulocyte cell free system) When 
compared with PróS*"*, gPrSO*"* contains 7,000 daltons of additional amino acids, 
presumably as or as part of a leader sequence at or very close to its N terminus 
We present evidence that this leader may have replaced part of the pl5 sequence 
Furthermore, gPrSO*"8 contains three separate carbohydrate groups One is 
attached to the presumed leader sequence or to the pi5 domain, and two are 
attached to the p30 domain Each of the Moloney munne leukemia virus gag 
precursor proteins Pr65*"*, gPrSO*"", and PrTS*"* corresponds with a read-
through product into the poi gene We designated these products PrieO*"*'"'', 
gPr200*"i Р"' and P r W * ""' (the unglycosylated vanant of gPrZOO*"* ""'). respec­
tively gPr200'f°Ä'"'' contains all of the extra amino acids and carbohydrate groups 
present in gPrSO*"* and at least one carbohydrate group in its pol sequences 
Several investigations have been published 
concerning the multiple expression of the gag 
gene of munne leukemia virus (MuLV) Com-
mon to these studies is the discovery of an 
unglycosylated (Рг65'гад) and a glycosylated 
(gPrSO*"*) gag precursor protein It is generally 
believed that these two precursor proteins are 
synthesized independently (7) and processed 
differently PrtS*"* is first phosphorylated (20, 
29, 35) and subsequently processed to the ma­
ture vmon proteins pi 5, РІ2, p30, and plO by 
proteolytic cleavage On the other hand, 
gPrSO*"", which is glycosylated, is believed to be 
further glycosylated to a 94,000-dalton (94K) 
polyprotem which is expressed on the cell sur 
face and which is eventually processed to an 
85K cell surface protein or released into the 
culture medium (7, 17, 19) The 94K protein on 
the cell surface has been correlated with immu­
nologically defined cell surface antigens such as 
Gross cell surface antigen (18, 31) 
t Present address Tumor Virology Laboratory The Salk 
Institute San Diego CA 92138 
t Present address Department оГ Organic Chemistry Um 
versity of Nijmegen Toernooiveld 6525 ED Nijmegen The 
Netherlands 
Studies using inhibition of glycosylation with 
tunicamycin (29) and cell-free translation of viral 
RNA (7) have shown that compared with 
РгбЗ*"*, gPrSO*"* contains additional protein se­
quences as well as N-glycosidically linked car­
bohydrates The contribution of the carbohy­
drates to the apparent molecular weights 
determined by sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis (SDS-PAGE) has 
been estimated to be 6K for gPrSO*"« of both 
Moloney MuLV (M MuLV) (8) and Rauscher 
MuLV (R-MuLV) (27) Although equal carbohy­
drate contents of the two gPreO""' proteins are 
not surprising in view of the high degree of 
similarity which is known to exist between M 
MuLV and R-MuLV, the above-mentioned pub­
lications substantially differ in their assignment 
of the region(s) to which the carbohydrates are 
attached Schultz et al (27) showed the 6K of 
carbohydrates to be attached to R-MuLV 
gPr80*"* in two separate groups of 3K One is 
linked to Asnny of the p30 region, the other is 
linked somewhere within a region of 20K at the 
amino terminus of gPrSO*"* Edwards and Fan 
(8) have shown that the attachment of the 6K of 
carbohydrates to M-MuLV gPrSO4"* is in a re-
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gion which overlaps the 20K ammo-terminal 
region of R-MuLV by only 3K and which clearly 
excludes the p30 glycosylation site in R-MuLV 
gPrSO*"* Additional conflicting evidence exists 
with respect to the size and location of the extra 
protein sequence in gPrSO4'"4' Both Edwards and 
Fan (8) and Schultz et al (27) locate additional 
protein sequences of 4K. and 7K for M-MuLV 
and R-MuLV, respectively, at or near the ammo 
terminus of gPrSO*"*1 On the other hand, Kop-
chick et al , studying R-MuLV, believe the 
sequence to be attached to the carboxy terminus 
(14) 
In an attempt to resolve the above-descnbed 
differences, we studied the gag precursor pro­
teins of M-MuLV by using a different approach 
We compared the various gag precursor pro­
teins synthesized in vitro and m vivo in the 
presence and absence of tumcamycin after frag­
mentation and immunological characterization 
of the fragments with monospecific antisera 
Fragments were generated by hydroxylamme 
cleavage, mild acid hydrolysis, and cyanogen 
bromide cleavage Proteins were cleaved while 
immobilized in gel slices to prevent excessive 
loss of material The adaptation of the hydroxyl­
amme cleavage method for this purpose will be 
published in more detail elsewhere In this way, 
we not only located the additional ammo acid 
sequences and the carbohydrates in gPr80i"'·', 
but, using the sensitive hydroxylamme cleavage 
method, we were able to extend our studies to 
the gag pol precursor proteins These proteins 
are read-through products of the gag gene into 
the adjacent pol gene They occur in very small 
amounts in infected cells and, after processing, 
give rise to the viral reverse transcriptase They 
are generally referred to as PrlSO""" ''"', suggest­
ing the existence of a single species In gel 
electrophoresis, however, they clearly migrate 
as a double band At least one of these bands can 
be labeled with radioactive mannose (R Ar-
linghaus and H Fan, personal communications) 
and binds to lectin (9) The cleavage studies 
reported here allow us to draw some new con­
clusions with respect to the structure of the two 
gag-pol precursor polyproteins 
MATERIALS AND METHODS 
Chemicals. L-(35Sjmcthionine (specific activity 800 
to 1,300 Ci/mmol), U-^C labeled protein hydrolysate 
(specific activity, 54 mCi/matom of carbon), L-
( S]cysteine (specific activity, 1,140 Ci/mmol), and 
14C-marker proteins ('"C methylated protein mixture) 
were obtained from The Radiochemical Centre Amer-
sham, England Tumcamycin was from Calbiochem, 
La Jolla, Calif , oligodeoxythymidylate cellulose (T 3 
grade) was from Collaborative Research, Ine , Wal-
tham, Mass , acrylamide (electrophoresis grade) was 
from Serva, Heidelberg, West Germany bisacryla-
mide (electrophoresis grade) was from Bio Rad Labo­
ratories Richmond Calif , Tns base (p a ) lithium 
hydroxide (98%) formic acid (98 to 100%, pa), 
methanol (p a ) and acetic acid (96% ρ a ) were from 
E Merck AG Darmstadt West Germany, guanidine 
hydrochloride was from Sigma Chemical Co , St 
Louis, Mo , cyanogen bromide was from Pierce 
Chemical Co , Rockford, 111 , hydroxylamme hydro­
chloride (punss ρ a ) and diethyl pyrocarbonate 
(purum) were from Huka A G Buchs Switzerland, 
protein A Sepharose CL 4B and SP-Sepharose (C25) 
were from Pharmacia Fine Chemicals, Uppsala, Swe­
den, and SDS was from BDH Poole England All 
water used was Dowex mixed bed deionized and Milli-
pore filtered (Milli-Q) 
Cells and viruses Cell lines used to metabolically 
label precursor proteins were M MuLV-producing 
clone 1A cells (10) and Abelson murine leukemia virus 
(AbLV)-transformed ANN-1 cells supennfected with 
and producing M-MuLV Cells were grown in Dul­
becco modified Eagle medium containing 10% calf 
serum AbLV transformed producer cells were pas­
saged by shaking the tissue culture flask and collecting 
the detached cells from (he supernatant medium by 
low-speed centrifugalion, cells that remained firmly 
attached to the substratum no longer expressed the 
AbLV specific polyprotem (unpublished data) 
Antisera. Rabbit anti Rauscher p30 serum was pre­
pared and described by van Zaane et al (33) Goat 
anti-Rauscher pl5 serum and goat anti Rauscher pl2 
serum were obtained through the Office of Program 
Resources and Logistics ot the National Cancer Insti­
tute, Bethesda, Md Rabbit anti-AKR plO serum was a 
gift of J N Ihle, Frederick Cancer Research Center, 
Frederick Md 
Metabolic labeling. Subconfluent monolayer cells, 
chronically infected with and producing a murine 
retrovirus, were labeled for 20 to 30 mm essentially as 
described by van Zaane et al (34) Per 25 cm2 of 
monolayer 1 ml of labeling medium containing 50 to 
200 μΟ of radioactive amino acids was used When 
the labeling was with [''SJcysteine, cells were preincu-
bated in labeling medium lacking unlabeled methionine 
as well as cysteine 
Labeling of cells in the presence of tumcamycin (1 
μg/ml of labeling medium) was preceded by a 4-h 
incubation in complete medium (Dulbecco modified 
Eagle medium) containing tumcamycin (1 μg/ml) 
When AbLV-transformed cells were labeled, the cells 
were collected by low-speed centnfugation after each 
change of medium 
DEP treatment. All solutions used in RNA isolation, 
cell-free translation, and hydroxylamme cleavage 
were treated with diethyl pyrocarbonate (DEP) to 
eliminate possible contamination with RNase or prote­
ase Solutions were vigorously shaken with 0 1% (vol/ 
vol) DEP for 5 mm and left overnight at room tempera-
lure DEP was removed by boiling while vigorously 
stirring, for 2 to 3 h Solutions were brought to the 
original volume with DEP-treated water and finally 
auloclaved Complete removal of DEP proved to be 
essential for solutions used in cell-free translation 
Isolation of RNA and cell-free-translation. Virion 70S 
RNA of M-MuLV was isolated as follows Clone 1A 
cells were grown in roller bottles in a Bélico automatic 
harvester, and medium was collected at 2-h intervals 
The virus was concentrated by Amicon ultrafiltration 
and further punned by discontinuous and linear su-
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erose gradient centnfugation The pelleted virus was 
suspended in 10 mM Tns-hydrochlonde (pH 7 4)-100 
mM NaCI-1 mM EDTA-20% glycerol and stored at 
-70°C For isolation of RNA, the virus suspension 
was brought to final concentrations of 0 5% SDS and 
0 1 mg of proteinase К (self-digested) per ml and 
incubated for 15 mm at ІТС The suspension (4 ml) 
was then layered on an isokinetic SW27 gradient of 
15 9 to 41 6% (wt/vol) sucrose in 10 mM Tris-hydro-
chlonde (pH 6 9)-100 mM NaCI-1 mM EDTA-0 2% 
SDS and centrifuged for 5 5 h at 24,000 rpm and 22°C 
Material sedimentmg at 70S was precipitated twice 
with 0 3 M LiCl-70% ethanol 
Cell free translations were performed with the 
mRNA-dependent rabbit reticulocyte lysate Prepara­
tion of this lysate was essentially as desenbed by 
Pelham and Jackson (22) except that leukocytes were 
removed by chromatography over SP-Sephadex by the 
method of Perucho et al (23) RNA was translated at a 
final concentration of 25 μg/ml for 2 h at 30°C 
Translation was stopped by the addition of RNase A 
(0 5 mg/ml final concentration) and incubation for 10 
mm at 370C 
After the addition of at least 5 volumes of electro­
phoresis sample buffer, the samples were incubated 
for 2 h at VC and analyzed by PAGE Alternatively, 
the translation mixtures were prepared for immuno-
precipitation as described below 
Immunopreclpltatlon. Viral polypeptides were im-
munoprecipitdted from lysates of mctabohcally la­
beled cells essentially as described by van Zaane et al 
(33) After being labeled, washed cells (25 enr of 
subconfluenl monolayer cells) were lysed m 2 5 ml of 
PBSTDS (10 mM sodium phosphate [pH 7 2] brought 
to pH 8 0 with Tris base, 0 9% [wl/voll NaCI. Г [vol/ 
vol] Tnton X-100.0 5% [wt/vol] sodium deoxycholate, 
0 1% SDS The lysate was clarified by centnfugation 
at 4°C and 45,000 rpm in a Beekman 50 Τι rotor for 20 
mm (start/stop) A 1-ml portion of lysate was kept 
overnight at 4°C with 5 μΐ of antiserum, 0 1 ml of a 10% 
(vol/vol) suspension of protein A-Sepharose was then 
added, and the mixture was shaken for 30 mm at room 
temperature The immunoprecipitate-Sepharose com­
plex was collected by centnfugation in an Eppendorf 
mmifuge for 2 mm and washed three times with 
PBSTDS and once with PBSTDS without detergents 
Radioactive polypeptides were released from the com­
plex by suspension in electrophoresis sample buffer (2 
h at 37°C and 5 mm at 95°C) and subjected to SDS-
PAGE 
Immunoprecipitation of cell free-synthesized poly­
peptides was initially performed by the same proce­
dure described above except that the SDS concentra­
tion in PBSTDS was raised to 0 5% to prevent 
nonspecific precipitation Later we found that the 
polypeptides from cell-free systems were precipitated 
(specifically) with a much higher efficiency by the 
procedure published by Dougherty and Hieben (6) 
RNase treatment of translation mixtures was per­
formed in the presence of 10 mM (final concentration) 
EDTA To 10 μΙ of this mixture 20 μΙ of i% SDS-5% 
2-mercaploelhanol-l 5% glycerol-62 5 mM Tns-hy­
drochlonde (pH 6 8) was added After a 5-min incuba­
tion at 950C, 60 μΙ of NET buffer (150 mM NaCI, 5 mM 
EDTA, 50 mM Tns-hydrochlonde [pH 7 4]) contain­
ing 0 05% Nonidet P-40 and 1 mg each of ovalbumin 
and methionine (or cysteine) per ml was added Final­
ly, 2 μΙ of antiserum was added, and the mixture was 
kept at room temperature for 2 h and at 4°C for 16 h 
Immunoprecipitates were collected with protein A-
Sepharose as described above washed three times 
with NFT buffer containing 0 05% Nonidet P-40 and 
once with NET buffer alone, released from the com­
plex in electrophoresis sample buffer, and subjected to 
SDS-PAGE 
PAGE. Samples were dissolved in electrophoresis 
sample buffer (10 M urea, 62 5 mM Tns-hydrochlonde 
[pH 6 8]. 3% SDS, 5% 2-mercaptoethanol) and applied 
to a Polyacrylamide slab gel prepared according to the 
discontinuous gel system described by Laemmh (15) 
The acrylamide/bisacrylamide ratio was 40 1 07 and 
gel percentages are indicated by their percent mono­
mer After electrophoresis the gels were dned on 
Whatman 3MM paper either directly or after fixing 
and processing for fluorography according to pub­
lished procedures (4) 
Hvdrox)lamine cleavage. The method presented 
here is a modification of a published procedure for 
protein cleavage in solution (5) SDS-PAGE was per­
formed, and slab gels were dried as described above 
Starting at this point in the procedure, only heat-
stenlized glassware or disposable plastics were used 
All solutions were made with DEP treated Milli-Q 
water, and gloves were worn when gels were handled 
Protein bands in the dried gel were located by 
autoradiography and excised The gel pieces (approxi­
mately 0 75 by 1 by 4 mm) were swelled in 5% 
methanol the paper backing was peeled off, and free 
SDS was removed by washing at 4°C in four changes 
of 3 ml of 5% methanol Pieces cut from low-percent­
age (less than 10%) gels were swelled m 40% melha-
nol-5% acetic acid before being washed in 5% metha­
nol Gel pieces could be stored at this point m 5% 
methanol at 4°C for at least 1 month without degrada­
tion of protein, provided that the water used in the 
procedure had been DEP treated Gel pieces were 
brought to near dryness in a vacuum dessicator, 
submerged in a reaction or control mixture (50 to 200 
μΐ of mixture per 3 μΐ of gel material) in closed 
polypropylene vials, and incubated for 3 h at 45°C The 
reaction mixture was made by dissolving 1 1 g of 
hydroxylamine hydrochloride (final concentration, 2 
M), 4 6 g of guanidme hydrochloride (final concentra­
tion, 6 M), and 15 mg of Tris base (final concentration, 
15 mM) in 4 5 M lithium hydroxide to give a pH of 9 3 
and a final volume of 8 ml The control mixture was 6 
M guanidme hydrochloride-15 mM Tris base (pH 9 3) 
To prevent the formation of insoluble carbonates 
when making 4 5 M LiOH, it was important to use 
DEP-treated water that had been freshly boiled or 
stored in tightly closed bottles When necessary, the 
reaction mixture was clarified by filtration through 
glass fiber filters 
After the reaction, gel pieces were blotted on tissue 
paper and washed with four changes of 3 ml of 5% 
methanol Again, low-pertentage gel pieces were 
briefly (5 mm) washed in 40% methanol-5% acid 
before the washing with 5% methanol, to prevent 
elution of small fragments After the washing, the gel 
pieces were again brought to near dryness, submerged 
in electrophoresis sample buffer (30 μΙ of buffer per 3 
μΙ of gel material), and kept at 37°C for 2 h and at 95°C 
for 5 mm At this point, protein was released from the 
gel matrix either by electroelution or by direct analysis 
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on a second SDS gel For electroelution gel pieces 
were embedded in \% agarose in electroelution buffer 
(50 mM ammonium bicarbonate |pH 8 01, 0 1% SDS) 
in polypropylene Eppendorf vials After solidifying of 
the agarose the lid and the bottom of the vial were cut 
off wiih a ra¿or blade, and the vial was placed on top of 
a cylindncal gel tube which was closed at the bottom 
with dialysis membrane and filled with electroelution 
buffer The tube was placed m an apparatus for 
cylindrical gel electrophoresis filled with electroelu-
tion buffer and 5 mA per tube was applied tor 8 to 16 
h The upper compartment buffer was removed by 
aspiration, leaving 0 4 ml of buffer in each tube 
Protein was recovered from the dialysis membrane by 
pipetting the 0 4 ml of buffer up and down 10 times, 
and after addition of 0 1 ml of 5χ PBSTDS, immuno-
precipitation was carried out as described above 
Alternatively, protein suspended in electroelution 
buffer was analyzed by SDS-PAGE directly after 
repeated lyophilization and dissolving in electrophore 
sis sample buffer lacking SDS Protein immobilized in 
gel pieces equilibrated with sample buffer was ana­
lyzed by SDS PAGE directly by placing the gel pieces 
at the bottom of a slot in the stacking gel The slot was 
filled with sample buffer, the upper-compartment elec­
trophoresis buffer was carefully overlaid, and electro­
phoresis was conducted normally The manipulation 
of gel pieces between glass plates was facilitated by 
chosing the analytical gel to be slightly thicker than the 
preparative gel from which the gel pieces had been 
excised Generally, we used 0 75- and 1 0-mm spacers 
for preparative and analytical gels, respectively When 
equilibrated gel pieces had been stored at -20°C, the 
excess sample buffer used for equilibration was taken 
to overlay the gel piece in the stacking gel slot, since 
some protein material was released from the gel matrix 
by the freezing-thawing process 
Mild acid hydrolysis and cyanogen bromide cleavage. 
Protein bands were excised from preparative gels and 
washed to remove SDS as described above The gel 
pieces were brought to complete dryness by lyophili­
zation, submerged in 70% formic acid (40 μΙ of acid per 
3 μΙ of gel material) in 1 ml Eppendorf vials, and kept 
in the dark for 36 h at room temperature Cleavage of 
proteins under these conditions is substantially con 
fined to aspartic acid-prolme (Asp-Pro) bonds (16) 
Subsequently, the acid was diluted 20-fold with Wr 2-
mercaptoethanol and lyophilized three times, 30 μ| of 
electrophoresis sample buffer was then added, and 
after equilibration at 37°C for 2 h and at 950C for 5 mm, 
the gel pieces were applied to Polyacrylamide slab gels 
as desenbed above Whether or not equilibrated gel 
pieces had been frozen for storage, the excess sample 
buffer was used to overlay the gel piece because a 
substantial amount of protein material is released from 
the gel matrix during the acid hydrolysis and subse­
quent lyophilization Cyanogen bromide cleavage was 
performed essentially as desenbed above for acid 
cleavage, except that 15 mg of cyanogen bromide per 
ml was present For immunological characterization, 
fragments were electroeluted as desenbed above for 
hydroxylamme fragments 
RESULTS 
Isolation of precursor proteins. For the cleav­
age analyses presented in the following sections, 
J VlROL 
we used ^a^-related precursor proteins from 
various sources We first compare these pro­
teins and explain their nomenclature 
Radioactive precursor proteins of M-MuLV 
were purified from virus-infected cells and from 
cell-free-translation mixtures by immunoprecipi-
tation with monospecific antisera and separated 
by preparative Polyacrylamide slab gel electro­
phoresis Individual bands were located in the 
gel by autoradiography and excised Subsequent 
cleavage of individual proteins was performed 
while the protein was still immobilized in the gel 
matrix Generated cleavage fragments were sep­
arated on SDS gels either directly or after elec­
troelution and immunoprecipitation as described 
above Generally, gaf> precursors were isolated 
from M-MuLV-infected clone 1A cells, whereas 
gag-pol precursors were isolated from M-
MuLV-mfected AbLV-transformed ANN-1 
cells We have studied gag and gag-pol precur­
sors from both sources and found no difference 
in their cleavage patterns (data not shown) We 
used two different cell lines for the following 
reasons gag-pol precursors were more easily 
isolated from ANN-1 cells During short pulses, 
expression of the pol gene in ANN-1 cells is 
confined to two precursors in the 180K to 200K 
range, whereas in clone 1A cells the label is 
distributed over the same two precursors in 
addition to a number of intermediary processing 
products Although processing in clone 1A cells 
appears to be faster for gag precursors as well, 
we used these cells because they were used in 
previous investigations (7, 8) Therefore, the 
structure of the M-MuLV gag precursors pre­
sented here can be directly compared with the 
findings in the above-mentioned publications In 
vitro translational products of the gag gene were 
isolated by immunoprecipitation from mRNA-
dependent reticulocyte lysates programmed 
with 70S RNA from virions of M-MuLV har­
vested at 2-h intervals from the culture medium 
of clone 1A cells Figure 1 shows some relevant 
gel electrophoresis patterns of immunoprecipi-
tates (lanes 1-3, 9, and 10) and of individual 
proteins eluted from gel slices (lanes 4-8) In 
keeping with the commonly used nomenclature, 
we refer to the glycosylated and unglycosylated 
gag precursor proteins as gPrSO4'"'1' and Ргбі""*, 
respectively The protein core of gPreO*"*, des­
ignated Pr75i"'·', can be isolated from reticulo­
cyte lysates as described above or from cells 
grown in the presence of tunicamycin In our 
analyses, we did not detect any differences 
between Pr75','"i;s isolated from these two 
sources When relevant, the source is indicated 
in this paper The smaller, apparently unglyco­
sylated (see below) gag-pol precursor (synthe­
sized in either the presence of absence of tunica­
mycin) is designated PrlSO*"'""'' For reasons 
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FIG. 1. SDS-PAGE analysis of pl5-related retroviral precursor proteins. Virus-infected cells were labeled for 
20 to 30 min with ("SJmethionine in the presence or absence of tunicamycin, and cell lysates were 
immunoprecipitated with anti-plS serum. The precipitates were separated in an 8% gel. In vitro products were 
synthesized in a reticulocyte cell-free system and precipitated with anti-pl5 serum. The immunoprecipitates 
analyzed were from AbLV-transformed M-MuLV-infected ANN-1 cells in the absence (lane 1) or presence (lane 
2) of tunicamycin; from M-MuLV-infected Clone 1A cells in the absence (lane 10) or presence (lane 9) of 
tunicamycin; or from in vitro products of M-MuLV 70S virion RNA (lane 3). Individual bands were excised from 
the preparative gel and prepared for cleavage. Small samples of electroeluted individual proteins were 
lyophilized and reelectrophoresed (lanes 4-8). Individual precursor proteins shown are PrtS*"* (in vivo) (lane 4), 
gPrSO8"8 (in vivo) (lane 5). Pr75'»"' (in vivo with tunicamycin) (lane 6). Pr75s''s (in vitro) (lane 7), and PròS«"« (in 
vitro) (lane 8). The radioactive marker protein mixture (lane M) consisted of myosin (200K). Phosphorylase 
(94K), bovine serum albumin (69K), carbonic anhydrase (29K). and lysozyme (14.5K). The proteins which we 
designated P77 and P82 are ^öif-related polyproteins of unknown origin. Structural aspects of P77 and P82 are 
discussed in the text. Polyproteins P120 and P90 are AbLV encoded (24, 36). 
given below, the larger gag-pol precursors are 
called PrlW"4'"''"' (when obtained in the pres-
ence of tunicamycin) and gPr200s"4"'"'' (when 
obtained in the absence of tunicamycin). The 
proteins which we designated P77 and P82 are 
^ag-related polyproteins of unknown origin. 
Structural aspects of P77 and P82 are discussed 
below. Polyproteins PI 20 and P90 are AbLV 
encoded (24, 36) and have not been included in 
the cleavage analyses presented here. 
Hydroxylamine cleavage of gag precursors. 
Clone 1 cells were labeled with ["SJmethionine, 
[35S]cysteine, or a mixture of 14C-amino acids in 
the presence or absence of tunicamycin. The 
gag precursors were precipitated from the cell 
lysates by anti-pl5 serum. Cell-free-synthesized 
gag precursors were purified from reticulocyte 
lysates programmed with 70S RNA from virions 
of M-MuLV. Immunoprecipitates were electro-
phoresed on 8 or 10% Polyacrylamide slab gels. 
and individual protein bands were treated with 
the hydroxylamine reaction mixture a control 
mixture as described in Materials and Methods. 
Reaction products were separated on a 12.5% 
gel (Fig. 2). Precursors labeled with r35S]cys-
teine (lanes 10-13) all yielded four major frag-
ments in addition to uncleaved material. A com-
parison of these lanes with the control lanes 
(lanes 1-4) shows that all cleavages were hy-
droxylamine specific. 
Pr75*"s synthesized in vitro (Fig. 2, lane 11) 
yielded the same cleavage pattern as Рг75А а д 
synthesized in vivo in the presence of tunicamy­
cin (lane 12). This indicates that no signal se­
quence is removed in vivo unless the loss of this 
sequence would be exactly compensated for by 
residual glycosylation. However, in the pres­
ence of tunicamycin, such carbohydrate groups 
would have to be O-glycosidically linked (32), 
and previous studies (7, 29) have shown that this 
type of glycosylation does not occur. We there­
fore believe that the two Pr75' ," is are identical. 
Similarly, VrdS""1' synthesized under three dif­
ferent conditions (in vitro and in vivo with or 
without tunicamycin) yielded identical cleavage 
patterns (data not shown). Thus, either the three 
forms are identical or possible small differences 
(phosphorylation?) do not significantly alter the 
mobilities of the fragments in the gel systems 
used here. Therefore, the source of PróS*"* 
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FIG. 2. SDS-PAGE of cleavage fragments generated by a hydroxylamine reaction mixture (lanes 6-13) or a 
control mixture (lanes 1-4). gag precursor proteins were immunoprecipitated with anti-pl5 serum from lysates of 
clone 1A cells which had been labeled for 30 min in the absence or presence of tunicamycin with [15S]methionine 
or [35S]cysteine. Also, 35S M-MuLV virion RNA cell-free products labeled with ["Slmethionine or ["SJcysteine 
were immunoprecipitated with anti-pl5 serum. Individual proteins were purified by SDS-PAGE and subjected to 
cleavage as described in the text. Fragments of methionine-labeled proteins (lanes 1-4 and 6-9) and cysteine-
labeled proteins (lanes 10-13) were separated on a 12.5% gel, and the autoradiogram is shown. Precursor 
proteins were gPrSO*'"* (in vivo) (lanes 1, 6, and 13), Pr75s"s (in vivo with tunicamycin) (lanes 2, 7, and 12), 
PrtS«"* (in vitro) (lanes 3, 8, and 11), and PrtS«"* (in vitro) (lanes 4,9, and 10). The marker protein mixture (lanes 
M and 5) was as described in the legend to Fig. 1. 
appears to be irrelevant in the kind of analysis 
presented here, and below we refer to all three 
forms as Рг65*ад. 
When comparing the cleavage patterns (Fig. 
2) of Рг65 е в д, Рг75*"е, and gPrSO*"8 labeled with 
either [35S]methionine (lanes 6-9) or [35S]cys-
teine (lanes 10-13), two differences are appar­
ent. As expected, the choice of radioactive 
amino acid(s) influenced the relative intensities 
of the bands. However, the effect of the choice 
of the label appears to be much stronger for 
Pr75í:ofí and gPrSO»""·' than for Рг65«и«. The impli­
cations of this phenomenon are discussed be-
TABLE 1. Size and antigenicity of hydroxylamine 
cleavage fragments 
Mol wt (xlO1) of fragments 
PrbS"1 
65 
46 
39 
29 
23" 
from precursor; 
Pr75""' 
72 
46 
39 
36 
30 
gPrSO"" 
80 
51 
45 
39 
33" 
Reactive with 
antibody" against: 
pl5, pl2, p30, plO 
p30, più 
p30, plO 
р15, р12 
р15, р12 
° PrtS'"'* fragments were not tested with anti-pl2 or 
anti-plO. 
' Weak activity with anti-pl2. 
low. Second, of all the fragments generated from 
[35S]cysteine-labeled precursors, only one was 
not radioactive when [35S]methionine was used 
as the label. Apparently, the smallest fragment 
of РгбЗ*"* does not contain methionine. 
In Table 1 we summarize the characteristics of 
the fragments generated from the various gag 
precursor proteins. Molecular weights were cal­
culated from the migration distance on 30-cm-
long 7 to 18% linear gradient gels which exhibit a 
linear relationship between log of molecular 
weight and migration distance. The antigenic 
activity of the fragments was determined by 
immunoprecipitation with monospecific antisera 
and subsequent SDS-PAGE of the precipitates 
applied to eluates of hydroxylamine-treated gel 
slices. Clearly, anti-p30 and anti-plO sera precip­
itated the same fragments. Also, anti-pl5 and 
anti-pl2 sera precipitated the same fragments, 
except the smallest fragment from each precur­
sor was less reactive with anti-pl2. Protein 
bands reactive with all four antisera (Table 1) 
represent the uncleaved molecules. Note that 
Pr75*"íí migrates with an apparent molecular 
weight of 72K. The presence of uncleaved and 
partially cleaved molecules, which is actually 
quite useful in this type of analysis, is inherent to 
the reaction with hydroxylamine (5). 
From the known subgene order within the gag 
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gene, i.e . p15-pl2-p30-plO (2, 25), and the data 
summarized in Table 1, we constructed a hy-
droxylamme cleavage map (Fig. 3). The place-
ment of the Prôi*'"- fragments according to their 
antigenic nature and size indicates two hydrox-
ylamine cleavage sites One is located approxi-
mately in the middle of pl2 and the other in p30 
close to the pl2-p30 junction 
From the fragments reactive with anti-p30 
serum and anti-plO serum, we concluded that 
РгбЗ*"* and Pr75'-'"t' have identical carboxyter-
mini. Although the presence of a cleavage site 
close to the carboxy terminus could mask a C-
terminal extension of РПУ" (as has been sug­
gested [14]). we believe this to be highly unlikely 
for the following reasons. The absence of any 
partial cleavage fragments would require com­
plete cleavage at this hypothetical site. This 
would be in conflict with the reaction mecha­
nism (5). In addition, a similar masking would 
also have to take place with other cleavage 
methods, including mild acid hydrolysis and 
cyanogen bromide cleavage (see below) and 
limited V8 proteolysis (8). Also, the difference in 
mass between Pr65l""! and Pr75*"'; of 7K is 
exactly accounted for by the 7K difference be­
tween the amino-termmal fragments of Рг65?ад 
and Рг75';"*. Therefore, we conclude that the 
additional ammo acid sequences present in 
P^'™' are located at or near the ammo termi­
nus Although these sequences need not be 
contiguous and could also be inserted in the pl5-
pl2 region, we have tentatively placed them at 
the amino terminus as a leader sequence, for 
reasons given below. It has been shown previ­
ously that Pr75i"''' is the precursor ofgPrSty·'"*' (7, 
29) From hydrovvlamine cleavage experiments 
with the em precursor of M-MuLV (manuscript 
in preparation), we know that removal of signal 
sequences also occurs in the presence of tumca-
mycin Having shown above that this is proba­
bly not the case with Pr75,;"ç, we assume that 
Pr75s"i' indeed represents the entire protein core 
of gPrSO*"* Therefore, we attribute any differ-
ences in the molecular weight of corresponding 
fragments generated from Pr75i;"'·' and gPrSO*"* 
to carbohydrate groups. Based on this reason-
ing, the map in Fig 8 (see below) shows that 3K 
of carbohydrates is attached to the pl5-pl2 
region or to the protein leader and that 6K is 
attached to the рЗО-plO region. 
Mild acid hydrolysis of gag precursors. In the 
cyanogen bromide cleavage analysis (see be­
low), a number of fragments could not be ac­
counted for by cleaving at methionine only. It 
was expected that cleavage at Asp-Pro bonds 
could have occurred, due to the acidic condi­
tions (16) To discriminate between the two 
kinds of cleavages, we subjected РгвЗ*"*, 
Pr75 i" ï, and gPrSO*"''' labeled with either 
kip'* 1 ,15 Ι ρ 30 »IS 
, , 
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gPrBO 
FIG 3 Hydroxylamme cleavage map. Fragments 
generated by hydroxylamme from PróS*"*, Рг75*''г, 
and gPreO8"* were placed on a physical map on the 
basis of iheir immunological properties as summanzed 
in Table 1 Map coordinates are defined on the basis of 
the molecular weights of the mature viral proteins pl5, 
pl2, p30, and plO Fragments are indicated by molecu­
lar weight in kilodaltons (kD) The orientation from the 
amino terminus to the carboxy terminus is from left to 
right 
["SJmethionine or a '''C-amino acid mixture to 
cleavage in acid alone Gel analysis of the frag­
ments is shown in Fig. 4 The fragments have 
been summarized in Table 2 and placed on a 
cleavage map (Fig 5) on the basis of the follow­
ing arguments. 
Both РгЬЗ*·'* and Pr75',"fi (Fig 4, lanes 1, 2, 5, 
and 6) yielded major methiomne-containing frag­
ments of 47K and 56K and a minor fragment of 
44K A high-resolution gel analysis of these 
fragments revealed (data not shown) that the 
44K and 56K fragments migrate as single bands 
whereas the 47K fragment appears as a doublet. 
The fact that Ргб. "'8 and Prl5*"* yielded an 
identical set of fragments suggests that these 
fragments stretch from acid-sensitive sites in the 
pl5-pl2 region to the common carboxy termi­
nus This conclusion is supported by an analysis 
of the gag polyprotein РбЗ4'"*' encoded by Mo­
loney sarcoma virus (unpublished data). A hy­
droxylamme cleavage analysis of Moloney sar­
coma virus РбЗ4'"" revealed that it is very similar 
to M-MuLV РгбЗ""«, except for some 1.5K of 
ammo acids at or near the carboxy terminus of 
Prb5*"* which apparently are missing from 
РоЭ*"* Indeed, the methiomne-containing acid 
cleavage fragments of РОЗ""* (two single bands 
and one doublet) are all 1.5K smaller than their 
PrtS""* counterparts, thus confirming the car-
boxy-terminal location of the latter fragments. 
РгбЗ*"* labeled with '4C-ammo acids yielded 
single bands at 13K and 24K and a doublet at 
19K (Fig. 4, lane 1). Although the molecular 
weights of these fragments and their supposed 
C-terminal complements do not add up exactly 
75 
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FIG. 4. SDS-PAGE analysis of acid cleavage frag-
ments. M-MuLV gag precursors were isolated by 
precipitation with anti-pl5 serum from lysates of clone 
1A cells pulse-labeled with MC-amino acids (lanes 1-3) 
or [35S]methionine (lanes 4-6). Labeling was in the 
presence (Pr75«',s) or absence (Pito8'« and gPrSO*"*) 
of tumcamycin. Precursors were PrtS*"* (lanes 1 and 
6), Pr75'""t (lanes 2 and 5), and gPrSO*"* (lanes 3 and 4). 
Lane 7 is a longer exposure of lane 6. Individual bands 
from the preparative gel were treated with acid and 
subsequently prepared for gel analysis as described in 
the text. The fragments were separated on a 10-cm-
long 7 to 18% gradient gel, and the auloradiogram is 
shown. The bands indicated with an asterisk are 
discussed in the text. The marker protein mixture (lane 
M) was as described in the legend to Fig 1. 
to the molecular weight of PróS8"", we believe 
them to fit on a cleavage map as presented in 
Fig. 5. This interpretation is in agreement with 
the relative intensities of the fragments and with 
the hydroxylamine cleavage experiments which 
predict the absence of methionine in the smaller 
N-terminal acid cleavage fragments of РтбЗ""" 
-23 и 
Pr 75 
дРг80 
k l ρΐί ι pii ι ρ» ipioj cNBr CLEAVAGE 
, 25 T « 57 SITES 
33 1
 ' 
«3 
23 
, 23 , 
2β , 
39 
. Ю , 
'? 1 
Pr65 
дРг О 
FIG. 5. Physical map of fragments generated from 
Pi««0», PrTS*"», and gPrêO*08 by mild acid hydrolysis 
or cyanogen bromide. Arguments for the placement of 
the various fragments are given in the text. Orientation 
and map coordinates are as in Fig. 3. Ammo-terminal 
(pl5-related) fragments produced by cyanogen bro-
mide have not been indicated since they are the same 
as the ones produced by acid alone. 
TABLE 2. Comparison of acid cleavage fragments 
Cleavage at 
coordinate": 
1 
r 
f r 
3 19 24 47 
L 
. 
1 
65 
56 
47' 
44 
24 
19' 
13 
2 
72 
56 
47' 
44 
33 
29' 
19 
Mol wt ( χ 10') of fragments* 
3 
80 
62 
57 
5У 
50 
32' 
23 
4 
80 
62 
^7 
53' 
50 
32' 
28 
23 
5 
72 
56 
47' 
44 
33 
29' 
19 
6 
65 
56 
47' 
44 
19'' 
Fragment 
location 
Uncleaved 
С terminal 
N terminal 
С terminal 
С terminal 
N terminal 
N terminal 
С terminal 
N terminal 
" Braces connect fragments which are produced by cleavage at the same site. Cleavage sites are indicated by 
their map coordinates as defined in the legend to Fig. 5. 
6
 The numbers at the top of each column refer to lanes 1 through 6 In Fig 4. 
' Fragments that migrate as doublets. 
d
 Only visible upon longer exposure (Fig. 4, lane 7) 
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The methionine-labeled band at 19K, which is 
only visible in longer exposures (Fig 4, lane 7), 
is discussed below. 
Before turning to the fragments of the other 
precursors, we note that the added molecular 
weights of the fragments produced by cleavage 
at a particular site tend to exceed the estimated 
molecular weight of the uncleaved molecule. 
The same phenomenon was observed with hy-
droxylamine cleavage In general the molecular 
weights of the fragments added up to an average 
of 68K, 75K, and 85K for Pros'™' (65K), Рг75і""'' 
(72K), und fiPrSO""1·' (80K), respectively In the 
cleavage maps in Fig. 3 and 5, we chose to 
define the map coordinates on the basis of the 
mature viral proteins pl5, pl2, p30, and plO 
since the positioning of most cleavage sites was 
based on relatively small fragments. Although 
we believe the relative positions of the cleavage 
sites to be accurate, the cleavage maps do reflect 
some numerical inconsistencies 
The fragments generated from PrlS""* (Fig 4, 
lanes 2 and 5) are easily accounted for by the 
acid cleavage sites introduced so far at coordi­
nates 13, 19, and 24. The two single bands at 
44K and 56K and the doublet at 47K which, by 
virtue of thier identity with the РгбУ"'* frag­
ments, had already been assigned to the С 
terminus leave N-terminal complements of 33K 
and 19K (single bands) and 29K (doublet), re­
flecting the presence of the 6K to 10K protein 
leader sequence. 
gPrSO*""·' (Fig 4, lanes 3 and 4) yielded a set of 
four large fragments, three of which (62K, 53K, 
and 50K) resemble the set generated from 
РгбЗ*"* and Pr75' ;" i in that their intensities and 
relative mobilities with respect to one another 
are similar On high-resolution gels the minor 
50K fragment and the major 62K fragment mi­
grated as single bands, whereas the major 53K 
fragment was found as a doublet. This typical 
electrophoretic behavior and the relative intensi­
ties of these fragments indicate that they are the 
glycosylated (6K of carbohydrates) counterparts 
of the C-termmal 44K, 47K, and 56K fragments 
of РгбЗ*"* and PT75>""! which are produced by 
cleavage at map coordinates 24, 19, and 13, 
respectively. Similarly, N-terminal fragments of 
gPrSO*"* (Fig. 4, lanes 3 and 4) produced bv 
cleavage at coordinates 13 and 19 were found at 
23K (single band) and 32K (doublet). The ex­
pected N-terminal fragment of approximately 
36K produced by cleavage at position 24 cannot 
be unambiguously identified, due to the pres­
ence of a number of bands in this region. 
Hydroxylamine cleavage had previously 
shown that gPrSO*"* carries 3K of carbohydrates 
in its N-terminal region The smallest N-terminal 
acid cleavage fragments of PrôS*"* (13K), 
р
г
75еад ( 1 9 K ) i a n d gPr8(K"í' (23K) now allowed 
us to confine the attachment of these carbohy-
drates to the 7K protein leader sequence and the 
13K ammo-termial sequences of pl5 In addition 
to the fragments discussed so far, gPr80','"'•' yield-
ed two fragments (57K and 28K, indicated by 
asterisks in Fig. 4, lane 4) for which there are no 
obvious counterparts in РгбЗ*'"* and Рг75*ад. 
The 57K. fragment consistently migrated slightly 
slower than the 56K fragments of РтвЗ""" and 
p
r
75»"/f Because the 57K. and 28K fragments 
add up to the same molecular weight (85K) as do 
the other sets of fragments, we believe them to 
be produced by cleavage at a single site Unlike 
the 23 К and 32K amino-terminal fragments of 
gPrSO*·""·'. the 28K fragment labels more effi­
ciently with [3,S] methionine than with a 1 4C-
amino acid mixture, arguing against an N-termi-
nal location of the 28K fragment. Also, if the 
28K fragment were to be N terminal and, conse­
quently, the 57K fragment were to be С termi­
nal, their positions on the gel between the frag­
ments produced by cleavage at sites 13 and 19 
(23K and 32K, and 53K and 62K, respectively) 
would predict fragments in similar relative posi­
tions for Рг65*'ад and PTIS""", since the cleavage 
analyses discussed so far show that no carbohy­
drates are attached to gPrSO*"" between map 
positions 13 and 19 Since no such fragments 
were found, we assign the weak acid cleavage 
site that gives rise to the 57K and 28K fragments 
to the carboxy-terminal region. The precise lo­
cation of this site is revealed by a 19K fragment 
generated from PróS*"" which labels with 
[•^Slmethiomne (Fig 4, lane 7) Although one 
could argue that the removal of the initiating 
methionine of PróS4'0''' may not always be com-
plete, thus sometimes leaving 35S label in the 
amino-terminal fragments (including the 19K N-
terminal fragment), we have never observed 
such a phenomenon in hydroxylamine cleavage 
experiments. Therefore, we assign the 19K 
[35S]methionine-labeled PrbS5"« fragment to the 
carboxy terminus and locate the weak acid 
cleavage site at coordinate 47 We chose coordi-
nate 47 rather than 48 (67 minus 19) for reasons 
given below in the discussion of the cyanogen 
bromide fragments. 
The size of the 19K carboxy-terminal frag-
ment of РгбЗ*"* reveals why none of the other 
Ргбв""* and Pr75'''°t' fragments produced by 
cleavage at position 47 could be identified. Both 
Ргб?*"" and ΡτΊδ""" contain a cleavage site at 
19K from the amino terminus (at positions 19 
and 13, respectively) and therefore produce frag­
ments which comigrate with those produced by 
cleavage by coordinate 47. The size difference 
between the 28K and 19K. carboxy-terminal 
fragments of gPrSO*''"·' and PróS""" indicates that 
all of the carboxy-terminal glycosylation sites in 
gPreO*"* are located within 19K from the car-
77 
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boxy-terminus. Although the 28K and 19K frag­
ments would suggest 9K of carboxy-terminal 
carbohydrates, we believe them to be 6K on the 
basis of all other fragments produced by acid, 
cyanogen bromide, or hydroxylamine. 
Cyanogen bromide cleavage of gag precursors. 
To locate the glycosylation sites within gPrSO™ 
more precisely, we used a cleavage method that 
was likely to yield fragments smaller than the 
one generated by hydroxylamine cleavage. The 
method we chose was cyanogen bromide treat­
ment at low pH, which cleaves at methionine 
residues as well as at a limited number of acid-
sensitive sites, particularly Asp-Pro bonds. 
Рг65у"« and gPrSO^, homogeneously labeled 
with 14C-amino acids, were cleaved with cyano­
gen bromide in the gel matrix, and after lyophili-
zation, fragments were analyzed by SDS-PAGE 
directly or after electroelution and immunopre-
cipitation (Fig. 6). Concentrating on the amino 
1 
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Β , 
32 
23 
3 
A 
l i 
?5 
¿j 
3 
в 
J • 
23 
4 
A 
111 
4 
В 
49 
m 
FIG. 6. Cyanogen bromide cleavage of gag precursors. M-MuLV Pros'""1 and gPr80s"1' were precipitated with 
anti-pl5 serum from lysates of pulse-labeled ('4C-amino acids) clone 1A cells. Individual bands were excised 
from the preparative gel and treated with cyanogen bromide as described in the text. Fragments were 
electroeluted from the gel matrixes and immunoprecipitated with anlisera directed against pl5 (lanes 1), pl2 
(lanes 2), p30 (lanes 3), or plO (lanes 4). A small sample of the mixture of fragments was taken before 
immunoprecipitation and prepared for direct gel analysis (lanes 5 and 6). Precursor proteins were РтЫ""' (lanes 
A and 5) and gPr80*'"r (lanes В and 6). Fragments were separated on a 30-cm-long 7 to 20% gradient gel, and the 
autoradiogram is shown. The molecular weights (kilodaltons) of the fragments are indicated. The marker protein 
mixture (lanes M) was as described in the legend to Fig. 1. 
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terminus first, we see pl5-related fragments of 
13K and 19K for РгбЗ*"* (lane 1A) and of 23K 
and 32K for gPrSO "^* (lane IB) Precipitation 
with anti-pl2 serum (lanes 2) is very weak 
Similar results were obtained with the hydroxyl-
amine fragments Apparently the weakness of 
the bands is primarily due to the relative weak­
ness of the antiserum rather than to a poor 
antigenic activity of the fragments 
We believe that the pl5-related cyanogen bro­
mide fragments are produced by cleavage at 
acid-sensitive sites, rather than at methionines, 
for the following reasons Hydroxylamine cleav­
age of Pr65'"'* yielded two ammo-terminal frag­
ments (23K and 29K), only one of which (29K) 
could be labeled with [''Slmethionine Thus, the 
methionine closest to the amino terminus of 
Pro5*0* is located between coordinates 23 and 29 
(in Fig 3 these coordinates were averaged to 23 
and 28) The pl5-reldted cyanogen bromide frag­
ments are therefore too small to be produced by 
cleavage at methionines alone Generation of 
these fragments by combined cleavage at methi­
onines and acid-sensitive sites is incompatible 
with the acid cleavage sites assigned to this 
region In fact, both PrôS*"* and gPrSO4"" yield 
ed pl5-related cyanogen bromide fragments that 
were indistinguishable from the ones generated 
by acid alone We therefore believe that the 
fragments of 13K and 19K from РгбЗ""« and of 
23K and 32K from gPrSO*"* are produced by 
acid hydrolysis at coordinates 13 and 19, respec­
tively 
Hydroxylamine cleavage (Fig 3) at map coor­
dinate 23 yielded amino-terminal fragments of 
23K, 30K, and 33K for PrtS«"*, PrTS*"*, and 
gPrSO""', respectively When ["SJmethionine 
was used as a label, the 23K fragment was not 
radioactive whereas the 30K and 33K fragments 
were Therefore, the methionine which rendered 
the 30K and 33K fragments radioactive must be 
located in the 7K protein leader sequence Com-
panng the relative intensities of acid hydrolysis 
fragments of gPrSO*"* (Fig 4, lanes 3 and 4), we 
note that the 23K ammo-terminal fragment la­
beled approximately as efficiently with a mixture 
of '''C-amino acids as with [15S|methionine, 
whereas the 28K carboxy-termmal fragment (as­
terisk) preferentially labeled with [' Sjmethio-
nine We take this result to indicate that the 23K 
fragment contains fewer methionines than the 
28К fragment, since both fragments have a 
protein core of 19K, although we can not ex­
clude some influence of the amino acid composi­
tion on the specific activity of the 14C labeled 
fragments In the cyanogen bromide cleavage 
map (Fig 5), discussed in more detail below, we 
see that the 28K carboxy-termmal acid hydroly­
sis fragment of gPrSO*"* contains two methio­
nines We therefore conclude that the 23K ami-
no-terminal acid cleavage fragment of gPrSO*"* 
and thus the 7K protein leader sequence contain 
only one methionine Since we found that the 
amino-terminal cyanogen bromide fragments of 
gPrSO4'"" are the same as those produced by acid 
hydrolysis, the methionine in the 7K leader 
sequence either is exceptionally resistant to cy­
anogen bromide or is located so close to the 
amino terminus that cleavage does not signifi­
cantly alter the electrophoretic mobility Below 
we show that all other methionines in both 
РгбЗ*"* and gPrSO*0* are, at least to a significant 
degree, susceptible to cyanogen bromide cleav­
age We therefore favor the interpretation that 
the methionine in the 7К leader sequence is 
located either at or, based on the resolution of 
our gels, within 5 to 10 amino acids from the 
amino terminus The inability to obtain specific 
cleavage with cyanogen bromide near the amino 
terminus was confirmed with individual hydrox­
ylamine fragments of РгбЗ*"*, Pr75A"*, and 
gPrSO*"* (data not shown) 
Thus, the attribution of the ammo-terminal 
glycosylation site to either the leader sequence 
or the pl5 domain awaits further investigation 
A major carboxy-termmal cyanogen bromide 
fragment which exclusively precipitates with 
anti-plO serum is a 10K fragment for both 
PrôS*"* (Fig 6, lane 4A) and gPreO*"" (lane 4B), 
confirming the identity of their С termini and 
confining the carboxy-termmal glycosylation 
sites to the p30 domain Having shown that the 
acid cleavage site closest to the С terminus is at 
position 47 on the map, we locate a methionine 
at 10K from the carboxy terminus at position 57 
Major рЗО-related fragments are 25K and 33K 
for Pr«*"* (Fig 6, lane ЗА) and 28K and 39K for 
gPrSO*"4 (lane 3B) Assuming that these major 
fragments are generated by cleavage at methio­
nines or at major acid cleavage sites, we place 
the 33K fragment of PróS""* between map coor-
dinates 25 and 57 Although the added molecular 
weights of the carboxy-termmal cyanogen bro-
mide fragments indicate a cleavage site at posi-
tion 24 rather than 25, we place a methionine at 
position 25 for the following reasons Cyanogen 
bromide fragments reactive with both anti-plO 
serum and anti-рЗО serum are 43 К and 49K for 
PrtS*"* and gPrSO*"*, respectively Acid cleav­
age at a relatively weak site which we 
positioned at coordinate 24 on the basis of a 24K 
amino-terminal fragment yielded carboxy-
termmal fragments which are IK larger (44К and 
50K for Pr65'""< and gPrSO*"*, respectively) than 
the cyanogen bromide fragments To indicate 
this fact we placed a methionine in position 25 
on the cleavage map, in keeping with the hy­
droxylamine map which locates a methionine 
between coordinates 23 and 28 However, to 
keep an internally consistent map in the car-
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boxy-terminal region, we used coordinate 24 for 
this methionine in the calculations described 
below Sequence studies (21) have shown that 
p30 of a large number of MuLVs (including M-
MuLV) contains two methionines The second 
major рЗО-related fragment (25K) from Рг65*"* 
therefore is likely to be generated by cleavage at 
methionines as well, since the only acid-sensi-
tive site in this region (at position 47) was shown 
to be relatively weak The presence of a methio­
nine at both ends of the PrfiS*'"· 25K fragment 
implies that the 33K fragment of PrbS1""1 is the 
result of partial cleavage at one of these methio­
nines The 8K difference between the РгбЗ*"" 
fragments of 25K and 33K locates the second 
methionine in p30 at coordinate 32 or 49 Before 
deciding between these two possibilities, we 
note that based on their relative intensities, the 
gPrSO*"« counterparts of the 25K and 33K frag­
ments are 28K and 39K, respectively Apparent­
ly, the larger fragment contains 6K of carbohy­
drates and the smaller contains only 3K of 
carbohydrates Thus, the carboxy-termmal 6K. 
of carbohydrates is divided into two separate 
groups of 3K each One group is attached to the 
sequence shared by the 28K and 39K fragments, 
the other is attached to the 8K sequence which is 
unique to the 39K fragment Locating the sec­
ond methionine at coordinate 32 would imply 
one glycosylation site between coordinates 24 
(25 on the map) and 32 Cleavage with acid 
alone, however, showed that the entire 6K of 
carbohydrates is attached to a 19K carboxy-
terminal fragment Therefore, we locate the sec­
ond methionine of p30 at position 49 
Both РтЪ5к"к and gPrSO*"* produced a p30-
related fragment of 23 К which migrated as a 
double band This fragment is too small to be 
produced by cleavage at methionines alone 
Cleavage by acid alone produced 23K to 24K 
fragments from both РгбЗ*"* and gPrSO*"" How­
ever, these fragments were amino terminal 
Therefore, the 23K anti-p30-specific double 
band must be produced by cleavage at a methio­
nine on one side and at a weak acid cleavage site 
on the other side The only way to place this 
fragment while keeping an internally consistent 
map is between the methionine in position 25 
and the weak acid cleavage site in position 47 
Thus, of the two glycosylation sites in p30, one 
is located between map coordinates 47 and 49, 
and the other is located between the two methio­
nines at coordinates 49 and 57 
Hydroxy lamine cleavage of gag-pol-precursors. 
The high-molecular-weight gag-pot precursor 
protein, commonly referred to as PrlSO*"*'*', 
usually appears in SDS gels as a double band 
When labeled in the presence of tunicamycin, 
the larger of the two proteins migrates slightly 
faster, whereas the mobility of the smaller pro-
J VIROL 
tern is unaltered Since the availability of the 
hydroxylamine cleavage technique would enable 
us to study the structure of the individual gag-
pol pol) proteins in some detail, we decided to 
extend our investigations to these molecules 
gag and gag poi precursor polyproteins labeled 
with [3,S]methionine in the presence or absence 
of tunicamycin were immunoprecipitated from 
ANN 1 cell lysates with anti-pl5 serum and 
separated on an 8% Polyacrylamide gel The gel 
pattern of these immunoprecipitates is shown 
above (Fig 1, lanes 1 and 2) The nomenclature 
which we use for the various gag-pol precursors 
is indicated in Fig 1 After hydroxylamine treat­
ment of individual bands, fragments were elee-
troeluted from the gel matrix and concentrated 
for SDS-PAGE analysis either by lyophilization 
or by immunoprecipitation with anti-pl5 serum 
(Fig 7) PrlSty"""'"' and gPr200t"*'"'' synthe­
sized in the absence of tunicamycin yielded pl5-
related fragments which comigrated with those 
generated from РгбЗ*'"·' and gPrSO*"1, respec­
tively The new protein, Рт\90>-"к p"', synthe­
sized in the presence of tunicamycin, yielded 
pl5-related fragments that comigrated with 
those from the simultaneously formed P^S*"* 
In addition, all three gag-pol precursors yielded 
a major pl5-related fragment that is approxi­
mately 30K smaller than its uncleaved parent 
molecule The faster migrating gag-pol precur­
sors synthesized in either the presence or the 
absence of tunicamycin yielded identical cleav­
age patterns (both after lyophilization and after 
anti-pl5 precipitation) except for some minor 
fragments which were obviously a result of 
contamination with the slower-moving species 
Therefore, the faster-moving species are re­
ferred to below as PrlSO*"* '"'' regardless of the 
presence or absence of tunicamycin during their 
synthesis 
The total mixture of fragments prepared by 
lyophilization contained a number of fragments 
which were not precipitated with anti-pl5 se­
rum Both Prl804" i '"' ' and PrigO*'"""'' yielded 
such a fragment of 26K in addition to a set of 
minor fragments in the 90K to 150K. range 
Because the 26K fragment does not fit in the 
cleavage map of the рЗО-plO region (Fig 3), it is 
apparently denved from the pol sequences This 
conclusion is supported by the finding of major 
pl5-related fragments which are some 30K 
smaller than the uncleaved molecules We there­
fore locate a hydroxylamine cleavage site in the 
pol sequences at 26K from the carboxy termi­
nus Minor pl5-related fragments, about 50K 
shorter than the uncleaved molecules, suggest a 
second cleavage site in the pol sequences 
However, the unambiguous establishment of 
such a site by finding a 50K fragment for both 
Prlgo*"» ""' and РГІ90'""""'' and (see below) a 
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FIG. 7. SDS-PAGE analysis of hydroxylamine cleavage fragments of gag and gag-pol precursor proteins 
isolated from AbLV-transformed M-MuLV-infected ANN-1 cells pulse-labeled with I^Slmethionine in the 
presence or absence of tunicamycin. Precursor proteins were precipitated with anti-pl5 serum from cell lysates 
and subjected to preparative gel electrophoresis (8% gel) Individual gel bands were treated with hydroxylamine. 
Fragments were electroeluted and prepared for analysis on a 30-cm-long 10 to 20% gradient gel either directly 
(lanes 9-12) or after immunoprecipitation with anti-pl5 serum (lanes 1-8). Precursor proteins were PróS*'"1 (with 
tunicamycin) (lane 1), PrtS»"« (lane 2), Pr75«"s (with tunicamycin) (lane 3), gPrSO*"8 (lane 4), Рг18№""""'' (with 
tunicamycin) (lanes 5 and 9), Pr^O""»""' (lanes 6 and 10), Pr 190*'"""'' (with tunicamycin) (lanes 7 and 11), and 
gPr200'""f-'"" (lanes 8 and 12). 
slightly larger fragment for gPr200s"Ä''"' was not 
possible because of a local distortion in the gel in 
this molecular weight range. 
All fragments of Рг^О*"«-"0' and P r l W 0 * " " ' 
were identical except those which encompass 
the amino terminus. Therefore, the only differ­
ence appears to be in the amino-termmal leader 
sequence. Although the leader was shown to 
lengthen the gag precursor by a stretch of 7K 
only, we used the designations Prl80A'"y"''"' and 
Р г І Э О ^ " " ' to indicate that they are read-through 
products of РгбЗ4""·' and Pr75e" , ;, respectively. 
Finally, the amino-terminal fragments of 
gPrlOO*™-''"' corresponded to those of gPrSO4""·'. 
Thus, they indicate the presence of an additional 
amino acid sequence of 7K and one 3K carbohy­
drate group. The apparently internally located 
fragments in the 90K to 150K range were all at 
least 10K larger than the ones generated from 
PrlSO*""·"'"''. Although carbohydrates attached to 
these fragments could all be located in the pol 
sequences, it seems likely that the two glycosy-
lation sites in the p30 domain of gPrSO*"* are 
also present in gPr200*"*"/"''. The carboxy-termi­
nal 26K fragment was absent, and instead a 29K 
fragment appeared. We can rule out the possibil­
ity that the fragment was derived from the amino 
terminus of contaminating PrlSO*"*"''"' because 
anti-pl5 precipitations showed that, unlike the 
other gag-pol precursors, gPr200*'2i"'"'/ was ab­
solutely pure. The shift of 3K being typical for 
the tunicamycin-sensitive attachment of a single 
carbohydrate group, we locate a glycosylation 
site in the 26K carboxy-terminal region of the 
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poi sequences To indicate that the glycosyl 
ated gag poi precursor which migrated slightly 
ahead of myosin (200 K) appears to be a read-
through product of gPrSO*"* with at least one 
additional carbohydrate, we chose to designate 
it gPrtOO'"'*'"" 
DISCUSSION 
In this report we present cleavage analyses of 
gag and gag-pol precursor proteins By compar-
ing fragments of glycosylated and unglycosylat 
ed proteins we were able to locate the differ-
ences Discrimination between additional amino 
acid sequences and attached carbohydrates was 
made possible by the study of protein cores of 
glycosylated molecules which were synthesized 
in vivo in the presence of tunicamycin or in vitro 
in a reticulocyte cell-free translation system In 
attnbuting the observed differences either to 
additional protein sequences or to glycosylation, 
we presumed that no other co- or post-transla 
tional modifications take place To our knowl-
edge only one such modification does in fact 
occur, namely, the phosphorylation of PróS*"* 
(20, 29, 35) Since phosphorylation of РгбЗ*"* is 
confined to the pi 2 domain (20) and possibly the 
plO domain, whereas gPrSO*"* is non-phosphor 
ylated (29, 35), we can assess the effect of 
phosphorylation on the electrophoretic mobility 
of these proteins and their cleavage fragments 
Comparing amino-terminal cleavage fragments 
of PróS*"" and gPrSO*"« which contain either 
none of the pl2 sequences (acid cleavage frag 
ments of 13Kand 23K respectively) orali of the 
pl2 sequence (hydroxylamine fragments of 29K. 
and 39K, respectively), we find a 10K difference 
in both cases Similar results were obtained with 
carboxy-terminal fragments Thus wc concluded 
that phosphorylation of these fragments does 
not significantly alter their electrophoretic mo-
bility Likewise, if the plO domain of Pr65,;"f is 
phosphorylated, it does not appear to affect the 
mobility in gels because both PröS*-"" and 
gPrSO8"* yield identical 10K carboxy terminal 
cyanogen bromide fragments Therefore, in the 
interpretation of the analyses presented here, 
phosphorylation has not been taken into ac-
count 
Fragments produced by hydroxylamine, acid, 
and cyanogen bromide were placed on a physi-
cal map as shown in big 3 and 5 Sequence data 
which became available during the course of this 
investigation (11, 30) allow us to verify the 
cleavage maps, which were entirely based on the 
size and antigenicity of the fragments Locating 
hydroxylamine cleavage sites at coordinates 23 
and 28 corresponds well with asparagine-glycine 
(Asn-Gly) bonds Asnny-Glyng and Азпгзг 
Gly222 (amino acid numbering from reference 
11) Asp-Pro bonds Asp91-Pro92 and Aspi89-
Pro,^ likely represent the acid cleavage sites at 
coordinates 13 and 24 Interestingly two Asp 
Pro bonds, which are only six amino acids apart 
(Asp,«,-?™,*, and Asp16é Pro,*:), coincide with 
an acid cleavage site (at coordinate 19) where 
cleavage invariably yielded fragments that mi-
grated as doublets The acid cleavage site at 
coordinate 47 also coincides with two Asp-Pro 
pairs (Азрзвз-Ргочит and Asp18,-Pro186) Al­
though cleavage by cyanogen bromide at this 
site generated a 23K fragment which migrated as 
a doublet we do not believe that this reflects the 
presence of these two Asp-Pro bonds, because 
all fragments produced by cleavage at this site 
by acid alone migrated as single bands Finally, 
the positions (25, 49, and 57) where cyanogen 
bromide-specific cleavage occurs are in excel­
lent agreement with those of the methionines 
N161,9,, Met394, and Met473 The introduced 
cleavage sites account for all Asn-Gly bonds, 
Asp Pro bonds, and methionines found in the 
PröS4"* sequence except for one at ASP247-
РГО248 Acid cleavage at this site is expected to 
produce Рг65*аА fragments of between 30K and 
40K Indeed, some material was found in this 
region of the gel but when [3,S]methiomne was 
used as a label, this 30K to 40K material could 
only be seen upon longer exposures Since both 
fragments produced by cleavage at this site 
contain methionine, we conclude that ASP247-
Pro24B is a very weak acid cleavage site 
The conclusions with respect to the structure 
of the various polyproteins are summanzed in 
the schematic drawing in Fig 8 Although very 
small differences would not be detected by our 
gel system, the three gag precursors appear to 
be identical at their carboxy termini, whereas at 
or near the amino terminus, Рг75к"* and 
gPrSO*"* contain 7K of amino acid sequences 
which are not present in VTW" Presumably 
these additional sequences contain the signal for 
glycosylation that PröS*"'1 lacks Although the 
7K sequence need not be contiguous, we have 
tentatively placed it as a leader A companson of 
fragments labeled with different radioactive ami-
no acids showed that the 7K leader sequence is 
rich in cysteine and contains at least one (and 
probably no more than one) methionine located 
very near or at the ammo terminus The absence 
of a more internally located methionine (in par-
ticular at the Ieader-pl5 junction) would have 
important implications for the structure of the 
mRNA encoding PrtS*"* and gPrSO«''* Pr65g°g 
and Pr75*"* are synthesized independently (7) 
To dale, it is unclear whether one or two mes-
sengers are used for this synthesis The nucleo-
tide sequence of M-MuLV (30) suggests that the 
synthesis of Pr75t"ir requires splicing of genomic 
RNA A companson of the translational efficien-
cy of virion RNA and polysomal RNA (unpub-
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FIG 8 Schemat ic drawing o f the structure of g lycosylated and unglycosylated gag precursor proteins and 
their respect ive read-through products into the adjacent pot gene Map coordinates are as defined in the legends 
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lished data) suggests that synthesis of PrfSS*"* 
may require a splice event as well. Where splic­
ing (if any) of the PrtSS*0* message would simply 
involve removal of upstream sequences 
(ATGs9), splicing of the Pr75*w message would 
be required to bring an open reading frame 
encoding the 7K leader sequence in phase with 
the reading frame of Рг658"? Since the initiating 
ATG of Pr65*°r is preceded by an in-phase open 
reading frame, it has been suggested (30) that the 
splice event(s) which generates the PrTS*"* mes­
sage also involves these upstream sequences. 
However, if this were the case, one would 
expect the initiating methionine of PröS*"* to be 
present at the leader-pl5 junction Although we 
cannot entirely exclude the possibility that this 
methionine is indeed present when it is unusual-
ly resistant to cyanogen bromide cleavage, we 
believe it to be replaced by the leader sequence 
along with additional pi 5 sequences The latter 
suggestion is based on preliminary evidence 
from limited proteolysis experiments When 
[3SS]methionine-labeled ammo-terminal hydrox-
ylamine fragments of PTIS*"* (30K and 36K) and 
gPreO""' (ЗЭК and 39K) were subjected to limit­
ed trypsin digestion, the two most sensitive sites 
were found to be located in the pi 2 domain. No 
cleavage occurred at a position equivalent to the 
Lys3o-Lys3|-Arg32-Argj3 sequence at approxi­
mately 3K to 4K from the amino terminus of 
pi 5 Limited trypsin cleavage of the [35S]me-
thionine-labeled 29K ammo-terminal hydroxyl-
amme fragment of РгбЗ*0* (the 23K fragment 
cannot be labeled with methionine) did produce 
a single fragment of approximately 26K, sug­
gesting cleavage at the Lys-Lys-Arg-Arg se­
quence, but, unfortunately, one of the cleavage 
sites in pi 2 is located such that it would also 
produce a 26K fragment. We therefore cannot 
exclude the possibility that the Lys-Lys-Arg-
Arg sequence is in fact present in all three gag 
precursor proteins but is unsusceptible to tryp­
sin cleavage due to modification by the hydrox-
ylamine treatment. This would then leave us 
with two examples of specifically blocked poten­
tial cleavage sites, whereas similar sites in the 
same molecule are highly susceptible to cleav­
age. We therefore propose a splicing pattern for 
the PrTS""* message by which a minimum of 3K 
of the amino-terminal pl5 sequences is replaced 
by the protein leader sequence Since an acid 
cleavage site is found at map coordinate 13 in all 
three precursor proteins, the maximum size of 
the replaced sequences would be 13K. Conse­
quently, the size of the leader would be between 
10K (7K plus 3K) and 20K (7K plus 13K) The 
nucleotide sequence preceding nucleotide 745 
(numbering from reference 30) fits the consensus 
sequence for acceptor sites rather well, and 
splicing at this point would accommodate the 
above-mentioned properties of gPrSO*"* and 
PrW* 
We showed that gPreO*"* contains three sepa­
rate groups of carbohydrates, each of which 
contributes approximately 3K to the apparent 
molecular weight of gPr80*a* on SDS gels Two 
of these groups are attached to the p30 domain; 
the third group is attached to the protein leader 
sequence or the 13K amino-terminal pl5 se­
quence If a splice event indeed occurs between 
nucleotides 744 and 745, the only glycosylation 
sequence present in pl5 (As^^Gln^-Se^) 
would be removed by it In that case the leader 
sequence would have to include at least one 
sequence of the general type Asn-X-Ser/Thr to 
allow for the attachment of this amino-terminal 
carbohydrate group. 
Of the two carbohydrate groups attached to 
the p30 domain, one is located between coordi­
nates 47 and 49, and the other is between 
coordinates 49 and 57. Since the amino acid 
sequence of M-MuLV places these coordinates 
at А5рз
в
г-Ргоз
в
з/А5рзв5-Ргоз86, Меіз,,,, and 
МеІ47з, respectively, we find only one Asn resi­
due in each of these two regions as part of the 
sequence which is believed (32) to be required 
(but not sufficient) for glycosylation. One is 
Asn)91, the other is Asn^ 
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Glycosylation of Asn}.,, has also been report-
ed by Schultz et al (27), who studied the struc-
ture of gPreO»·"* of R-MuLV Their proposed 
structure is in fact very similar to the one we 
present here for M-MuLV Both contain a 6K to 
7K leader sequence at or near the ammo termi-
nus and have carbohydrates attached to the 
leader sequence or the amino-terminal region of 
pl5 and to Asnjçi in the p30 domain However, 
the third carbohydrate group which we find to 
be attached to Asn473 of M MuLV gPrSO*"*, is 
not present in R-MuLV The determined amino 
acid sequences show that Asn^! of M-MuLV is 
replaced by a serine residue in R-MuLV (11) 
Thus, we showed that the ammo acid change of 
Ser473 in R-MuLV to Asn471 in M-MuLV, which 
introduces a potential glycosylation site, actual-
ly results in the attachment of an additional 
carbohydrate group 
On the basis of V8 protease cleavage frag-
ments, Edwards and Fan (8) have proposed a 
structure of gPrSO*"* of M MuLV which agrees 
with the one proposed m the present report with 
respect to the location of the additional protein 
sequences in gPreO*"* and, hence, the carboxy-
termmal identity of РгбЗ*"", Pr75'"",, and 
gPrSO*"* The attachment of carbohydrates, 
however, was confined in the previous report to 
a region which almost entirely excludes the 
regions which we believe to be glycosylated In 
addition, their estimate of the size of the leader 
sequence was 4K as opposed to 7K in our 
measurements Although the latter difference 
may seem trivial, we believe it to be the main 
reason for the difference in assignment of glyco­
sylation sites V8 protease generates ammo-
termmal fragments from Pr65s"* which are 10K 
smaller than their gPr8(F"s counterparts, where­
as internal fragments of Ртб "" and gPr80*w 
differ by 6K Using their estimate of 4K for the 
leader sequence, Edwards and Fan concluded 
that both sets of fragments contain the same 6K 
of carbohydrates, attached to the region held in 
common In our interpretation the 10K differ­
ence consists of a 7K protein leader and 3K of 
amino-terminal carbohydrates, whereas the 6K 
difference represents the glycosylation of the 
p30 domain (two groups of 3K each) V8 frag­
ments larger than 55К do not quite fit our 
proposed model, but this might be due to (he 
relative inaccuracy of size estimates in this 
molecular weight range Thus, when 7K is taken 
as the size of the leader, the actual V8 cleavage 
map shown by Edwards and Fan (8) is not in 
conflict with the structure which we propose 
here, but the reason for the different estimates of 
the size of the leader sequence remains undeter­
mined 
By means of tryptic peptide mapping, Kop-
chick et al (14) found that gPrSO*"" contains two 
J VlROl 
peptides that are not found in PrbS""" but are 
shared with all gag-pol and pot intermediates 
The authors therefore proposed that gPrSC·"" 
contains a carboxy terminal extension into the 
pol gene We discussed above that a carboxy-
terminal extension may have been masked in our 
analyses by the presence of a cleavage site near 
the junction, although it seems highly unlikely 
that such an extension would go undetected in 
all of the cleavage methods used by us and 
others Since Kopchick et al have suggested 
that the extension which they propose is part of 
the pol sequences, we can more specifically 
check this sequence for the presence of cleavage 
sites The DNA sequence is not conclusive in 
this respect because the mechanism by which 
read-through occurs is not known However, the 
presence of a hydroxylamme cleavage site in the 
carboxy-termmal extension near the gag-pol 
junction would produce a pl5-related hydroxyl­
amme cleavage fragment from PrlSO''"'"'"' 
which would comigrate with PrtS""* Likewise, 
P r l W * ""' and gPrtOO*"* ""' would produce frag­
ments comigratmg with Рг75*"* and gPrSO4""*, 
respectively Figure 7 clearly shows that such 
fragments are not found The model proposed by 
Kopchick et al is therefore in conflict with our 
findings As for gPr200sas'"'', this discrepancy 
could be resolved by assuming that the two 
peptides unique to gPrSO*"* and the gag-pol and 
pol intermediates represent sequences also pre­
sent in PróS*·"'· but with an altered mobility due 
to glycosylation It remains unclear, however, 
why these peptides should also be found in pol 
intermediates which lack all other £u#-specific 
peptides Alternatively, the two peptides might 
be denved from the protein leader sequence in 
gPrSO*"* and gPrtOO'·'"""'' In that case one 
would have to postulate that the pol intermedi-
ates which lack the ga#-specific peptides are in 
fact primary translation products of a messenger 
in which the leader sequences of gPrôOO""* ^ ' 
are (aberrantly) spliced directly onto the pol 
sequences Expenmental data on the kinetics of 
biosynthesis of these pol intermediates are insuf-
ficient to allow us to choose any of these alterna-
tives Kopchick et al (14) also found two tyro-
sine-labeled, рЗО-specific tryptic peptides 
present in РгбЗ*"" but missing from gPr80í""í 
Schultz et al (27) suggested that this might be 
due to glycosylation since they found that the 
single glycosylated sequence in the p30 domain 
of R-MuLV gPrSO*"* is found in a tryptic digest 
as two (overlapping) peptides Because these 
peptides, which include Met394, also contain two 
tyrosines, it was expected that they would be 
prominent in a tyrosine labeling and that glyco-
sylation might cause unrelarded flow through 
the ion-exchange column, thus explaining their 
apparent absence from gPreO*"* However, the 
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observation by Kopchick et al was not made 
with ion-exchange chromatography but with 
two-dimensional peptide mapping In fact, ion-
exchange chromatography of methionine-la-
beled peptides showed no difference at all be­
tween Ргб "* and gPrStr"' In addition. Schultz 
et al reported (27 28) that on two-dimensional 
maps, the peptides containing Metv« (whether 
glycosylated or not) do not move from the ongin 
in either dimension It seems striking that the 
different experimental conditions used by Kop­
chick et al (reduced rather than oxidized pep­
tides and a slightly different solvent system) 
would result in such an improved resolution of 
these two peptides Two-dimensional maps of 
methionme-labeled peptides would have easily 
clarified this point, but as yet the nature of the 
p30 peptides present in PröS""'' and missing from 
gPrSO*"4 remains obscure 
Finally, in the context of the multiple expres-
sion of the gag gene, we wish to point out two 
minor proteins which in Fig 1 have been desig-
nated P77 and P82 Hydroxylamine cleavage of 
Pr75*w and P77 yielded identical C-terminal 
fragments, whereas the N-terminal fragments 
differed by 2 5K (data not shown) A similar 
result was obtained with gPrSO*"* and P82 P77 
is found both in vivo and in vitro and therefore 
cannot be a partially glycosylated variant of 
PrlS1""1 It is more likely that P77 and P82 
contain additional ammo acid sequences, possi-
bly as part of a leader sequence which is 2 5K 
larger than the one in Рг75,'ад and gPrSO*"* The 
extra 2 5K sequence probably does not repre­
sent an amino-terminal signal which would nor­
mally be removed to yield Pr75''"fi and gPrSO""4, 
because Pr75*"'' and P77 are found simulta­
neously both in vivo (with tunicamycin) and in 
vitro From experiments with the env precursor 
of M-MuLV (to be published elsewhere) we 
know that such a signal is either removed quanti­
tatively (in vivo with and without tunicamycin) 
or not at all (in a reticulocyte cell-free system) 
Possibly the 2 5K sequence is a result of aber­
rant splicing of the Pr75i·"* and gPrSO*"* mRNA 
Alternatively, P77 and P82 might be encoded by 
a contaminating virus Such a virus would have 
to be virtually identical to M-MuLV in its gag 
sequences since a number of viruses closely 
related to M-MuLV all yield a unique hydroxyl­
amine cleavage pattern (to be published else­
where) Clearly, more experiments need to be 
done to elucidate the origin of P77 and P82 
This report shows that all three gag precur­
sors can be found as part of a read-through 
product into the pol gene One of these, desig­
nated gPrtOO*'""'"', is glycosylated and repre­
sents the read-through product of gPrSO*"* In 
addition to the carbohydrates attached to the 
gPrSO*"* part, gP^OO*"* ^' contains at least one 
carbohydrate group in its pol sequences. Al­
though glycosylation of gag-pol precursors has 
been observed before (9, R Arlmghaus and H 
Fan, personal communication), this is the first 
report of glycosylation of actual pol sequences 
We confined the glycosylation site(s) (or one of 
them) in the pol gene to the 26K carboxy-
terminal region Peptide mapping (14) oí gag-pol 
precursors of R-MuLV indicates that this region 
is probably not part of the mature reverse tran-
scriptase Our assignment of the glycosylation 
site in the pol gene was based on a 26K (29K 
when glycosylated) methionme-labeled carboxy-
terminal hydroxylamine fragment The proposed 
reading frame of the DNA sequence (30) is in 
excellent agreement with a number of features of 
this fragment Indeed, an Asn-Gly bond is pre-
dicted (nucleotides 5,163 to 5,168) at approxi-
mately 26K from the carboxy terminus of Ihepol 
open reading frame The proposed reading frame 
also predicts the presence in this fragment of 
two methionines (nucleotides 5,274 to 5,276 and 
5,457 to 5,459) and a single glycosylation se-
quence, Asn-Arg-Thr (nucleotides 5,277 to 
5,285) In disagreement with the DNA sequence 
would be our finding that a second hydroxyl-
amine cleavage site may be present in pol at 
about 50K. from the carboxy terminus 
The possible significance of glycosylated gag 
gene products has been the subject of specula-
tion. but, to our knowledge, a possible role in 
determining the tropism of the virus has not 
been proposed Rommeleare et al (26) have 
sequenced oligonucleotides of N-, B-, and NB-
tropic M-MuLVs which appear to be associated 
with the tropism The nucleotide sequence of M-
MuLV (30) contains a sequence (in the p30 
domain) which is identical to the sequence 
shared by all three oligonucleotides Using the 
reading frame of M-MuLV, the oligonucleotide 
of NB-tropic BALB/c virus encodes a potential 
glycosylation site (Asn-Tyr-Thr), whereas the 
N- and B-tropic oligonucleotides do not If addi-
tional glycosylation is indeed relevant to the 
NB-tropism, we speculate that the number of 
sites rather than their exact location determines 
the NB-tropic phenotype, because the sequence 
characteristic for the tropism of the BALB/c 
viruses is not glycosylated in M-MuLV, which 
nevertheless is NB-tropic When glycosylation 
is the mechanism by which the tropism determi-
nant is lost in NB-tropic viruses, it must be 
assumed that glycosylated рЗО-related proteins 
are present in the virion (for a review of Fv-1 
restriction, see reference 12) Such proteins 
have not, to our knowledge, been found in 
virions, but they might still be present in small 
amounts Alternatively, according to our inter­
pretation of the literature, it has not been ruled 
out that the viral tropism determinant is not 
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present in the virion as such but as a packaged 
mRNA encoding it Interestingly, the so-called 
abrogation phenomenon, i.e , the capability of a 
coinfccting virus with the same tropism to can-
cel the Fv-1 restriction, has been shown to 
reside in the translational activity of less than 
one-half of the genome (or packaged mRNA) 
rather than in the virion proteins (3). It seems 
tempting to postulate that the tropism determi-
nant is complexed with reverse transcriptase or 
perhaps with another po/-encoded enzymatic 
activity, because reverse transcriptase activity 
is enhanced by p30 binding (1) and the key event 
in Fv-1 restriction is at the level of cDNA 
synthesis or subsequent circulanzation (13). A 
convenient source for a complex between pol 
gene products and glycosylated p30 sequences 
would be gPrôOO*"4""'', which might be present 
in the virion in small amounts or synthesized de 
novo from packaged mRNA upon infection. 
Obviously, many questions remain unan-
swered with respect to the possible role of 
glycosylation in the action of the Fv-1 gene 
product. The study of a recently constructed 
recombinant virus which is incapable of synthe-
sizing glycosylated gag and gag-pol polypro-
tems (H Fan, personal communication) will, we 
hope, elucidate the biological significance (if 
any) of these proteins 
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SUMMARY 
Retroviruses have been studied for decades, because they Induce 
tumors 1n many animal species. In recent years, considerable progress has 
been made 1n understanding the mechanisms of retroviral tumor1genes1s. In 
an unexpected way, this work has contributed to our understanding of human 
cancer, where retroviruses rarely are directly Involved. The study of 
retroviruses has led to the discovery of a set of normal cellular genes 
called proto-oncogenes, which can be activated 1n a number of ways by 
these viruses. It was subsequently found that, 1n many human tumors, one 
or more of these proto-oncogenes turned out to be activated by non-v1ral 
mechanisms, such as point mutation, translocation and amplification. 
Retroviruses are divided into two major categories by their mode of 
proto-oncogene activation: the acute viruses, which carry an oncogene In 
their genome (transduction); and the non-acute viruses which transform 
only those cells in which proviral Integration into the cellular genome 
has occurred In the vicinity of a resident proto-oncogene 
(promoter/enhancer-insertion). 
Moloney Murine Leukemia Virus (MuMoLV), the main subject of this 
thesis, 1s a prototype of the non-acute viruses. At the time we Initiated 
our studies, little was known about this virus, nor Its mechanism of 
transformation. In particular, it was not yet excluded that non-acute 
viruses contain a distinct gene responsable for transformation, as had 
been shown for the prototype acute virus RSV. In addition, we had 
obtained some preliminary evidence that the 3' end of the MoMuLV genome 
might encode an until then unidentified protein. 
In Chapter II, we describe the development of an experimental method 
that would enable us to Identify a transforming gene. High resolution 
size fractionation of RNA was combined with a blotting procedure that 
Involves non-covalent binding to a newly developed solid support (modified 
ECTEOLA ion-exchange paper) and subsequent In vitro translation to reveal 
any coding potential. When, during the course of this work, MoMuLV was 
molecularly cloned and sequenced. It became dear that this virus does not 
encode the kind of protein we had anticipated; and we focussed our efforts 
on developing this method Into a generally applicable technique. We show 
how any highly purified species of RNA can be rapidly Isolated and Its 
coding potential assessed by In situ translation (i.e. in vitro 
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translation of RNA still bound to the solid support). Later we found that 
1n situ reverse transcription was also possible as a first step In cDNA 
cloning. 
A second major aspect of MoMuLV gene expression studied was the 
multiple expression of the gag-gene. The gag-gene encodes a precursor 
protein which, upon proteolytic cleavage, yields the major structural 
proteins of the virus particle. Alternatively, gag sequences are 
expressed as a glycosylated polyprotein which Is expressed on the surface 
of the Infected cell. We decided to study this molecule in more detail 
because In some mouse strains, an endogeneous virus (AKR) resembling 
MoMuLV causes a high incidence of leukemia; and the onset of disease 
coincides with the appearance of this glycosylated gag antigen (also 
called GCSA). In order to determine the precise structure of the two gag-
gene products, we developed a number of chemical cleavage methods that can 
be applied to small amounts of protein. Chapter III describes the details 
of these methods and how they can be used to answer a variety of questions 
regarding protein structure. 
Finally, 1n Chapter IV we show how these methods were applied to the 
structural analysis of the gag proteins. We found that glycosylated gag 
(gPrSO9*9) differs from the precursor of the structural proteins (Pr65 9 a 9) 
by the attachment of three separate carbohydrate groups, and by the 
presence of an additional 7 kD of protein sequence at the ami no-terminus. 
We also show that both Pr65 9 a 9 and дРг О 9 3 9 can be read through Into the 
pol-gene to yield Prl80 9 a 9" p o 1 and gPr200 9 a 9"P o 1. Analysis of gPr200 9 a 9' 
p o 1
 Indicated, for the first time, that at least one of the carbohydrate 
groups in this molecule 1s attached to the pol sequences. Mutants 
Incapable of synthesizing glycosylated gag (and consequently, as this 
thesis shows, glycosylated poi) are Identical to wild-type virus for the 
parameters tested (replication, leukemogenldty). The significance of 
glycosylatlon of gag- and pol-gene products therefore remains unclear. 
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SAMENVATTING 
Retrovirussen worden al gedurende tientallen jaren bestudeerd omdat 
zij In een groot aantal diersoorten tumoren kunnen veroorzaken. De 
laatste jaren is ons Inzicht in de mechanismen van retrovirale 
tumoMgenese aanzienlijk toegenomen. Zo Is gevonden dat een groep normale 
cellulaire genen, proto-oncogenen genoemd, op een aantal verschillende 
manieren door deze virussen geactiveerd kan worden. Deze ontdekking 
leidde ook tot een beter inzicht 1n kanker bij de mens. Hoewel 
retrovirussen slechts in zeldzame gevallen direct betrokken zijn bij het 
ontstaan van humane kanker, blijken 1n vele menselijke tumoren een of meer 
van de bovengenoemde proto-oncogenen geactiveerd te zijn; niet door 
virussen, maar via mechanismen als punt-mutat1e, translocatie en 
amplificatie. 
Retrovirussen kunnen onderschelden worden naar de wijze waarop zij 
proto-oncogenen activeren: de acute virussen die zelf een (reeds 
geactiveerd) oncogen in hun genoom meedragen (transductie), en de n1et-
acute virussen die alleen die cellen transformeren waar provirale 
integratie In het cellulaire DNA heeft plaats gevonden 1n de nabijheid van 
een daar gelegen proto-oncogen dat hierdoor oncogeen wordt 
(promoter/enhancer-lnsertie). 
Moloney muize-leukemievlrus (MoMuLV), het onderwerp van dit 
proefschrift, Is een proto-type van de ni et-acute virussen. Op het moment 
dat de hier beschreven studies begonnen werden, was er nog weinig bekend 
van dit virus, en al helemaal niets over de wijze waarop het kanker 
verwekte. Zo was het allerminst uitgesloten dat ook de niet-acute 
virussen (evenals de acute virussen, zoals reeds was aangetoond voor het 
proto-type RSV) zelf een transformerend gen bevatten. Bovendien meenden 
wij aanwijzingen te hebben dat het 3' gedeelte van het MoMuLV genoom een 
eiwit codeerde dat nog niet eerder gevonden was. 
In Hoofdstuk II, wordt beschreven hoe we een methode ontwikkelden die 
ons in staat zou stellen bovengenoemde aanwijzingen verder uit te werken. 
In deze procedure, wordt RNA eerst op grootte gescheiden, vervolgens 
overgeblot op een nieuw soort vaste drager (gemodificeerd ECTEOLA ionen-
wisselaarpapler) en tenslotte In vitro vertaald om eventuele eiwit-
coderende sequenties aan te tonen. Toen echter, In de loop van deze 
voorbereidingen, uit de literatuur duidelijk werd dat MoMuLV niet zelf het 
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soort eiwit codeert waarnaar wij op zoek waren, richtten w1J onze aandacht 
op het verder ontwikkelen van de blotting techniek zodat deze algemeen 
toepasbaar zou zijn. De resulterende procedure beschrijft een snelle 
isolatie van hooggezuiverde RNA fracties waarvan vervolgens eiwit-
coderende sequenties vertaald worden In situ (d.w.ζ. In vitro vertaling 
van RNA dat nog aan de vaste drager gebonden 1s). Later, vonden we dat 
reverse transcriptie van ECTEOLA-gebonden RNA toepasbaar was 1n cDNA-
cloneMng. 
Het tweede onderwerp van dit proefschrift is de meervoudige expressie 
van het gag-gen van MoMuLV. Het was bekend dat gag de precursor van de 
structurele virus-eiwitten codeert. Daarnaast, worden de gag-sequenties 
tot expressie gebracht in een geglycosyleerd poly-proteine dat op het 
oppervlak van de geïnfecteerde cel voorkomt. In sonnige muize-stammen, 
veroorzaakt een op MoMuLV lijkend endogeen virus (AKR) het veelvuldig 
optreden van leukemie. Het zichtbaar worden van de eerste 
ziekteverschijnselen valt daar samen met het opkomen van een antigeen (ook 
wel GCSA genoemd) dat later identiek bleek te zijn aan het geglycosyleerde 
gag eiwit van het AKR virus. Deze observatie was voor ons aanleiding om 
deze antigenen in detail te bestuderen. Om de precieze structuur van de 
twee gag-gen producten op te helderen hebben wij een aantal eiwit-
chemische splitsingstechnieken uitgewerkt zodat deze toepasbaar zouden 
zijn op eiwitten die alleen 1n kleine hoeveelheden verkregen kunnen 
worden. In Hoofdstuk III, worden de details van deze methoden beschreven 
en laten we zien hoe deze toegepast kunnen worden om diverse problemen 
betreffende eiwit-structuur op te lossen. 
Tenslotte, wordt in Hoofdstuk IV getoond hoe deze technieken zijn 
toegepast bij de structuur-analyse van de gag eiwitten. Uit deze analyse 
kwam naar voren welke de verschillen zijn tussen de geglycosyleerde gag 
(gPr809a9) en de precursor van de structurele eiwitten (Pr659a9). De 
carbohydraten van gPr809a9 zijn aangehecht als drie afzonderlijke groepen 
en verder bevat gPr809a9 een extra aminotermlnale eiwit sequentie van 7 kD 
die niet voorkomt 1n Pr659a9. We konden ook bewijzen dat zowel Pr659a9 
als gPr809a9 doorgelezen kunnen worden in het pol-gen, hetgeen 
respectievelijk Prl809a9"Po1 en gPr2009a9"po1 oplevert. Onze analyse van 
gPr2009a9"po1 toonde (voor het eerst) aan dat van de sulkergroepen 1n dit 
molecuul, er tenminste een 1s aangehecht in het pol-gedeelte. Mutanten 
die geen geglycosyleerde gag kunnen maken (en daardoor, zoals 1n dit 
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proefschrift wordt aangetoond, ook geen geglycosyleerde pol) blijken zich 
Identiek te gedragen aan wild-type virus, althans wat betreft die 
eigenschappen die getest zijn (replicatie, leukemogenese). Het 1s daarom 
nog steeds niet duidelijk wat het belang is van de geglycosyleerde gag- en 
pol-eiw1tten. 
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STELLINGEN 
I 
De structuur van retrovirale vectoren geeft aan dat bij de 
constructie ervan geen rekening is gehouden met de mogelijk 
storende werking van het gPr808a8 initiatie codon op de ex-
pressie van het te inserieren gen. 
Dit proefschrift, hoofdstuk I en IV. 
II 
Peptide-antisera die wel het peptide maar niet een bepaald 
eiwit herkennen bewijzen nog niet dat deze peptide sequentie 
niet in dat eiwit voorkomt. 
Wawrousek, E.F. and J. Piatigorsky (1987) Gene 58, 
155-165. 
III 
De frequente aanwezigheid van cellen met bepaalde provlraal ge-
activeerde genen in oligoclonale primaire virus-geinduceerde 
tumoren en het daarop veelvuldig verdwijnen van deze cellen 
tijdens tumor progressie ondersteunt de gedachte dat intercel-
lulaire communicatie een belangrijk aspect is van tumorigenese. 
IV 
Bij het zoeken naar een ligand voor transmembraan receptoren 
betrokken bij de verwerking van positie-informatie zoals bij-
voorbeeld tijdens de embryogenese, moet behalve aan gradiënt-
vormende, diffundeerbare factoren ook gedacht worden aan mole-
culen op het oppervlak van intacte cellen. 
Hafen, E., К. Basler, J.E. Edstroem and G.M. Rubin 
(1987) Science 236, 55-63. 
ν 
Het onevenredig veel voorkomen van upstream AUG codons in proto-
oncogen messenger RNA's doet vermoeden dat de relatieve efficiën-
tie waarmee deze codons eiwitsynthese initiëren niet onder alle 
omstandigheden constant is en daardoor kan fungeren als onderdeel 
van signaal transductie. 
Kozak, M. (1987) Nucl. Acids Res. 15, 8125-8148. 
VI 
Omdat veel geactiveerde oncogenen alleen een phenotype hebben 
(d.w.z. noch neutraal noch lethaal zijn) in een specifieke 
cellulaire omgeving, is gezien het tot nu gebruikte beperkte 
arsenaal aan transformatie-essay systemen te verwachten dat de 
meeste oncogenen nog ontdekt moeten worden. 
VII 
De kwaliteit van het leven ven terminale kanker patiënten is 
alleen gebaat bij verdere medische behandeling als deze een 
menselijke stervensbegeleiding niet in de weg staat. 
VIII 
Een genetisch paspoort zal in Nederland nog wel even op zich 
laten wachten als het ook nog fraude-bestendig moet zijn. 
IX 
Nonsense suppressie is nog weinig aangetoond bij de mens. 
29 april 1988 Chris Saris 


